Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.7687091563283445,-2.324758285355406,0.0,0.0,0.0,7/22,8.28%,ALDH1A2;RBP1;PTGDS;RBP4;CYP26B1;ABCA4;CRABP2
prerank,I-SMAD binding (GO:0070411),-0.7726542804054894,-2.069548038831283,0.0,0.00896271721772744,0.017,5/13,4.03%,SMAD6;CTNNB1;SMAD7;SMAD9;TGFBR1
prerank,insulin-like growth factor I binding (GO:0031994),-0.7075975901954266,-1.9047752299719578,0.0,0.072033690231365,0.178,6/13,5.85%,IGF1R;IGFBP2;IGFBP3;ITGA6;IGFBP5;INSR
prerank,voltage-gated ion channel activity (GO:0005244),0.8135347595895972,1.7994816534604616,0.002894356005788712,0.7349898426424859,0.445,5/14,6.77%,KCNK15;CACNA1E;VDAC2;ANO6;KCND2
prerank,serine-type peptidase activity (GO:0008236),0.5943273478421999,1.787810495636399,0.0,0.4430967375603543,0.504,13/96,7.59%,HGFAC;KLK12;MMP2;FAP;HTRA3;CORIN;PARL;HTRA1;NAALAD2;PCSK4;PCSK6;KLK1;KLK6
prerank,neuropeptide receptor activity (GO:0008188),0.6892077126345042,1.7707530205029327,0.0,0.3835164982725778,0.594,4/29,2.34%,SSTR1;SORCS2;SORCS1;SORCS3
prerank,insulin-like growth factor binding (GO:0005520),-0.6373661755792472,-1.7684154879119218,0.0,0.24572783038602738,0.589,6/15,5.85%,IGF1R;IGFBP2;IGFBP3;ITGA6;IGFBP5;INSR
prerank,ligand-gated ion channel activity (GO:0015276),0.6712548003187361,1.7528246828385623,0.004944375772558714,0.37750840691582727,0.703,12/30,14.38%,GRIA1;GRIK3;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRID2;GRIK1;ANXA6;GRIN2D;GRIN2A
prerank,ligand-gated channel activity (GO:0022834),0.6739267688415197,1.7519679197165765,0.0050062578222778474,0.3052110409229288,0.708,12/29,14.38%,GRIA1;GRIK3;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRID2;GRIK1;ANXA6;GRIN2D;GRIN2A
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.45291125696210843,-1.7303630868151538,0.0,0.27704754777464163,0.716,19/55,14.60%,SLC7A2;SLC13A3;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC38A11;SLC16A11;PDPN;SLC38A7;SLC16A2;SLC6A11;SLC38A5;SLC16A9;SLC38A10;SLC36A4
prerank,serine-type endopeptidase activity (GO:0004252),0.5823345133516198,1.7153703640642923,0.0,0.41756234929416436,0.87,10/80,7.59%,HGFAC;KLK12;MMP2;FAP;CORIN;PARL;PCSK4;PCSK6;KLK1;KLK6
prerank,solute:anion antiporter activity (GO:0140323),-0.6342596950152377,-1.7148709706584926,0.011661807580174927,0.2653960153915959,0.758,4/14,8.07%,SLC7A11;SLC26A7;SLC26A2;SLC4A3
prerank,acetylcholine receptor activity (GO:0015464),0.6922013711969837,1.7000355825760944,0.008021390374331552,0.4344422250107493,0.905,3/22,4.08%,CHRM3;ANXA9;CHRNA4
prerank,pyridoxal phosphate binding (GO:0030170),0.7094051597640155,1.6996304029343106,0.005547850208044383,0.3822648125732548,0.905,9/20,13.39%,PYGL;CTH;CBS;PDXK;PSAT1;PNPO;PLPBP;OAT;SRR
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7201254308556465,1.689368488471444,0.012448132780082987,0.38140254020261,0.924,9/17,14.38%,GRIA1;GRIK3;GRIA3;GRIN2B;GRIK5;GRIK2;GRIK1;GRIN2D;GRIN2A
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.671904207904734,1.6628350142571051,0.012178619756427604,0.4648260013006022,0.972,8/23,8.71%,RAG2;PLEKHA4;PLEKHA5;SESTD1;WIPI1;MAPKAP1;GBF1;HIP1
prerank,lipoprotein particle receptor binding (GO:0070325),0.6495335782370891,1.6555114679883758,0.00522875816993464,0.46034724228920626,0.983,5/27,8.86%,RELN;HSPG2;LRP1;SYT1;ANKRA2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5842573070114494,-1.6386384714059514,0.020895522388059702,0.439742205079294,0.93,5/15,10.36%,SLC26A7;SLC26A2;SLC4A3;SLC39A8;SLC4A8
prerank,tau-protein kinase activity (GO:0050321),-0.5387042457417717,-1.6317842777567044,0.017006802721088437,0.40842604432449636,0.943,8/20,10.39%,ROCK2;SIK3;MARK1;ROCK1;TTBK2;GSK3B;GSK3A;MARK2
prerank,ephrin receptor binding (GO:0046875),0.66848846280368,1.6200070448717452,0.019151846785225718,0.6166638211998151,1.0,13/21,19.23%,EFNA4;EFNA5;CHN1;ANKS1B;FYN;PTPN1;CBL;EFNB1;ANKS1A;EFNB3;ABL1;EFNB2;GRB2
prerank,NAD binding (GO:0051287),-0.4979950646874149,-1.6124761521065396,0.00851063829787234,0.42113705840334126,0.964,11/26,16.85%,ALDH1A1;ZC3HAV1;CRYL1;ME1;ALDH2;SIRT3;SORD;BDH2;HPGD;NNT;QDPR
prerank,steroid hydroxylase activity (GO:0008395),0.6896773779352734,1.6089649496086005,0.01971830985915493,0.6387063273099449,1.0,5/16,14.24%,CYP2S1;CYP39A1;CYP1B1;CYP7B1;CYP27A1
prerank,alpha-tubulin binding (GO:0043014),0.5923364739085821,1.5944182803640308,0.025252525252525252,0.6845647901840437,1.0,13/31,16.43%,DLEC1;EFHC1;TBCE;FYN;PACRG;SETD2;HDAC6;CDK5R1;ARL8A;TRAPPC14;SNCA;WASHC1;DIP2B
prerank,transcription corepressor binding (GO:0001222),0.6267868063043561,1.5936223291070897,0.02540106951871658,0.6430660448842024,1.0,9/27,14.16%,RORA;USP11;EED;ZBTB16;ESR1;HDAC6;PER3;PER1;LCOR
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.49050514601254624,-1.5844926441979175,0.022556390977443608,0.46217745119414505,0.981,9/25,16.88%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP14;SIRT4
prerank,sodium channel activity (GO:0005272),0.5884247775775352,1.5715039304381813,0.03088803088803089,0.7442523168174765,1.0,9/37,8.05%,SCN7A;SCN2A;GRIK3;KCNK1;GRIK5;GRIK2;SCN5A;SCN3A;GRIK1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6307675709587663,-1.56903941271617,0.03804347826086957,0.46778141276765345,0.991,7/10,18.41%,SHANK3;SHISA6;NSF;SHANK2;SQSTM1;GNAS;SHISA7
prerank,chemoattractant activity (GO:0042056),0.6153649485953376,1.5675987168180354,0.029216467463479414,0.7246229399092694,1.0,5/26,3.14%,LGALS3;CXCL10;FGF2;FGF10;VEGFA
prerank,potassium channel regulator activity (GO:0015459),0.5611662674624381,1.5602408782540422,0.015046296296296295,0.7307619265025505,1.0,15/49,14.35%,WNK2;SLC5A3;WNK3;RASA1;DPP10;ENSA;KCNMB2;KCNMB3;FLNA;SGK3;SGK2;KCNAB2;KCNIP4;NEDD4L;SUMO1
prerank,telomerase RNA binding (GO:0070034),-0.5112626791749852,-1.5535858753733738,0.021897810218978103,0.4809991573513727,0.994,12/22,19.33%,XRN1;DCP2;NAF1;DKC1;SNRPD3;WRAP53;SNRPB;TERT;PINX1;EXOSC10;GAR1;TENT4B
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.5422742907458973,-1.551769688771749,0.036101083032490974,0.44874869625168673,0.994,7/17,15.21%,LBR;PTGR2;BLVRA;BDH2;DECR2;PECR;DHCR24
prerank,microtubule plus-end binding (GO:0051010),-0.518086529976743,-1.5456982214710364,0.02120141342756184,0.43590104055741075,0.994,9/20,14.34%,CLIP4;TTBK2;CLIP3;CLIP1;PAFAH1B1;DCTN1;NUMA1;STIM1;KIF18A
prerank,glutamate receptor activity (GO:0008066),0.6482657578504494,1.5430487154770747,0.032564450474898234,0.7994450683381521,1.0,8/19,13.46%,GRIA1;GRIK3;GRIK5;GRIK2;GRID2;GRIK1;GRM5;GRIN2D
prerank,sterol binding (GO:0032934),0.5450488203343887,1.5340611946969709,0.016203703703703703,0.8163994805264562,1.0,9/56,6.31%,APOD;RORA;PTCH1;VDAC2;ERLIN2;NPC1;OSBPL5;GRAMD1A;RORC
prerank,translation elongation factor activity (GO:0003746),-0.5644165951427116,-1.5322777556455196,0.038461538461538464,0.44335574503691744,0.996,9/14,16.84%,GTPBP2;GTPBP1;EEF1A1;GFM2;GFM1;EIF5AL1;EIF5A;TSFM;EEF1B2
prerank,sodium channel regulator activity (GO:0017080),0.5714013480015577,1.5248788253696273,0.026381909547738693,0.8367936128540928,1.0,12/37,16.79%,FXYD3;FGF13;FGF12;FGF14;SGK3;SGK2;FXYD6;FXYD1;NEDD4L;PKP2;GPLD1;SGK1
prerank,sodium:proton antiporter activity (GO:0015385),-0.5976825351516494,-1.522501483085319,0.04411764705882353,0.4421607160745538,0.996,6/11,11.86%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6295440118731096,-1.5212973923545798,0.056022408963585436,0.41937315399810954,0.996,4/10,5.09%,SLCO3A1;SLCO2A1;SLCO1C1;SLC22A6
prerank,protein tyrosine kinase activator activity (GO:0030296),0.636325137992442,1.5198877862934748,0.047128129602356406,0.8308462092888246,1.0,5/19,9.79%,ERBB3;EFNA5;NRG3;ALKAL2;GRM5
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7168614624180648,1.5173247781443817,0.04393939393939394,0.8125290506596798,1.0,1/11,0.09%,ROR2
prerank,transaminase activity (GO:0008483),0.712310475725993,1.5123130011890125,0.0391566265060241,0.8105499360249532,1.0,4/11,10.45%,AADAT;PSAT1;GOT2;OAT
prerank,LRR domain binding (GO:0030275),-0.545615467781157,-1.5099282047413414,0.054285714285714284,0.4272781794599323,0.997,2/14,0.37%,PAWR;ROBO1
prerank,tau protein binding (GO:0048156),-0.4203789415979412,-1.5098671140215416,0.035175879396984924,0.40515674908206506,0.997,19/40,22.87%,ROCK2;MARK1;MAP2;ROCK1;TTBK2;STUB1;GSK3B;GSK3A;MARK2;DCTN1;PPP2CB;LGMN;HSP90AA1;TAOK2;APOE;HSP90AB1;MARK3;CLU;BRSK2
prerank,intracellular chloride channel activity (GO:0061778),0.6500347637489159,1.4972254474009048,0.05286343612334802,0.8418645446616067,1.0,6/16,18.44%,ANO2;ANO6;TTYH3;TTYH1;ANO10;TTYH2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.6500347637489159,1.4972254474009048,0.05286343612334802,0.8418645446616067,1.0,6/16,18.44%,ANO2;ANO6;TTYH3;TTYH1;ANO10;TTYH2
prerank,peptidase inhibitor activity (GO:0030414),0.5579579401208627,1.486453689489461,0.04597701149425287,0.8761799895261243,1.0,5/33,6.24%,GPC3;A2M;RECK;CSTB;UCHL5
prerank,death receptor binding (GO:0005123),0.6640605046600712,1.4856929128447685,0.06142857142857143,0.8505383139142781,1.0,3/15,2.66%,EDA;NGF;FADD
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6893697809933428,1.4848455979900737,0.07441860465116279,0.8262852078565579,1.0,2/11,2.62%,SLC5A3;SLC17A5
prerank,heme binding (GO:0020037),0.5111727693205108,1.482756960962398,0.02696629213483146,0.8115262508704251,1.0,11/65,8.36%,CYP2S1;CYB561D2;STEAP4;SUOX;CBS;PXDN;PGRMC2;CYP1B1;PTGES2;SDHC;RSAD1
prerank,CXCR chemokine receptor binding (GO:0045236),0.6882101669632528,1.4785331614762083,0.06420545746388442,0.8104463018326435,1.0,2/11,12.46%,CXCL10;YARS1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3905494692650814,-1.4780013075172562,0.012121212121212121,0.46954679646205427,0.999,16/47,14.60%,SLC7A11;SLC7A2;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC38A11;PDPN;SLC38A7;SLC16A2;SLC66A1;SLC38A5;SLC6A1;SLC38A10;SLC36A4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5025692441022784,-1.4767371507626559,0.06143344709897611,0.451170855076502,0.999,7/18,13.70%,ALDH1A2;ALDH1A1;ALDH2;FAR2;ALDH3A2;ALDH9A1;ALDH18A1
prerank,ion gated channel activity (GO:0022839),0.5949527709623479,1.4751660313648003,0.04702627939142462,0.8049903653771266,1.0,7/24,13.34%,ANO2;TMEM63A;ANO6;TTYH3;TTYH1;KCNT2;ANO10
prerank,deoxyribonuclease activity (GO:0004536),0.6536291808976276,1.4747086592183778,0.06442166910688141,0.7834187002453844,1.0,4/14,5.66%,ZRANB3;MBD4;ERCC5;ERCC4
prerank,endodeoxyribonuclease activity (GO:0004520),0.6088677662541919,1.4698072676823108,0.06593406593406594,0.7865592934545951,1.0,6/20,10.47%,ZRANB3;MBD4;ERCC5;ERCC4;SETMAR;ENDOV
prerank,chemokine receptor binding (GO:0042379),0.5461339449645154,1.4698011073166974,0.06088082901554404,0.7641433907021471,1.0,4/35,9.37%,CCL11;CXCL10;CCL4;CKLF
prerank,chemokine activity (GO:0008009),0.5575662155810981,1.464036326976125,0.06982872200263504,0.774626556454382,1.0,4/31,9.37%,CCL11;CXCL10;CCL4;CKLF
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.600765121291619,1.4635388614232596,0.07333333333333333,0.7563699875606523,1.0,4/21,9.79%,GRIA1;ANXA9;CHRNA4;GRM5
prerank,microtubule minus-end binding (GO:0051011),-0.5590405126653526,-1.4592869134457063,0.07580174927113703,0.4770157274768272,0.999,7/13,16.76%,MACF1;TUBGCP4;TUBGCP3;TUBGCP6;NUMA1;HAUS7;TUBGCP2
prerank,potassium channel activity (GO:0005267),0.488446489838724,1.4566258909791623,0.02841530054644809,0.7723559546770136,1.0,17/89,10.11%,KCNK15;KCNA2;KCNH8;GRIK3;KCNK1;KCNA1;KCNA6;GRIK5;GRIK2;KCND1;KCND2;KCND3;GRIK1;KCNMB2;KCNMB3;TMEM38B;KCNT2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6941322950206035,1.4545487340599503,0.06842923794712286,0.7636438168054501,1.0,2/10,2.40%,KAT2B;CDKN2B
prerank,active ion transmembrane transporter activity (GO:0022853),-0.4097774697530546,-1.448800296715487,0.05555555555555555,0.4852856742815902,0.999,18/37,24.41%,SLCO3A1;SLC22A8;SLCO2A1;SLC22A4;SLCO1C1;COX6B1;SLC22A6;COX6A1;COX4I1;UQCR11;COX5B;COX5A;SLC16A7;UQCR10;UQCRH;SLCO5A1;UQCRFS1;UQCRC1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5652781273196652,-1.4482116309568556,0.07142857142857142,0.46730611715762244,0.999,6/12,23.08%,AOX1;SDHB;ISCA1;XDH;FXN;CIAPIN1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6477575137754179,1.4471743549599336,0.07981927710843373,0.7838806860580438,1.0,3/14,9.94%,CAPN5;CAPN1;CAPN6
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6480587683879154,1.4387740634616037,0.08482142857142858,0.8104084853646232,1.0,8/15,20.48%,KMT2A;SETD3;CXXC1;SETMAR;PRDM9;ASH2L;SETD4;KMT2D
prerank,ADP binding (GO:0043531),-0.4375891357984299,-1.436355014355886,0.053497942386831275,0.47860909942664537,1.0,8/25,15.16%,PRKAG2;MYH9;ME1;PGK1;ABCG1;ATP5F1D;MYH10;ERN1
prerank,solute:sodium symporter activity (GO:0015370),0.5474472936591972,1.4332688455745974,0.07630522088353414,0.8191984881664661,1.0,2/27,2.53%,SLC28A1;SLC5A3
prerank,symporter activity (GO:0015293),0.6667942919072863,1.4223408158942423,0.10177705977382875,0.860391284332803,1.0,1/10,0.36%,SLC28A1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5530618348535952,1.4219692415748808,0.08104575163398693,0.8430672132985785,1.0,12/29,20.04%,DUSP4;MAPK7;MAPKAPK3;MAPKAPK2;DUSP6;PTPRJ;MAPK14;PRMT1;ABL1;NBR1;DUSP16;DUSP1
prerank,platelet-derived growth factor binding (GO:0048407),0.661132608323822,1.417113442373161,0.09545454545454546,0.8515690671536571,1.0,4/11,14.62%,PDGFRA;COL3A1;COL1A2;COL1A1
prerank,cholesterol binding (GO:0015485),0.5101933744840619,1.4106646431254197,0.06324582338902147,0.8692358549507496,1.0,7/47,5.51%,APOD;PTCH1;VDAC2;ERLIN2;NPC1;OSBPL5;GRAMD1A
prerank,mechanosensitive ion channel activity (GO:0008381),0.6363026676202107,1.4062917890247895,0.106544901065449,0.8742625135612039,1.0,2/12,2.96%,PIEZO2;TMEM63A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4899669593500783,-1.4008888224021936,0.09782608695652174,0.5360295033960202,1.0,4/16,0.62%,PTPRK;PTPRM;PTPRB;PTPRG
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4899669593500783,-1.4008888224021936,0.09782608695652174,0.5360295033960202,1.0,4/16,0.62%,PTPRK;PTPRM;PTPRB;PTPRG
prerank,growth factor receptor binding (GO:0070851),0.4565225328648879,1.3988467902248087,0.035164835164835165,0.8957062864355636,1.0,19/95,11.99%,EFEMP1;PDGFRA;GLMN;FGF2;PYCARD;FGF10;VEGFA;PSEN1;ATXN2;FYN;HIP1;BTC;TRIP6;ERBB4;PTPRJ;NCSTN;ARF4;IL6ST;FGF7
prerank,phosphatase binding (GO:0019902),0.46520415081240235,1.3984144123857192,0.030851063829787233,0.8797766700662198,1.0,42/105,22.89%,LGALS3;ANK1;ERBB2;EGFR;PTPRT;EIF2AK3;MAST2;SH3YL1;SPRED1;PDLIM4;SHOC2;RCAN3;ANAPC7;PIK3R1;MAPK14;MAPK1;MAGI2;FBXL2;TBK1;PPP1R3F;HSP90B1;RPA2;CRY1;IQGAP1;MET;ELL;JUP;SYTL2;TP53;TERF2IP;VRK3;KIF3A;STX17;STAT3;CDC27;SIRPA;ANAPC4;PXN;DLG4;ANAPC5;STAT6;KIFAP3
prerank,low-density lipoprotein particle binding (GO:0030169),-0.48328957480338486,-1.3962262902484117,0.09657320872274143,0.5291204128894093,1.0,5/16,11.93%,CDH13;PLTP;THBS1;SCARF1;STAB1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5703488200550344,-1.390957934860634,0.12668463611859837,0.5259157631781447,1.0,4/10,12.23%,SLC6A12;SLC6A13;SLC6A11;SLC6A1
prerank,pentosyltransferase activity (GO:0016763),-0.39089949597750673,-1.3829805280733918,0.046296296296296294,0.53055966404051,1.0,12/36,21.08%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP14;SIRT4;QTRT2;QPRT;LARGE1
prerank,potassium:proton antiporter activity (GO:0015386),-0.5645331262306132,-1.3828819319652617,0.12,0.5137339560784847,1.0,5/10,11.86%,SLC9A6;SLC9A2;SLC9A8;SLC9A9;SLC9A7
prerank,methylation-dependent protein binding (GO:0140034),0.4789727318652267,1.3752705265482679,0.07727797001153403,0.9934779597810843,1.0,18/57,18.96%,RAG2;LRWD1;KDM8;CXXC1;KAT8;SPIN1;ATRX;MBTD1;CDYL;MSH6;ING4;PHF8;MSL3;PYGO1;PHF19;ING1;ZMYND11;KMT2E
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5443200721948142,1.3736212635059484,0.11473272490221642,0.9827941596802274,1.0,7/25,8.71%,RAG2;PLEKHA4;SESTD1;NCF1;MAPKAP1;GAB2;HIP1
prerank,peptidase activator activity (GO:0016504),-0.45426659421710064,-1.3696495282690124,0.09881422924901186,0.5311965978798253,1.0,14/22,33.18%,PSMD14;MAL;PCOLCE2;APH1B;CAV1;PCOLCE;PINK1;PSENEN;CASP8AP2;ADRM1;VCP;PSME3;VSIR;PSME2
prerank,poly(A) binding (GO:0008143),0.5570735002983574,1.369174118058392,0.12087912087912088,0.9889279859805299,1.0,5/21,4.57%,PABPC5;RBMS3;HNRNPDL;ELAVL4;PABPC1
prerank,protein phosphatase 2A binding (GO:0051721),-0.43292871339824546,-1.3671692065853023,0.1044776119402985,0.5217991360664147,1.0,14/23,26.06%,MFHAS1;PTPA;PPME1;STRN4;CTTNBP2NL;ARPP19;MAPT;IGBP1;SPHK1;MASTL;GRIN3A;BOD1;SMG5;BOD1L1
prerank,methylated histone binding (GO:0035064),0.4744089431776121,1.3633678400176197,0.07428571428571429,1.0,1.0,20/62,18.96%,RAG2;LRWD1;KDM8;CXXC1;KAT8;SPIN1;ATRX;MBTD1;CDYL;MSH6;ING4;PHF8;TAF7;MSL3;PYGO1;PHF19;ING1;ZMYND11;TAF1;KMT2E
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5455055741007029,-1.3623245917837665,0.13230769230769232,0.5182266527230446,1.0,3/11,9.86%,ITPR1;RASA3;MCOLN1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5542034496102505,1.359791113325128,0.12211668928086838,0.9687332063789246,1.0,3/22,9.85%,CHRM3;HRH1;HTR2C
prerank,serotonin receptor activity (GO:0099589),0.5542034496102505,1.359791113325128,0.12211668928086838,0.9687332063789246,1.0,3/22,9.85%,CHRM3;HRH1;HTR2C
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5542034496102505,1.359791113325128,0.12211668928086838,0.9687332063789246,1.0,3/22,9.85%,CHRM3;HRH1;HTR2C
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4176199243537991,-1.359256457311669,0.05533596837944664,0.5110455998336589,1.0,12/26,12.64%,ABCG2;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC6A13;SLC16A11;SLC16A2;SLC6A11;SLC6A1;SLC16A9;SLC5A6
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4763497098199384,1.3590341016268792,0.09154113557358054,0.9556730111322538,1.0,13/60,7.80%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;ACVR1;EPHB2;NTRK2;TGFBR2;FGFR1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4566693334524206,1.354144269976574,0.0753045404208195,0.9650237772325565,1.0,15/91,8.71%,STXBP6;RAG2;PLEKHA4;PLEKHA5;SESTD1;GSN;ANXA9;PLCB1;WIPI1;MAPKAP1;LAPTM4B;FZD7;GBF1;RPH3A;HIP1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6045393047891503,1.3536310455802147,0.12314540059347182,0.9513999355518828,1.0,2/15,1.57%,SLC1A3;SLC1A5
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6281984973981786,1.3535030011760516,0.13513513513513514,0.9360606333817383,1.0,3/12,4.32%,BACE2;HM13;PSEN1
prerank,single-stranded DNA binding (GO:0003697),0.44715394137554354,1.3434097166333747,0.0757238307349666,0.9749523548090974,1.0,31/93,21.95%,DDX11;RAD23B;SSBP2;MEIOB;APTX;ERCC5;ERCC4;STN1;RPA3;SETMAR;REXO4;TDP1;FBH1;MCM4;RPA2;POLR2G;RAD52;BLM;HNRNPU;FAM111A;FUBP1;PARK7;TOP1;HMCES;FUBP3;HSPD1;SSBP1;CTC1;MLH1;TOP3A;RBMS1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4716346177687216,1.3425475142980994,0.09557109557109557,0.9637333853458684,1.0,11/60,4.52%,ROR2;ROR1;EFEMP1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;EPHB2;NTRK2
prerank,filamin binding (GO:0031005),-0.5385498562476523,-1.341918931897079,0.15041782729805014,0.5399760496606162,1.0,4/11,20.87%,NEBL;SYNPO2;CEACAM1;RFLNA
prerank,lipoprotein particle binding (GO:0071813),-0.43997093866970544,-1.3389475029051434,0.12857142857142856,0.5322454443860666,1.0,8/20,21.76%,CDH13;PLTP;THBS1;SCARF1;STAB1;MAPT;LPL;COLEC12
prerank,phospholipase A2 activity (GO:0004623),0.5306435502740718,1.336459387551134,0.13225371120107962,0.9807493890924258,1.0,6/26,13.50%,PRDX6;PLA2G7;PLA2G12A;PLAAT5;PLAAT3;PNPLA8
prerank,glucuronosyltransferase activity (GO:0015020),0.5602670314547524,1.3353125536632506,0.1271186440677966,0.9713237487459165,1.0,3/19,8.60%,EXT1;CSGALNACT1;CHSY1
prerank,endopeptidase activity (GO:0004175),0.4180737600364412,1.33245953905439,0.022155085599194362,0.9709691847007044,1.0,68/257,21.21%,HGFAC;KLK12;MMP2;ADAMTS12;ADAM19;ADAMTS20;FAP;BACE2;HTRA3;CORIN;USP35;USP11;PARL;KDM8;MIPEP;PSEN1;PCSK4;PCSK6;MMP15;CTSK;CTSO;ADAMTS1;CASP6;KLK1;KLK6;CTSB;PSMB7;UCHL1;ADAMTS4;USP46;PMPCB;THOP1;MMP16;USP33;ADAMTSL1;USP48;GZMM;MALT1;MMP19;TYSND1;USP40;ADAM33;PSEN2;USP14;CASP2;ADAMTS2;THSD4;USP1;USP25;PSMB2;USP2;ADAMTSL4;USP37;PIK3IP1;CASP7;ADAMTS14;MASP2;USP5;KLK2;SENP1;CPNE1;MBTPS1;PCSK7;USP13;PSMA8;PLAT;FURIN;RHBDD1
prerank,ubiquitin-specific protease binding (GO:1990381),0.5647102371264032,1.3301526214997366,0.13426573426573427,0.9684557764750054,1.0,7/19,14.35%,PTEN;PRKN;RHBDD2;DERL2;SELENOS;LCOR;SUMO1
prerank,anion channel activity (GO:0005253),0.45932190645376747,1.3223243072826665,0.08974358974358974,0.9951013400874782,1.0,7/61,6.83%,FXYD3;ANO2;VDAC2;CLCN5;ANO6;LRRC8D;TTYH3
prerank,endonuclease activity (GO:0004519),0.4753264622879356,1.321239434774499,0.10739856801909307,0.9862988796383321,1.0,10/49,10.78%,ZRANB3;INTS11;MBD4;ERCC5;ERCC4;NOB1;SETMAR;ZC3H12B;REXO4;RCL1
prerank,nucleosomal DNA binding (GO:0031492),0.5466474199312937,1.3210738976098761,0.14266304347826086,0.9728318939608072,1.0,11/21,20.78%,MTA2;MBD2;HDAC2;RCC1;SMARCC2;RBBP4;SMARCC1;SMARCE1;SMARCA4;HNRNPC;GATAD2B
prerank,WW domain binding (GO:0050699),0.5317860527039103,1.3203178878329471,0.14670255720053835,0.963254399260745,1.0,5/26,15.92%,ENAH;KIF20B;TRAF4;NDFIP1;TCEAL8
prerank,gated channel activity (GO:0022836),0.5792892542313568,1.31985219055666,0.15486725663716813,0.9518170645173291,1.0,2/14,2.96%,PIEZO2;TMEM63A
prerank,leak channel activity (GO:0022840),0.5685629857329693,1.3194635650102633,0.145578231292517,0.9407252487545488,1.0,2/18,3.10%,KCNK15;KCNK1
prerank,voltage-gated cation channel activity (GO:0022843),0.43816658803377523,1.3190336785341976,0.08187772925764192,0.9297452789053732,1.0,31/97,22.88%,CACNA1E;KCNA2;KCNH8;CACNA2D1;CACNG7;KCNK1;NCS1;KCNA1;CACNA1A;GRIN2B;KCNA6;KCND1;CACNB4;KCND2;KCND3;TPCN2;GRIN2D;GRIN2A;KCNH2;CACNA2D4;KCNMA1;CACNA2D2;KCNA5;HCN1;KCNS3;KCNH7;LRRC55;PKD2;KCNQ3;KCNA4;KCNC1
prerank,metalloendopeptidase activity (GO:0004222),0.4444981987671683,1.317577050086428,0.10356347438752785,0.9246371407615382,1.0,18/76,18.59%,MMP2;ADAMTS12;ADAM19;ADAMTS20;MIPEP;MMP15;ADAMTS1;ADAMTS4;PMPCB;THOP1;MMP16;ADAMTSL1;MMP19;ADAM33;ADAMTS2;THSD4;ADAMTSL4;ADAMTS14
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5254728069903063,1.3175668562105545,0.15334207077326342,0.9123887534361411,1.0,3/28,4.68%,EDA;FADD;TRAF4
prerank,voltage-gated anion channel activity (GO:0008308),0.5809010613276929,1.3171292325982313,0.15948275862068967,0.9027025507128322,1.0,3/15,3.48%,VDAC2;CLCN5;ANO6
prerank,potassium ion leak channel activity (GO:0022841),0.580909449737066,1.3141378210884342,0.16877637130801687,0.904685912153824,1.0,2/15,3.10%,KCNK15;KCNK1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5076518068537039,1.31390759733556,0.15281501340482573,0.8941015611800212,1.0,10/28,21.01%,GRIK3;CHRNA4;GRIK5;GRIK2;GRID2;GRIK1;GABRG2;GABRA3;GABRA2;GRID1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4528977952487262,1.3129952820285733,0.09339407744874716,0.8868779412246421,1.0,11/72,8.71%,STXBP6;RAG2;PLEKHA4;SESTD1;GSN;ANXA9;PLCB1;MAPKAP1;FZD7;RPH3A;HIP1
prerank,protease binding (GO:0002020),0.42894312957863345,1.3122772239825642,0.08485499462943072,0.8788711137796689,1.0,27/99,16.11%,A2M;FAP;PYCARD;PTEN;BCL2;PRKN;FADD;ANXA9;RHBDD2;NTRK2;PRNP;CSTB;BIN1;ADAMTS4;COL3A1;DERL2;SELENOS;COL1A2;NFRKB;TYSND1;LCOR;SUMO1;COL1A1;ITGB1;CRADD;TP53;POLG
prerank,CCR chemokine receptor binding (GO:0048020),0.5058693449852477,1.3102865049373602,0.144,0.8773544106761064,1.0,6/28,15.86%,CCL11;CCL4;CCR2;NES;CCL14;CNIH4
prerank,actin monomer binding (GO:0003785),-0.41117657066614427,-1.3100743099819958,0.13168724279835392,0.5917227837984441,1.0,10/22,27.67%,MTSS1;NOS3;ABL2;PFN2;TMSB4X;LIMA1;ABITRAM;TMSB10;MYL4;TWF2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6002913502907746,1.3087824537253114,0.16666666666666666,0.8726508464324233,1.0,6/12,22.30%,SULF1;GALNS;IDS;SGSH;ARSK;SULF2
prerank,phospholipid transfer activity (GO:0120014),-0.4306298612583921,-1.308727780332434,0.14028776978417265,0.5802784865323536,1.0,10/21,19.91%,PITPNM2;ABCA3;PLTP;PITPNA;GLTP;OSBPL2;TNFAIP8L3;C2CD2L;PRELID2;CERT1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6151352056817003,1.3012543679333028,0.16691729323308271,0.8959656719057847,1.0,3/10,7.13%,FAP;NAALAD2;DPP10
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.47359163166513973,-1.2991733098410099,0.15584415584415584,0.5914397506231476,1.0,5/15,12.61%,ALDH1A2;ALDH1A1;ALDH2;ALDH3A2;ALDH9A1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.36862751572056496,-1.2974890247747195,0.10362694300518134,0.5812407127919178,1.0,4/35,3.34%,GPCPD1;MPPED2;PLCL1;PLCB3
prerank,chloride transmembrane transporter activity (GO:0015108),-0.45929689666345813,-1.2972481414061474,0.14596273291925466,0.5678521551517315,1.0,7/16,30.83%,SLC26A7;SLC26A2;SLC4A8;SLC26A6;SLC26A8;SLC1A1;CLCN6
prerank,syntaxin-1 binding (GO:0017075),-0.40839740862619905,-1.2945897880694532,0.1245674740484429,0.5617099312629492,1.0,6/22,10.71%,DAPK1;UNC13C;STXBP1;NSF;CPLX1;UNC13B
prerank,tropomyosin binding (GO:0005523),-0.4516512475731763,-1.2889368681682776,0.15436241610738255,0.5634289960053205,1.0,3/16,0.81%,NEBL;CALD1;TMOD3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5310141894238191,1.2884524439614446,0.17496443812233287,0.9455114564524364,1.0,9/19,21.01%,GRIK3;GRIK5;GRIK2;GRID2;GRIK1;GABRG2;GABRA3;GABRA2;GRID1
prerank,protein tyrosine kinase activity (GO:0004713),0.41967945174284127,1.2883502185874252,0.09168443496801706,0.9347294288262231,1.0,19/108,10.95%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;PKDCC;PEAK1;EPHB6;ERBB2;EGFR;EPHB2;TEC;NTRK2;CSK;FGFR1;FYN;ERBB4;TYK2;STYK1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.37593915234117187,-1.2867650867481528,0.11363636363636363,0.5563966328101316,1.0,7/30,9.03%,SLC30A10;SLC31A1;ATP7A;SLC40A1;SLC39A8;SLC39A6;SLC30A1
prerank,neuropeptide binding (GO:0042923),0.5449650268566045,1.2850111895228435,0.16063675832127353,0.9398121974033372,1.0,3/18,16.75%,SSTR1;GPR37;OPRK1
prerank,epidermal growth factor receptor binding (GO:0005154),0.5071838823864223,1.2841270372385485,0.17565698478561548,0.9331993086474698,1.0,12/25,24.52%,EFEMP1;ATXN2;HIP1;BTC;ERBB4;ARF4;SNX1;HBEGF;GRB2;CCDC88A;SNX4;LINGO1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.4969518443830516,1.2826894217761315,0.17955439056356487,0.9291035366856827,1.0,9/27,13.78%,SLC12A3;MRS2;KCNA1;ATP2B3;SLC12A2;SLC8A2;MAGT1;ATP2B1;TUSC3
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5970796823173992,1.2817715923570305,0.1948249619482496,0.9228608341687424,1.0,4/10,15.62%,HAT1;KAT8;ATF2;MSL3
prerank,phosphatidylglycerol binding (GO:1901611),-0.4807264652485069,-1.2817393539681443,0.17592592592592593,0.5567059740431429,1.0,7/13,29.59%,PLTP;PITPNA;STOML2;GSDMD;GSDME;UQCC3;MME
prerank,calcium ion binding (GO:0005509),0.39854173871129184,1.279862901258814,0.026078234704112337,0.921541079269591,1.0,67/323,16.37%,DCHS1;CDH19;PCDHA4;ASTN2;S100A4;DHH;PLSCR4;GSN;LRP1;C2CD5;EFHD1;ANXA9;NCS1;LETM1;CAPN1;CD320;HPCA;NUCB1;DSG2;CDH10;NRXN1;PRNP;CDH22;EML1;CABCOCO1;CDH8;AOC1;SYT1;PPP3CB;ITSN1;RCN1;S100A6;RPH3A;PPP3CA;S100A16;ANXA11;RCN3;SPARC;FKBP9;SYT11;SYT12;CDH20;CDH7;MCTP1;GLCE;ANXA6;CALU;ADGRL3;SLC25A23;CDK5R1;HSP90B1;OTOF;CCDC47;SRR;SMOC2;KCNIP4;SNCA;SCUBE1;PVALB;CALM1;GALNT3;IQGAP1;IDS;CALM2;CDH18;LRP2;SLC25A24
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5859687702292354,1.2682731559412614,0.20404984423676012,0.9635283946358055,1.0,6/10,12.66%,SETD3;SETMAR;PRDM9;SETD2;NSD2;SETD5
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5174848978625521,1.2671824129224472,0.19812583668005354,0.9581599607200469,1.0,7/22,14.90%,RBMS3;ELAVL4;EXOSC8;CPEB3;ZFP36L2;CPEB1;KHSRP
prerank,transcription coactivator binding (GO:0001223),0.5270826787126441,1.263416864035094,0.17414965986394557,0.9653323128843584,1.0,2/20,2.29%,RORA;VGLL4
prerank,monocarboxylic acid binding (GO:0033293),0.5331443990450072,1.2624960654742035,0.2,0.9589936459221862,1.0,1/18,0.79%,PYGL
prerank,ion channel activity (GO:0005216),0.42318892155307947,1.259144358044682,0.13172338090010977,0.964140555091183,1.0,16/80,14.38%,PIEZO2;GRIA1;TMEM63A;GRIK3;CALHM6;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRID2;GRIK1;ANXA6;TMEM120A;GRIN2D;GRIN2A
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4666028364838202,1.2562739437055828,0.18696186961869618,0.9672609855801971,1.0,7/38,9.31%,PLEKHA4;PLEKHA5;SESTD1;WIPI1;BBS5;HIP1;LANCL2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5840118591528582,1.2544716353931367,0.2161290322580645,0.9656097067486846,1.0,3/10,9.76%,NCF1;NOX1;NCF2
prerank,cAMP response element binding (GO:0035497),0.5952935763130192,1.2535968772773054,0.223950233281493,0.959455405440269,1.0,3/10,10.50%,CREB3L1;CREB3L2;ATF2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.466480360988302,-1.2499143226850389,0.20521172638436483,0.6254408672172072,1.0,4/13,11.83%,SLC7A2;SLC38A7;SLC66A1;SLC38A5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.5153286675241111,1.2490106837669848,0.21109607577807848,0.9609441450842802,1.0,6/21,8.84%,CDK8;CDKL3;CDK13;CDK6;CDK15;CDK19
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.5153286675241111,1.2490106837669848,0.21109607577807848,0.9609441450842802,1.0,6/21,8.84%,CDK8;CDKL3;CDK13;CDK6;CDK15;CDK19
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5157359162017062,-1.246166613537387,0.20604395604395603,0.6221204594693867,1.0,5/10,20.88%,PML;ANKRD13B;LAPTM5;ANKRD13A;FAAP20
prerank,transcription coregulator binding (GO:0001221),0.44323032821423436,1.2455605712444793,0.16314553990610328,0.967729025150274,1.0,12/50,15.32%,RORA;USP11;VGLL4;EED;ZBTB16;ESR1;HDAC6;PER3;PER1;AHR;LCOR;MED25
prerank,"DNA binding, bending (GO:0008301)",-0.4624250976966038,-1.2452594542151858,0.2138364779874214,0.6120255471533881,1.0,6/14,24.50%,LEF1;FOXL1;HMGA2;HHEX;HMGB2;FOXD1
prerank,aspartic-type peptidase activity (GO:0070001),0.6002275831157808,1.2445869007362405,0.2304147465437788,0.9627475542055793,1.0,2/10,4.32%,BACE2;PSEN1
prerank,poly(U) RNA binding (GO:0008266),0.5121942474145664,1.242861912957076,0.20718232044198895,0.960730750900978,1.0,9/20,21.95%,PABPC5;RBMS3;PABPC1;DAZAP1;PNPT1;SSB;MCRS1;HNRNPC;RBMS1
prerank,poly-purine tract binding (GO:0070717),0.4805108197803343,1.2416476132529939,0.19922380336351875,0.9565189547195966,1.0,5/27,4.57%,PABPC5;RBMS3;HNRNPDL;ELAVL4;PABPC1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5074480176822753,1.2414674265608296,0.21095890410958903,0.9480863527481865,1.0,2/21,1.62%,FGF2;FGF10
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5025606555240199,1.2406683927667053,0.22281167108753316,0.9426940952539242,1.0,6/22,18.00%,HSPG2;SYT1;ANKRA2;HSP90B1;APBB3;DNAJA1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3904257484873087,-1.2391232079043148,0.17269076305220885,0.6154199984679115,1.0,9/24,24.72%,RPS14;RPL5;MYH10;IGF2BP3;UTP23;RPL26;MRPS11;RPL41;IGF2BP2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5928987457823537,1.2390401043681032,0.23622047244094488,0.9325058459956609,1.0,4/10,20.04%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5928987457823537,1.2390401043681032,0.23622047244094488,0.9325058459956609,1.0,4/10,20.04%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.587695410807605,1.2379635297179354,0.25267993874425726,0.9288564357640565,1.0,1/10,1.91%,DPEP1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.4307104782199267,-1.2343716304892787,0.19402985074626866,0.6157523414897977,1.0,12/17,20.42%,ATP10A;PITPNM2;ABCA3;ABCA1;PLTP;PITPNA;ABCG1;ATP8B2;ABCB4;ATP10B;ABCA7;PCTP
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5547703359720877,1.2335401801392987,0.2240117130307467,0.9392285360971158,1.0,3/14,3.46%,LXN;NGF;RECK
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.47432134322287794,1.2334468376147825,0.20689655172413793,0.9311819910307914,1.0,12/30,23.12%,DPEP1;MT3;CSTB;UBE2Z;PRDX3;SNCA;UBE2O;XIAP;CAST;PTTG1;RPS6KA3;CARD16
prerank,receptor ligand activity (GO:0048018),0.3830363939644714,1.2333565273872142,0.08012170385395538,0.9232433718206703,1.0,32/245,12.11%,LGALS3;BMP5;CCL11;EDA;CXCL10;IL16;CRH;FGF2;FGF10;SEMA3E;CRLF1;NGF;SEMA6C;NRG3;VEGFA;PTHLH;SEMA3A;TGFB1;CCL4;GDF9;WNT5A;TAFA4;TAFA1;IL18;BTC;AMELX;GDNF;DAND5;BMP7;EDN3;FGF7;GRN
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5500919692249837,1.23156650451924,0.21961932650073207,0.9225787599449237,1.0,2/14,4.89%,AASS;ALDH1L1
prerank,voltage-gated sodium channel activity (GO:0005248),0.49693347003329735,1.2310118118171332,0.20804438280166435,0.9167258224248971,1.0,4/22,6.94%,SCN7A;SCN2A;SCN5A;SCN3A
prerank,cytokine activity (GO:0005125),0.3959444969706435,1.2306020844571448,0.13249211356466878,0.910469647153492,1.0,11/131,5.52%,BMP5;CCL11;CXCL10;IL16;FGF2;CRLF1;VEGFA;TGFB1;CCL4;GDF9;WNT5A
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.47710028043008035,1.2294796162811465,0.2187902187902188,0.9076102490518841,1.0,13/31,21.70%,UBE2T;UBE2E2;UBE2K;UBE2Z;UBE2J2;AKTIP;UBE2O;UBE2Q1;TAF1;UBE2L3;UBE2G1;UBE2E1;UBE2D3
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5602888798638427,1.229339894269104,0.22617354196301565,0.9005119036674945,1.0,2/12,11.19%,RHO;GPR88
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.420589387309886,1.2274323440080335,0.17146017699115043,0.9009930673893144,1.0,15/73,21.43%,SORCS2;SORCS1;SORCS3;PTH2R;LGR5;TSHR;MAS1;GPR37;GLP2R;OPRK1;APLNR;S1PR2;VIPR2;ADCYAP1R1;MC5R
prerank,leucine zipper domain binding (GO:0043522),-0.49475698240439825,-1.2273524303806198,0.24479166666666666,0.621510815954933,1.0,1/10,0.14%,PAWR
prerank,histone acetyltransferase activity (GO:0004402),0.4811942469443628,1.226289965379147,0.21638924455825864,0.8978309966142464,1.0,11/30,18.82%,KAT2B;BAZ1A;HAT1;KAT8;MCM3AP;ATF2;TAF9;EPC1;NCOA3;EPC2;TAF1
prerank,poly-pyrimidine tract binding (GO:0008187),0.48839001868993376,1.2240219623807291,0.23015873015873015,0.8994863772475192,1.0,10/23,21.95%,PABPC5;RBMS3;PABPC1;DAZAP1;PNPT1;HNRNPU;SSB;MCRS1;HNRNPC;RBMS1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.4754147843197457,-1.223775433839634,0.228486646884273,0.6184086982596343,1.0,4/12,10.80%,PIK3R3;PIK3C2A;PIK3C2B;PIK3R6
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.48395567103422177,1.223231703492489,0.23293172690763053,0.8949407927020933,1.0,2/23,4.92%,CHRM3;PLCB1
prerank,alkali metal ion binding (GO:0031420),-0.45528082398666914,-1.2212819841756712,0.22058823529411764,0.6136141769247843,1.0,5/13,11.44%,ATP1A2;DRG1;ATP1A1;IMPA1;HDAC4
prerank,GTPase inhibitor activity (GO:0005095),0.5465884085962626,1.2211072251890784,0.2344213649851632,0.8963382851165332,1.0,5/13,14.88%,RTKN;IQGAP2;ARL2;RHOH;IQGAP1
prerank,ankyrin binding (GO:0030506),0.5102798894206371,1.2201988133722887,0.22300140252454417,0.8929749657713498,1.0,4/19,6.45%,NRCAM;SCN5A;SPTBN1;PLEC
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.4660702893497703,-1.2193450551275438,0.20634920634920634,0.6071109258795983,1.0,5/13,12.61%,ALDH1A2;ALDH1A1;ALDH2;ALDH3A2;ALDH9A1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.44443002480991217,1.2181121514518352,0.22263222632226323,0.8943092436872868,1.0,19/44,21.43%,PRDM16;SUV39H1;KMT2A;SETD3;CXXC1;EED;SETMAR;MEN1;PRDM9;SETD2;NSD2;SETD5;ASH2L;SETD4;KMT2E;N6AMT1;SETDB1;KMT2D;NSD1
prerank,ligand-gated cation channel activity (GO:0099094),0.417964606507437,1.2166236515747288,0.18888888888888888,0.8932670013447229,1.0,14/75,16.10%,GRIA1;GRIK3;KCNK1;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRIK1;GRIN2D;KCNJ3;GRIN2A;KCNJ10;KCNH2
prerank,chloride channel regulator activity (GO:0017081),0.5403610160152277,1.2161385642916889,0.24818577648766327,0.8880928584993637,1.0,5/14,16.79%,WNK2;WNK3;SGK3;STX8;SGK1
prerank,NAD+ binding (GO:0070403),-0.4584253284538088,-1.2137172769560336,0.23615160349854228,0.6107273758103442,1.0,4/12,14.79%,ZC3HAV1;CRYL1;SIRT3;HPGD
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.3639158622953742,-1.2121683193713706,0.20704845814977973,0.6041884733400592,1.0,11/27,14.85%,SLC8A3;SLC41A1;SLC8B1;SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC4A8;SLC9A9;SLC9A7;CNNM4
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4659760363318043,1.211487092363668,0.22813688212927757,0.9002517781247588,1.0,7/31,11.14%,KCNA2;SLC12A3;KCNK1;KCNA1;SLC12A2;TMEM38B;SLC12A4
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4221008306422955,1.2106065806105177,0.19090909090909092,0.896778042315609,1.0,20/71,15.42%,PTPRH;UBASH3B;PTPDC1;PTEN;PTPN22;DUSP4;PTPRT;PTPN2;PTPN13;PTPN1;DUSP11;PTPRJ;PTPN11;CDC25B;PTPRA;PTPN18;PTPRZ1;PTPN21;PTPRF;CDC14A
prerank,bHLH transcription factor binding (GO:0043425),-0.4021142974751297,-1.2094105542857811,0.21305841924398625,0.6011373419729032,1.0,6/19,19.58%,FHL2;KDM1A;LMO2;TCF12;CREBBP;TWIST1
prerank,frizzled binding (GO:0005109),-0.34300800420976213,-1.2029738692988183,0.17889908256880735,0.6064771983995569,1.0,12/34,21.40%,WNT4;WNT5B;ZNRF3;WNT6;WNT9A;RYK;FZD1;RNF43;CCDC88C;WNT16;DVL2;WNT11
prerank,chloride channel activity (GO:0005254),0.4181589864121508,1.199242182726247,0.20162224797219003,0.934444503381124,1.0,14/59,20.50%,FXYD3;ANO2;CLCN5;ANO6;TTYH3;TTYH1;FXYD1;CLIC1;CLCN2;GABRG2;TTYH2;GABRA3;GLRB;GABRA2
prerank,receptor tyrosine kinase binding (GO:0030971),0.41699168352405774,1.1976341805614419,0.2183507549361208,0.9334571271271463,1.0,12/56,10.64%,SHC4;LRP4;CBLB;PTPN2;NRG3;SOCS5;ALKAL2;GAB2;GRB14;PTPN1;PIK3R1;CBL
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.4880350910504049,-1.1970367866916272,0.23796791443850268,0.6109585570084206,1.0,5/10,20.88%,USP15;ANKRD13B;LAPTM5;ANKRD13A;FAAP20
prerank,acid-thiol ligase activity (GO:0016878),0.5406807500540423,1.1955804292595023,0.2691176470588235,0.9348162093704419,1.0,3/13,7.11%,ACSS2;ACSS3;ACSS1
prerank,voltage-gated potassium channel activity (GO:0005249),0.40796314602718764,1.1950080432355894,0.21262458471760798,0.9299797166752087,1.0,28/80,26.21%,KCNA2;KCNH8;KCNK1;KCNA1;KCNA6;KCND1;KCND2;KCND3;KCNT2;KCNJ3;KCNJ10;KCNH2;KCNMA1;KCNA5;HCN1;KCNS3;KCNH7;LRRC55;PKD2;KCNQ3;KCNK6;KCNA4;KCNC1;KCNJ13;KCNQ5;KCNN2;HCN2;HCN3
prerank,cytokine receptor activity (GO:0004896),0.39926855390612775,1.1939178577842677,0.2002212389380531,0.9275198077738462,1.0,14/83,17.14%,GFRA1;IL2RA;CRLF1;IL20RB;GFRA4;CCR2;IL1RL2;CSF3R;IL6ST;PRLR;ACKR4;GFRA2;IL1RAP;CD74
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.42637280210009704,-1.1931328930140155,0.23417721518987342,0.6106238835968296,1.0,6/15,14.94%,HS3ST3A1;HS3ST1;NDST3;NDST1;HS3ST2;HS3ST3B1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3545779442883518,-1.1924199355387137,0.18828451882845187,0.6027507640007885,1.0,9/27,13.06%,SLC22A8;SLC26A7;SLC26A2;ANO1;SLC22A6;SLC5A5;SLC39A8;SLC25A30;LRRC8A
prerank,phosphate ion binding (GO:0042301),0.5590886889210218,1.1915829468704584,0.2748447204968944,0.929916537966912,1.0,2/10,7.66%,ADSS1;RPH3A
prerank,metal ion binding (GO:0046872),0.36870580144385817,1.1913024331272901,0.051,0.9240815376519207,1.0,92/477,15.79%,DCHS1;CDH19;PCDHA4;ASTN2;S100A4;DHH;IDH2;PLSCR4;GSN;PSPH;LRP1;C2CD5;EFHD1;ANXA9;NCS1;PDXK;IRAK3;LETM1;SIK2;CAPN1;CD320;MAST2;HPCA;DXO;NUCB1;DSG2;CDH10;NRXN1;GSS;PRNP;MT3;PGM1;CDH22;EML1;CABCOCO1;UBA2;ACVR1C;CDH8;AOC1;SYT1;HMGCLL1;PPP3CB;ITSN1;NUDT22;POSTN;RCN1;S100A6;RPH3A;CSGALNACT1;PPP3CA;S100A16;RPE;ANXA11;RCN3;SPARC;FKBP9;SYT11;SYT12;CDH20;CDH7;MCTP1;ENDOV;GLCE;PI4K2A;MSH6;ANXA6;CALU;ADGRL3;SLC25A23;CDK5R1;NUDT3;GNAI1;HSP90B1;OTOF;CCDC47;SRR;EXD2;SMOC2;KCNIP4;SNCA;SCUBE1;PVALB;IDH3A;CALM1;GALNT3;IQGAP1;OPA1;IDS;ABL1;CALM2;PAPOLA;CDH18
prerank,chloride channel inhibitor activity (GO:0019869),0.5780427399783146,1.1911927289889774,0.2701863354037267,0.9176623261731006,1.0,2/10,3.54%,WNK2;WNK3
prerank,nucleotidase activity (GO:0008252),0.5187885575574176,1.1890691646592582,0.250733137829912,0.9190917953113829,1.0,6/15,18.57%,NT5DC2;NT5C2;BPNT1;BPNT2;NT5C3B;NT5C
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.37816210207008116,1.1857876735287318,0.17864476386036962,0.9253984480682005,1.0,30/173,15.14%,OSR2;CREB3L1;PRDM16;MYC;ZNF25;ZBTB20;OTP;ZBTB37;SATB1;NFX1;FOXP2;ZEB1;ZBTB16;RORC;MLX;TRPS1;E2F6;LRRFIP1;TBX18;ZBTB6;NFATC3;ZGPAT;PATZ1;FOXP4;ZBTB1;GATA3;ZBTB39;NACC2;CREM;ZEB2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5110478144312517,1.1840451578564437,0.2510176390773406,0.925260476832529,1.0,4/18,6.44%,STXBP6;PAK4;CNN3;BAIAP2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3745651761537312,1.1833400394875413,0.14519427402862986,0.9214910118416182,1.0,58/188,21.35%,SOX6;KLF15;CREB3L1;PRDM16;ZBTB20;SUV39H1;SOX11;GLI1;RFX3;CREB3L2;GATA6;TBX18;MEN1;CHD3;ATMIN;TFAM;BRCA1;SOX12;SOX5;CARM1;ARID4B;PRDM9;ERBB4;NFE2L2;SP1;TAF9;SFPQ;TAF2;CREBZF;PER3;XRCC6;ATF5;PER1;GATA3;AHR;SNCA;TAF7;RUNX1;TP53;KCNH2;FOXJ1;PAX2;GABPB2;GABPB1;RNF10;ASH2L;EGR1;BCOR;PPARG;JUN;STAT3;TFE3;KMT2D;PBX1;ZBED4;HNRNPL;NFKB1;THRA
prerank,hexose transmembrane transporter activity (GO:0015149),0.5350410997095161,1.1809454665326011,0.2921875,0.9242447203801288,1.0,3/12,10.56%,SLC5A3;MFSD4A;SLC2A2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5048582128925722,1.180537183611502,0.28317373461012313,0.9191533565778118,1.0,5/15,21.50%,P2RY14;P2RY12;P2RY1;PTAFR;P2RX7
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4884062710979434,1.1779486047846524,0.2791666666666667,0.9228792450717765,1.0,9/20,23.17%,MAGI3;DTYMK;DLG2;AK3;AK6;AK2;AK8;CARD11;CMPK1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.44074123290278144,-1.1777147729914774,0.23809523809523808,0.6279592666515702,1.0,4/13,15.84%,PIK3C2A;PIP5K1B;PIK3C2B;PIP4K2B
prerank,amyloid-beta binding (GO:0001540),0.3947447383654698,1.1776091231992933,0.2388888888888889,0.9177985390286152,1.0,20/79,18.25%,HSPG2;LRP1;GRIA1;EPHB2;GRIA3;CACNA1A;PRNP;GRIN2B;NLGN1;APBB2;GSAP;CRYAB;NGFR;APBA1;CLSTN1;GRIN2A;TM2D1;CD74;APBB3;PGRMC1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.45363021493711847,1.1767818729925388,0.26616915422885573,0.9143141050111547,1.0,12/33,17.40%,WAC;ZNF326;ERCC5;RPRD1A;URI1;DRAP1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,FAD binding (GO:0071949),0.4689157570722184,1.1757376067021401,0.2859042553191489,0.9118993271813265,1.0,4/24,8.74%,STEAP4;SQLE;DAO;MTRR
prerank,methyl-CpG binding (GO:0008327),0.4735768154029355,1.1756640436752517,0.27851458885941643,0.9059275348264982,1.0,6/22,16.09%,LRWD1;MBD1;MBD2;ZBTB38;PRMT1;TET3
prerank,semaphorin receptor activity (GO:0017154),-0.46615871492790817,-1.1749232319986445,0.27450980392156865,0.6247293985669081,1.0,5/11,13.22%,PLXNA2;NRP1;PLXNB1;PLXNA1;PLXNA4
prerank,transmitter-gated ion channel activity (GO:0022824),0.44949189304231807,1.173009855327818,0.2440318302387268,0.909508658471342,1.0,10/29,21.01%,GRIK3;GRIK5;GRIK2;GRID2;GRIK1;GRIN2D;GABRG2;GABRA3;GABRA2;GRID1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.544978566579379,1.1719579946691612,0.28156748911465895,0.9076855066183463,1.0,5/12,11.40%,CDK8;CDK13;CDK6;CDK19;MAPK1
prerank,sulfotransferase activity (GO:0008146),-0.3459822577356909,-1.1707358902323604,0.22869955156950672,0.6257355497545712,1.0,15/33,22.82%,HS3ST3A1;HS3ST1;CHST15;CHST11;TPST1;GAL3ST1;CHST2;UST;CHST3;CHST12;HS3ST2;CHST10;CHST1;SULT4A1;GAL3ST2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.528265780955764,1.1695310623474557,0.2932330827067669,0.9109067575681425,1.0,5/13,19.01%,AGPAT2;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.45233043646085985,1.1682486676125592,0.26996197718631176,0.9095759587011748,1.0,12/33,17.40%,ERBB2;WAC;ZNF326;ERCC5;RPRD1A;URI1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5591097851598553,1.1642023402287602,0.3125,0.9187636545809879,1.0,4/10,19.50%,KDM8;KDM4B;PHF8;RIOX2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.37522674637013104,-1.1594048799558911,0.25475285171102663,0.6456023259173468,1.0,8/20,26.20%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC39A3;SLC39A10;SLC39A13;SLC39A1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3630456349150736,1.1588033433621994,0.17421953675730112,0.9336168193157136,1.0,69/254,19.98%,PRDX6;UBE2T;ERBB3;GLMN;PTPN22;BCL2;CBS;HM13;PRKN;EGFR;ERLIN2;FBXW7;BLZF1;TRAF4;SCN5A;SPOP;FBXO7;YWHAZ;LAPTM4B;RALB;NAE1;PACRG;BAG5;BRCA1;UBE2K;ANKRA2;UCHL1;CASC3;HIF1A;SYT11;CUL3;GPR37;SLF2;NGFR;UBE2J2;HDAC6;PATZ1;PRKACA;PER1;DET1;RPA2;NEDD8;SUMO1;RTN4;JKAMP;WASHC1;GABARAPL2;CCDC50;UBB;UBOX5;TP53;KCNH2;USP25;DBT;USP2;CUL4B;RIPK1;DNAJA1;HSPA9;MDM2;MID1;POLR2A;MAGEC2;NKD2;BCL10;UBE2L3;JUN;RRAGA;UBE2G1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5507757283764267,1.1587774946104847,0.3203125,0.927612892807398,1.0,1/11,0.66%,SLC22A3
prerank,carbohydrate kinase activity (GO:0019200),0.5335901754872112,1.1559313501865094,0.28699551569506726,0.931848509118726,1.0,6/11,22.83%,NAGK;FGGY;GNE;GALK2;HK2;HK1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4390028640171897,1.1546613760106514,0.2943396226415094,0.9307791616206972,1.0,17/34,27.08%,UBE2T;UBE2E2;UBE2K;UBE2Z;UBE2J2;AKTIP;UBE2O;UBE2Q1;TAF1;UBE2L3;UBE2G1;UBE2E1;UBE2D3;UBE2Q2;UBE2I;UBE2R2;UBE2J1
prerank,tubulin binding (GO:0015631),0.3579603586963023,1.1512200425609638,0.176056338028169,0.9379829674952463,1.0,76/295,19.60%,DLEC1;SGIP1;SAXO2;DNM1;FGF13;EFHC1;KIF20B;PRKN;KIF19;TTLL5;MAP4K4;MAP1B;GAS2L3;ARL3;TBCE;MAST2;TTLL11;STARD9;PRNP;EML1;PAK1;NDE1;MACO1;KIF21A;CCDC170;FYN;PACRG;BRCA1;CEP57;SETD2;CAPN6;DYNC1I1;TUBGCP5;VAPA;MID2;AGBL4;KIF5C;CLASP1;TTLL4;HDAC6;EMD;STMN4;AGBL1;CEP295NL;APC2;CDK5R1;UNC5C;KATNB1;RMDN2;ARL8A;ATF5;CKAP5;TRAPPC14;SNCA;MDM1;KIF22;TPGS1;WASHC1;OPA1;GABARAPL2;MAP6D1;EML5;NAV3;DIP2B;DCX;KIF21B;HTT;KIF3A;MAPRE3;CAMSAP1;MID1;HOOK2;KIF2A;IFT81;MAP6;CCDC66
prerank,CoA-ligase activity (GO:0016405),0.508055986130176,1.1511272164321802,0.30703012912482064,0.9323632488906747,1.0,3/14,7.11%,ACSS2;ACSS3;ACSS1
prerank,calcium activated cation channel activity (GO:0005227),0.4919688760150564,1.15111847950835,0.2998565279770445,0.9265308180347414,1.0,6/17,17.39%,TMEM63A;ANO6;KCNMB2;KCNMB3;ANO10;KCNMA1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.5044272533536526,1.147918795261752,0.3147353361945637,0.9326748235650695,1.0,3/15,9.31%,PLEKHA5;SESTD1;LANCL2
prerank,transcription cis-regulatory region binding (GO:0000976),0.3530042083099113,1.1463760895950816,0.13613613613613615,0.9324918519940536,1.0,77/406,17.15%,RORA;OSR2;SOX6;KLF15;LHX5;CREB3L1;PRDM16;MYC;HOXB8;ZNF25;ZBTB20;SOX9;SUV39H1;OTP;SATB1;TFCP2;NFX1;SOX11;RFXANK;GLI1;E2F2;PHOX2A;HOXD3;RFX3;MLX;TRPS1;CREB3L2;XRN2;TWIST2;DRAP1;E2F6;GATA6;TBX18;MEN1;FOXM1;CHD3;ATMIN;TFAM;BRCA1;SOX12;SOX5;CARM1;BBX;HIF1A;ARID4B;PRDM9;ERBB4;ATF2;NFE2L2;SP1;TAF9;SFPQ;RBAK;TAF2;CREBZF;PER3;XRCC6;ATF5;PER1;GATA3;AHR;SALL2;POLRMT;SNCA;TAF7;CREM;RUNX1;PURG;TAF4;TP53;SP3;KCNH2;FOXJ1;PAX2;GABPB2;GABPB1;RNF10
prerank,potassium ion antiporter activity (GO:0022821),-0.39710229677549425,-1.143249524489626,0.26517571884984026,0.677227669305664,1.0,6/15,11.86%,SLC9A6;SLC9A2;SLC9A8;SLC24A3;SLC9A9;SLC9A7
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4168728234152577,1.1400233097374464,0.2922705314009662,0.9498223767939495,1.0,11/42,11.58%,STXBP6;PAK4;CNN3;LRRC4C;BAIAP2;NTNG1;CNTN6;CNTN2;DSCAM;PALLD;PPP1CA
prerank,cation channel activity (GO:0005261),0.37579331227107854,1.1372816602048574,0.28354978354978355,0.9543343231054501,1.0,10/94,4.32%,PIEZO2;CACNA1E;KCNA2;TMEM63A;KCNK1;ANXA9;ANO6;KCNA1;CALHM6;PSEN1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5095168169073157,1.1364566756567336,0.33187134502923976,0.9514948339219762,1.0,2/14,8.29%,RDH10;DHRS3
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3997285481732192,1.1359525734448845,0.28935185185185186,0.9474092503889338,1.0,18/57,19.88%,CYB561D2;UQCRQ;CYBRD1;NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;CYB5A;NDUFA5
prerank,metallopeptidase activity (GO:0008237),0.3701712759487924,1.1359498961378975,0.26119402985074625,0.9417200624087496,1.0,21/113,16.42%,MMP2;ADAMTS12;ADAM19;ADAMTS20;DPEP1;ADAM23;MIPEP;MMP15;ADAMTS1;ADAMTS4;PMPCB;LNPEP;THOP1;MYSM1;MMP16;ADAMTSL1;MMP19;ADAM33;PAPPA2;ADAMTS2;THSD4
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4944534102432873,1.1349312916924614,0.3237410071942446,0.9400024689684926,1.0,8/14,27.32%,RPP38;PRORP;TSEN2;POP1;RPP21;TSEN34;RPP30;RPP14
prerank,actin binding (GO:0003779),-0.24075887708804478,-1.1346199827988959,0.13793103448275862,0.6896166520679207,1.0,40/170,15.12%,MACF1;PAWR;ABLIM1;CALD1;SORBS1;PHACTR1;CAPZB;PDLIM5;SYNE2;MYH9;MYRIP;MTSS1;PHACTR4;PARVB;NOS3;P4HB;MICAL3;ABL2;TPM1;GIPC1;MICAL2;EPS8;PFN2;EPS8L2;TMSB4X;MAEA;MAPT;PDLIM1;FXYD5;MYH10;DAG1;LIMA1;KIF18A;CAP1;SYNPO2;SHROOM2;AVIL;CEACAM1;TPM2;TMOD1
prerank,RNA stem-loop binding (GO:0035613),0.5125318284644209,1.1343491544008717,0.34534534534534533,0.9365827651305988,1.0,5/12,25.00%,EPRS1;CPEB3;RC3H1;CSDE1;FMR1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.47169416379305396,-1.1329362051778245,0.32303370786516855,0.6845726297443607,1.0,3/10,10.29%,PIK3R3;PIK3C2A;PIK3C2B
prerank,delayed rectifier potassium channel activity (GO:0005251),0.43315537778813135,1.130536110197973,0.30375,0.9449767831585018,1.0,10/32,24.76%,KCNA2;KCNA1;KCNA6;KCNH2;KCNA5;KCNS3;KCNQ3;KCNA4;KCNC1;KCNQ5
prerank,four-way junction DNA binding (GO:0000400),0.48574246536681515,1.12965795321004,0.3319268635724332,0.9425988504464374,1.0,6/17,17.24%,MEN1;MSH6;XRCC3;ABL1;BLM;WRN
prerank,sequence-specific mRNA binding (GO:1990825),0.5345948124901465,1.1287789429655766,0.334375,0.9404185491592176,1.0,3/10,25.00%,ETF1;SSB;FMR1
prerank,receptor antagonist activity (GO:0048019),0.4863695636823321,1.1287101947336355,0.33086053412462907,0.9351838712128171,1.0,2/17,9.20%,PXDN;DKK3
prerank,FMN binding (GO:0010181),0.5326165280591719,1.1286817025079459,0.337295690936107,0.9298650062254128,1.0,3/11,8.74%,POR;PNPO;MTRR
prerank,DNA binding (GO:0003677),0.3464327183624642,1.1282603018023503,0.095,0.9260862809492477,1.0,157/694,20.70%,RORA;OSR2;RAG2;SOX6;NKX6-2;MEOX1;MEOX2;TSHZ3;GLI2;SOX8;DDX11;PRDM16;CRLF3;MYC;RAD23B;BCL2;BANF2;CBFB;SOX9;SSBP2;HMGN1;MEIOB;EGFR;C1D;OTP;HOXA7;SATB1;APTX;MBD4;TFCP2;FOXP2;CHTF18;KDM5B;RFX2;ERCC5;TIPIN;EZH1;MBD1;GLI1;E2F2;ERCC4;TIGD2;MPG;DDB2;STN1;RFX3;ZBTB16;RPA3;MLXIPL;MLX;SETMAR;DRAP1;DEDD;LRRFIP1;MEN1;CHD3;TFAM;RARG;BRCA1;XPA;RARB;SOX12;REXO4;HIF1A;TDP1;NHEJ1;ZBTB6;CHD2;PRDM9;HDAC2;HUWE1;PSIP1;ENDOV;FBH1;NFE2L2;MCM4;LIN9;SP1;TAF9;MSH6;SFPQ;ZMYM6;CREBZF;ZGPAT;PATZ1;NR6A1;XRCC6;ATF5;GATA3;AHR;DDB1;POLRMT;RPA2;ORC1;POLR2G;PAX3;PDS5B;CRY1;ZNF638;POLG2;CREM;SLTM;ZEB2;GTF3C1;CGAS;POU3F1;ABL1;MEIS3;MSL3;RAD52;TAF4;BLM;TP53;TAF4B;PHF19;POLG;TRNP1;HNRNPU;QRICH1;FOXJ1;FAM111A;PAX2;CUL4B;FUBP1;WRN;NR5A1;PCID2;CSRNP3;AIFM1;MLF1;IRF3;ZNF496;ZMYND11;RNF4;PARK7;BATF;TAF1;CGGBP1;POLR2A;EGR1;CNBP;TOP1;CENPC;FOXJ3;PPARG;JUN;STAT3;PRDM2;HMCES;HP1BP3;MBD6;SMARCA4;FUBP3;KMT2D;SPO11;PBX1;MEIS1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.5265461920021067,1.1281862352787202,0.34516129032258064,0.9210518489733985,1.0,6/11,19.95%,GNPTAB;PTDSS1;PIGN;SGMS2;DPAGT1;PIGO
prerank,cysteine-type endopeptidase activity (GO:0004197),0.38380686132363817,1.1278538199413113,0.29464285714285715,0.916945116960895,1.0,26/78,19.10%,PYCARD;CAPN5;USP35;USP11;CAPN1;CTSK;CTSO;CASP6;CTSB;UCHL1;USP46;CAPN6;USP33;CASP12;USP48;MALT1;USP40;USP14;CASP2;USP1;USP25;USP2;USP37;CASP7;USP5;CAPN11
prerank,protein phosphatase binding (GO:0019903),0.366199412030507,1.1276517305708071,0.2780692549842602,0.9124661457993806,1.0,39/117,22.89%,LGALS3;ANK1;ERBB2;EGFR;PTPRT;EIF2AK3;PPP1R15A;PPP3CB;ENSA;PDLIM4;SHOC2;ANAPC7;PIK3R1;MAPK14;FBXL2;TBK1;PPP1R3F;HSP90B1;STRN;RPA2;AKAP11;IQGAP1;MET;JUP;TP53;SLC9A1;VRK3;KIF3A;STX17;STAT3;CDC27;ADCY8;SIRPA;ANAPC4;PXN;DLG4;ANAPC5;STAT6;KIFAP3
prerank,cysteine-type peptidase activity (GO:0008234),0.38370737235660957,1.1267650552679176,0.31456953642384106,0.9103552282829217,1.0,25/73,19.07%,USP50;USP35;USP11;OTUD7B;CTSK;CTSO;CASP6;OTULIN;CTSB;UCHL1;USP46;USP33;USP48;MALT1;USP40;USP14;CASP2;USP1;USP25;USP21;ATG4C;USP2;USP37;CASP7;USP5
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.43465717306412105,-1.1256157688455015,0.2916666666666667,0.6930314389593247,1.0,6/12,11.86%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.44952695651406405,-1.1247719626804638,0.3342541436464088,0.6853463046832524,1.0,4/11,8.81%,UBE4B;PPIL2;STUB1;UBE4A
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3516385801901586,1.124502697909686,0.21730382293762576,0.912866268034104,1.0,69/269,19.98%,PRDX6;UBE2T;ERBB3;GLMN;PTPN22;BCL2;CBS;HM13;PRKN;EGFR;ERLIN2;FBXW7;BLZF1;TRAF4;SCN5A;SPOP;FBXO7;YWHAZ;LAPTM4B;RALB;NAE1;PACRG;BAG5;BRCA1;UBE2K;ANKRA2;UCHL1;CASC3;HIF1A;SYT11;CUL3;GPR37;SLF2;NGFR;UBE2J2;HDAC6;PATZ1;PRKACA;PER1;DET1;RPA2;NEDD8;SUMO1;RTN4;JKAMP;WASHC1;GABARAPL2;CCDC50;UBB;UBOX5;TP53;KCNH2;USP25;DBT;USP2;CUL4B;RIPK1;DNAJA1;HSPA9;MDM2;MID1;POLR2A;MAGEC2;NKD2;BCL10;UBE2L3;JUN;RRAGA;UBE2G1
prerank,glutamate receptor binding (GO:0035254),-0.3810489891873214,-1.124106922369963,0.27044025157232704,0.6775288625160165,1.0,7/17,13.99%,SHANK3;SHISA6;NSF;SHANK2;CAMK2A;SQSTM1;GNAS
prerank,calcium channel inhibitor activity (GO:0019855),-0.4470528888736209,-1.1240552779112403,0.3028571428571429,0.6683704221694646,1.0,3/11,9.13%,ITPR1;SLC30A1;MCUB
prerank,sequence-specific DNA binding (GO:0043565),0.34732474686006687,1.12356716085942,0.13,0.910971288919752,1.0,88/590,16.43%,RORA;OSR2;RAG2;ETV1;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;LHX5;TLX3;GLI2;CREB3L1;SOX8;PRDM16;TGIF2;BCL2;CBFB;HOXB8;ZBTB20;LRWD1;SOX9;HIVEP1;ZBTB37;HOXA7;KMT2A;SATB1;TFCP2;EGR3;FOXP2;UPF3A;KDM5B;RFX2;ZNF276;MBD1;E2F2;PHOX2A;CXXC1;HOXD3;STN1;RFX3;RORC;MLX;GATA6;TBX18;TFAM;RARG;MBD2;XPA;RARB;SOX12;BBX;KLF5;HIF1A;PRDM9;HDAC2;ZBTB38;NFATC3;ATF2;ESR1;NFE2L2;SP1;PRMT1;UPF1;KLF13;ZGPAT;NR6A1;XRCC6;ATF5;GATA3;AHR;ZNF250;POLRMT;PAX3;CREM;SLTM;IRX5;HOXB7;ZEB2;POU3F1;ABL1;MEIS3;SP3;TET3;SMG6;SREBF2;TERF2IP;HNRNPU
prerank,TBP-class protein binding (GO:0017025),0.4619484991985854,1.1234741666538313,0.30833333333333335,0.9062093816849107,1.0,10/21,21.35%,DRAP1;GTF2B;ESR1;TAF11;AHR;PSMC1;TAF1;RUVBL2;YEATS2;THRA
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.28867516959570105,-1.1226081597389812,0.24817518248175183,0.6627969755109522,1.0,21/54,25.72%,HDAC8;ACER2;TGM2;UPB1;NTAQ1;ASPG;NIT1;HDAC4;HINT3;ASAH2;AMDHD2;ASRGL1;SIRT4;HDAC11;HDAC3;HDAC5;SUDS3;MIER2;SIRT7;FAAH;HDAC10
prerank,retinoic acid binding (GO:0001972),-0.43939748568345804,-1.1223523524487697,0.32098765432098764,0.6545970312840669,1.0,2/12,19.29%,CYP26B1;RARA
prerank,flavin adenine dinucleotide binding (GO:0050660),0.40124977439371456,1.122223519615849,0.318448883666275,0.9055877260662631,1.0,8/53,8.74%,STEAP4;GCDH;POR;SQLE;DAO;ETFA;ACOX1;MTRR
prerank,phospholipase binding (GO:0043274),0.49282664063401493,1.1220027996301398,0.3358433734939759,0.901350499763877,1.0,2/13,8.06%,PRKN;FYN
prerank,protein kinase C activity (GO:0004697),0.5040006618234492,1.1214401843822244,0.3377777777777778,0.8985144160914362,1.0,3/14,5.78%,PRKCA;PRKCQ;PKN1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.46999049991037317,1.1203601720020369,0.32531824611032534,0.8973111504781551,1.0,5/18,14.61%,SOSTDC1;ACVR1;TGFBR2;LTBP1;BMPR1A
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.5017296237123876,1.1200348793131296,0.3533724340175953,0.8936497533725898,1.0,2/13,8.12%,GPSM2;GDI2
prerank,transforming growth factor beta binding (GO:0050431),-0.35839424714063445,-1.118216345399277,0.2873134328358209,0.656335588770102,1.0,8/23,11.39%,ACVRL1;ENG;TGFBR1;THBS1;CD109;TWSG1;LRRC32;VASN
prerank,G protein-coupled receptor binding (GO:0001664),0.3578680350155112,1.1126976575367542,0.28900523560209423,0.9139099464776969,1.0,21/132,15.49%,PTCH1;PTCH2;GNA14;BICD1;PRKN;GPRC5B;GPRASP2;NPB;WNT5A;FZD7;ARHGEF11;PACRG;FLNA;USP33;DVL1;MYOC;GNAI1;HOMER2;PENK;PDCD6IP;HOMER1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.41395433788762015,1.111221866779511,0.3161856963613551,0.9139702450014304,1.0,6/35,10.95%,PKDCC;PEAK1;TEC;CSK;FYN;STYK1
prerank,ion channel inhibitor activity (GO:0008200),0.4192117971025532,1.1104006807839328,0.3391304347826087,0.911921245516106,1.0,9/35,15.54%,WNK2;WNK3;RASA1;ENSA;KCNMB2;STX8;NEDD4L;CALM1;CALM2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3662938059205238,1.1073336711806,0.2980561555075594,0.917793927554986,1.0,17/100,9.31%,RAG2;PLEKHA4;PLEKHA5;SESTD1;IQGAP2;OSBPL5;WIPI1;MAPKAP1;LAPTM4B;GBF1;RPH3A;ARHGAP9;BBS5;GAB2;HIP1;DENND1C;LANCL2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.48839235783016666,1.1065130497477242,0.3620933521923621,0.91567296700466,1.0,3/16,11.77%,SLC22A3;SLC44A2;SLC7A8
prerank,sialyltransferase activity (GO:0008373),-0.36777687801835557,-1.1042652142729827,0.3289036544850498,0.6830547577735312,1.0,5/20,7.55%,ST6GALNAC3;ST3GAL6;ST8SIA4;ST3GAL1;ST6GALNAC2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4151675441403919,-1.1025873638828494,0.31626506024096385,0.6782044709482644,1.0,6/13,11.86%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5109890571410131,1.1017451971378482,0.36538461538461536,0.9271444589168938,1.0,3/11,16.10%,KCND3;KCNJ3;KCNH2
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4248448500949326,-1.0975016245639484,0.328,0.6817085575492016,1.0,5/11,18.04%,LEF1;SRRM2;GATA2;HMGA2;THAP7
prerank,ATPase regulator activity (GO:0060590),0.4071189269944648,1.0940986893599478,0.35696517412935325,0.949044959313866,1.0,12/38,18.96%,HSPH1;TSC1;DNAJB4;BAG5;DNAJB6;AHSA1;KATNB1;DNAJC19;DNAJA2;DNAJA1;FNIP1;DNAJC10
prerank,cadherin binding (GO:0045296),0.3416984316171588,1.0935125595570434,0.25376128385155466,0.9461247025633466,1.0,73/315,16.32%,DCHS1;CDH19;STXBP6;PTPRH;PRDX6;ANK3;OLFM4;TBC1D10A;EGFR;PTPRT;ACVR1;PAK4;CNN3;FMNL2;PLIN3;PACSIN2;PSEN1;BZW2;CDH10;RPL23A;CDH22;CTNNA2;SPTBN1;CDH8;YWHAZ;UBAP2;CTNNA3;GOLGA3;BAIAP2;PLEC;EPS8L1;LRRFIP1;EPS15;FLNB;ZC3H15;PPP1R13L;FLNA;FASN;CDH20;CDH7;PTPN1;SLK;VAPA;PTPRJ;CBL;GLOD4;PTPN11;UBFD1;EMD;PPP1CA;CDK5R1;RAB1A;PDXDC1;AHSA1;SCRIB;CKAP5;LYPLA2;CORO1B;NCK1;RTN4;SNX1;IQGAP1;CDC42EP1;PKP2;CLIC1;ITGB1;JUP;GCN1;CDH18;NOP56;DIAPH3;OLA1;ANLN
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.4134993831676669,1.0932027405291804,0.353904282115869,0.9374717174231791,1.0,14/34,21.98%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.4134993831676669,1.0932027405291804,0.353904282115869,0.9374717174231791,1.0,14/34,21.98%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1
prerank,MAP kinase phosphatase activity (GO:0033549),0.5039784869126679,1.0931409441832496,0.3828125,0.932911214257675,1.0,4/12,20.04%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,beta-tubulin binding (GO:0048487),0.4177891029557861,1.0925092594520247,0.354140127388535,0.9305714226421616,1.0,7/31,14.97%,DLEC1;FGF13;PACRG;EMD;CDK5R1;ARL8A;GABARAPL2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.4978858077777876,1.0923431451157537,0.36946564885496186,0.9263530874475312,1.0,7/11,26.14%,STN1;RPA2;TERF2IP;CTC1;RAD50;HNRNPA2B1;NABP2
prerank,sterol transfer activity (GO:0120015),-0.3777071061254946,-1.092293654007887,0.3076923076923077,0.68600886548853,1.0,6/17,12.31%,ABCA1;PLTP;OSBP;OSBPL2;ABCG1;STARD4
prerank,gamma-tubulin binding (GO:0043015),-0.36666880255064915,-1.0910250250144635,0.325,0.680982090497538,1.0,6/21,8.63%,NDRG1;DIXDC1;TUBGCP4;TUBGCP3;TUBGCP6;BRCA2
prerank,phospholipase C activity (GO:0004629),0.42840756034807037,1.089849512933564,0.37032085561497324,0.9298072116279203,1.0,2/25,4.92%,CHRM3;PLCB1
prerank,ATPase binding (GO:0051117),0.37649482137620166,1.0882294531027634,0.3329646017699115,0.9303823394112373,1.0,14/71,12.05%,ANK1;ANK2;EGFR;PSEN1;RALB;PPP3CA;SELENOS;PIH1D1;NCSTN;ESR1;TAF9;FBL;SNX10;PDE4D
prerank,hexosaminidase activity (GO:0015929),0.5052364659955966,1.0881722434186303,0.3841554559043348,0.9258756296675636,1.0,7/12,25.74%,NAGA;SPAM1;HYAL1;OGA;CEMIP;HEXB;CEMIP2
prerank,SUMO transferase activity (GO:0019789),0.4724499143933222,1.087909500486165,0.3793103448275862,0.9221926957459677,1.0,6/16,25.92%,RANBP2;CBX4;PIAS2;MDM2;UBE2I;TOPORS
prerank,acetyltransferase activity (GO:0016407),0.41854338120842777,1.0873713325437926,0.3593556381660471,0.9193705090098238,1.0,9/31,18.52%,KAT2B;NAA16;PAFAH1B3;KAT8;GTF2B;DBT;SMARCE1;NAA10;NAA15
prerank,retinoid X receptor binding (GO:0046965),0.5022794513392503,1.0869201110970546,0.3856,0.9162925474298931,1.0,6/11,21.43%,TACC1;RARG;NRIP1;MED25;PPARG;NSD1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.46403825207435156,1.0856678528335326,0.37621023513139695,0.9157624231167552,1.0,1/18,1.35%,HSD17B7
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3957286563789824,1.0856166375923764,0.36662606577344703,0.9115077602011238,1.0,8/42,16.02%,KAT2B;CDKN2B;CCNJ;CCNC;CKS1B;CDK5R1;CDK5R2;CCND2
prerank,fatty acid synthase activity (GO:0004312),0.5169631900019679,1.0853064518592432,0.3675078864353312,0.9081750016711277,1.0,3/10,9.43%,OXSM;ELOVL6;ELOVL5
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.4009192546954829,1.084706466990645,0.38404907975460123,0.9057940347223565,1.0,11/40,16.85%,SUV39H1;METTL9;THUMPD3;SETD3;COMT;AS3MT;FBL;LRTOMT;THUMPD2;MEPCE;PCMTD2
prerank,phosphatase inhibitor activity (GO:0019212),0.4519024830646759,1.0839898259437843,0.3645251396648045,0.9039173446231227,1.0,4/20,11.60%,LGALS3;URI1;ENSA;ANP32E
prerank,small GTPase binding (GO:0031267),0.34371822314481687,1.0788943682565963,0.33958333333333335,0.9160725771602832,1.0,41/170,15.04%,RTKN;DOCK7;HPS6;BICD1;AKAP13;FGD4;RHOBTB3;HACE1;RANBP2;IQGAP2;NOX1;PAK1;PKN1;MAPKAP1;ALS2;CDKL5;MTSS2;AP1G1;RAB34;BRK1;FLNA;TRIP11;SIKE1;MYO9B;RCC1;NGFR;USP33;BICD2;RIMS1;STK19;RHOH;WASF1;USP6NL;CCDC186;TBC1D20;RAB3GAP2;RAB11FIP3;IQGAP1;CYFIP1;SGSM1;ANKRD27
prerank,chemokine binding (GO:0019956),0.41838421666418013,1.0768342779851798,0.35989717223650386,0.9183310958686102,1.0,5/30,15.19%,FGF2;CCR2;ACKR3;ACKR4;ITGB1
prerank,cGMP binding (GO:0030553),-0.43048646392277945,-1.075910281969697,0.37349397590361444,0.710131387360673,1.0,2/11,12.43%,PDE5A;PDE2A
prerank,iron ion binding (GO:0005506),-0.29318809465705137,-1.0753249358710166,0.3092105263157895,0.7029673883124941,1.0,19/48,21.72%,AOX1;PHF2;ABCE1;PHYH;FBXL5;FTH1;EGLN2;FTL;TET1;CDO1;ALKBH3;ETHE1;TYW5;FXN;CYP2R1;EGLN3;ACO2;JMJD6;DNAJC24
prerank,glucose transmembrane transporter activity (GO:0005355),0.4619710260948935,1.0742893056593967,0.39823008849557523,0.9222702302628868,1.0,3/17,10.56%,SLC5A3;MFSD4A;SLC2A2
prerank,O-acyltransferase activity (GO:0008374),0.41719954423254996,1.0739543359554642,0.37468030690537085,0.9191022808154333,1.0,2/30,2.67%,PRDX6;MBOAT2
prerank,RNA polymerase II complex binding (GO:0000993),0.4152758070160668,1.0732953240083931,0.39272271016311167,0.91689528769722,1.0,11/32,17.40%,WAC;ZNF326;ERCC5;RPRD1A;URI1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,anion:anion antiporter activity (GO:0015301),-0.38234393741185785,-1.0724839620751412,0.3639344262295082,0.701676430222773,1.0,3/17,8.07%,SLC26A7;SLC26A2;SLC4A3
prerank,outward rectifier potassium channel activity (GO:0015271),0.4990449640436869,1.069590326434309,0.4124031007751938,0.9241659105398011,1.0,6/11,21.48%,KCND1;KCND2;KCND3;KCNT2;KCNA5;PKD2
prerank,chemorepellent activity (GO:0045499),0.41475008736542074,1.0667724509589753,0.3859416445623342,0.9289930506459477,1.0,4/25,3.81%,SEMA3E;SEMA6C;NRG3;SEMA3A
prerank,endopeptidase activator activity (GO:0061133),-0.4360516917844826,-1.0664068558493685,0.38372093023255816,0.7096011682694091,1.0,8/10,36.49%,PSMD14;APH1B;PSENEN;ADRM1;PSME3;VSIR;PSME2;NLRC4
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.32863304090915846,1.0657529161655905,0.273,0.9280801609633754,1.0,121/597,20.66%,OSR2;ETV1;SOX6;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;LHX5;TLX3;GLI2;CREB3L1;SOX8;DDX11;PRDM16;TGIF2;HOXB8;ZBTB20;SOX9;SUV39H1;HIVEP1;ZBTB37;HOXA7;MBD4;TFCP2;EGR3;KDM5B;RFX2;SOX11;ZNF276;GLI1;E2F2;PHOX2A;HOXD3;RFX3;RORC;MLX;CREB3L2;GATA6;TBX18;MEN1;CHD3;ATMIN;TFAM;RARG;BRCA1;MBD2;XPA;RARB;SOX12;SOX5;CARM1;BBX;KLF5;ARID4B;PRDM9;ERBB4;NFATC3;ATF2;ESR1;NFE2L2;MCM4;SP1;TAF9;SFPQ;TAF2;CREBZF;PER3;KLF13;NR6A1;XRCC6;ATF5;PER1;GATA3;AHR;ZNF250;ORC1;SNCA;PAX3;DHX33;TAF7;CREM;IRX5;HOXB7;POU3F1;RUNX1;ABL1;MEIS3;TP53;SP3;KCNH2;SREBF2;HNRNPU;FOXJ1;PAX2;GABPB2;GABPB1;RNF10;NFIX;NR5A1;KLF16;IRF3;ORC4;ASH2L;RFX7;BATF;EGR1;CENPC;BCOR;FOXJ3;PPARG;JUN;STAT3;ONECUT2;TFE3;ORC2;JDP2;KMT2D;PBX1;ZBED4;NR1D2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4191764353959877,1.0648725285650111,0.39040207522697795,0.9264988977308731,1.0,4/26,8.52%,LGALS3;PPP1R14C;ENSA;PPP1R8
prerank,endopeptidase inhibitor activity (GO:0004866),0.3507631533121182,1.0620782795383357,0.3751363140676118,0.9309901684033897,1.0,13/82,15.39%,A2M;LXN;NGF;RECK;PRNP;CSTB;UCHL5;BIN1;SERPINE2;UBE2Z;PROS1;USP14;UBE2O
prerank,NADP binding (GO:0050661),-0.3064925187198205,-1.0617785896835885,0.3607305936073059,0.7128139325215092,1.0,10/32,16.85%,CRYZL1;NOS3;LBR;ME1;PGD;GMDS;NOS1;NNT;SPR;QDPR
prerank,exopeptidase activity (GO:0008238),0.37618585624740347,1.0611907735480914,0.38525564803804996,0.9297589339405854,1.0,9/50,9.81%,FAP;DPEP1;KDM8;NAALAD2;LTA4H;DPP10;TRHDE;DPEP2;LNPEP
prerank,G protein-coupled receptor activity (GO:0004930),0.33139830306215085,1.0574061631777556,0.3649193548387097,0.9376095662435312,1.0,28/239,15.45%,FFAR4;SSTR1;LGR6;MRGPRF;GPR63;RHO;HRH1;LPAR1;GPR65;GPR173;PTH2R;LGR5;P2RY14;TSHR;ADGRB3;MAS1;GRM5;GPR37;GPR88;S1PR3;ADGRL3;DRD2;GLP2R;P2RY12;P2RY1;ADGRG2;XPR1;TM2D1
prerank,protein tyrosine kinase binding (GO:1990782),0.35560079484489265,1.0566098984308723,0.3961625282167043,0.9362025285139305,1.0,14/71,10.85%,SHC4;LRP4;CBLB;ACVR1;PTPN2;NRG3;PHYHIP;SOCS5;ALKAL2;GRB14;PTPN1;GRM5;CBL;PTPN11
prerank,voltage-gated calcium channel activity (GO:0005245),0.39519418488516167,1.0563894710897812,0.40226986128625475,0.9326846582384212,1.0,6/37,6.44%,CACNA1E;CACNA2D1;CACNG7;NCS1;CACNA1A;CACNB4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4955253287114215,1.053310372085385,0.4067796610169492,0.9341474373287554,1.0,2/11,8.56%,HSPH1;BAG5
prerank,adenyl nucleotide binding (GO:0030554),0.4955253287114215,1.053310372085385,0.4067796610169492,0.9341474373287554,1.0,2/11,8.56%,HSPH1;BAG5
prerank,DNA secondary structure binding (GO:0000217),0.40352151842448636,1.052560959972123,0.39719029374201786,0.9323613783070165,1.0,8/31,17.24%,KMT2A;ERCC5;MEN1;MSH6;XRCC3;ABL1;BLM;WRN
prerank,BMP binding (GO:0036122),0.49217261447067934,1.0519891363426892,0.4279210925644917,0.9300463933934822,1.0,1/11,0.48%,SOSTDC1
prerank,Hsp90 protein binding (GO:0051879),0.4025369015729942,1.0514616646685975,0.41005291005291006,0.9274455376094894,1.0,9/33,13.21%,FKBP6;SLC12A2;TSC1;PACRG;PPID;HIF1A;HDAC6;AHSA1;AHR
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.4348541014930872,1.049116198325641,0.41514726507713884,0.9303703613503811,1.0,6/20,19.01%,AGPAT2;MOGAT3;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,GTPase binding (GO:0051020),0.3313585669079199,1.049071772440992,0.4024767801857585,0.9265031731917212,1.0,45/195,15.04%,RTKN;DOCK7;HPS6;BICD1;AKAP13;FGD4;EPRS1;RHOBTB3;HACE1;RANBP2;IQGAP2;NOX1;SPTBN1;PAK1;PKN1;RASA1;MAPKAP1;ALS2;CDKL5;MTSS2;AP1G1;RAB34;BNIP3;BRK1;FLNA;TRIP11;SIKE1;MYO9B;RCC1;NGFR;USP33;BICD2;RIMS1;STK19;RHOH;WASF1;USP6NL;CCDC186;TBC1D20;RAB3GAP2;RAB11FIP3;IQGAP1;CYFIP1;SGSM1;ANKRD27
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.3988620055512788,-1.047313539562271,0.4166666666666667,0.7409408499406096,1.0,3/12,2.70%,CDH5;VEGFC;VEGFD
prerank,clathrin adaptor activity (GO:0035615),0.4623532371062395,1.0465796482884857,0.42898134863701576,0.9301405916396986,1.0,4/15,8.71%,STON2;STON1;AP1G1;HIP1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.4790571833116515,1.0461732530303016,0.43116490166414523,0.9273648021576688,1.0,2/13,1.40%,BMP5;PYCARD
prerank,neuropeptide hormone activity (GO:0005184),0.42210998163199226,1.0458921824277176,0.417910447761194,0.9242832337862618,1.0,1/22,0.98%,CRH
prerank,GTP binding (GO:0005525),0.33305895390997636,1.0455821214252174,0.3935617860851506,0.9212619799902526,1.0,41/172,18.40%,RHOJ;RASEF;RHOD;RAB38;RND3;RAP2B;ADSS1;RHOBTB3;RAB14;ARL3;RALB;ARL1;BMS1;RAB21;RAP1A;RAB39A;RABL3;LANCL2;TUBB6;RHOT2;ARL2;MRAS;ARL5C;ARF4;ANXA6;RAB22A;RHOH;RHOC;ATL3;ARL8A;GNAI1;RAB4A;TRIM23;GTPBP10;EIF2B2;RAC3;RAB7A;RHOT1;TUBA1A;NRAS;KRAS
prerank,ubiquitin binding (GO:0043130),0.3565285448448564,1.0445781456896628,0.42393736017897093,0.9204387472537127,1.0,19/73,19.07%,RAD23B;PRKN;MVB12B;FBXW7;FBXO7;CKS1B;UCHL1;RNFT1;USP33;UCHL3;TOLLIP;VPS36;MVB12A;PLAA;USP25;N4BP1;NBR1;MDM2;USP5
prerank,anion transmembrane transporter activity (GO:0008509),0.490041835207063,1.0435351825130947,0.4393491124260355,0.9196942883187924,1.0,2/12,5.60%,SLC22A3;SLCO2B1
prerank,double-stranded DNA binding (GO:0003690),0.3224867292446067,1.0433917570974092,0.362,0.9161666143542457,1.0,72/531,15.55%,OSR2;ETV1;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;LHX5;TLX3;GLI2;CREB3L1;SOX8;DDX11;TGIF2;HOXB8;ZBTB20;SOX9;EGFR;HIVEP1;ZBTB37;HOXA7;SATB1;APTX;TFCP2;EGR3;KDM5B;RFX2;ERCC5;ZNF276;MBD1;E2F2;PHOX2A;HOXD3;RFX3;RORC;MLX;SETMAR;GATA6;TBX18;MEN1;RARG;XPA;RARB;SOX12;BBX;KLF5;REXO4;TDP1;NFATC3;PSIP1;ATF2;FBH1;ESR1;SP1;MSH6;KLF13;NR6A1;XRCC6;GATA3;AHR;ZNF250;PAX3;CRY1;ZNF638;POLG2;CREM;IRX5;HOXB7;CGAS;POU3F1;ABL1;MEIS3
prerank,GTPase regulator activity (GO:0030695),0.33158187248269333,1.04321779509151,0.3944954128440367,0.912848619619765,1.0,42/212,14.95%,ARHGAP24;SIPA1L1;DLC1;ARHGAP32;RTKN;ARHGAP19;TBC1D10A;GPSM2;NPRL2;RANBP2;ELMOD2;IQGAP2;PLCB1;NF1;RGS11;RASA1;CHN1;ALS2;MTSS2;ARHGAP9;ARHGEF10L;TBCK;VAV3;ADGRB3;DOCK1;ARHGAP11A;ARL2;MYO9B;RIMS1;OPHN1;STXBP5;RHOH;ACAP2;USP6NL;ELMOD3;TBC1D20;RAB3GAP2;ARFGAP3;ARFGAP1;ARHGAP44;IQGAP1;SGSM1
prerank,thyroid hormone receptor binding (GO:0046966),0.40098003995679316,1.042950151442481,0.40921052631578947,0.9098545071235783,1.0,12/28,22.78%,TACC1;GTF2B;TRIP6;BRD8;MED13;TAF11;TAF7;MED12;NCOA3;MED30;NSD1;MED24
prerank,PDZ domain binding (GO:0030165),0.36217401896182955,1.0429363671245622,0.4143835616438356,0.9061207269512588,1.0,12/61,8.17%,TBC1D10A;PTEN;PRKN;GRIA1;ATP2B3;PSEN1;SDC2;GRID2;NLGN1;FZD7;ACOX1;CADM1
prerank,BMP receptor binding (GO:0070700),0.4790580542511473,1.0427528161040234,0.4311377245508982,0.9028812385103607,1.0,2/12,1.40%,BMP5;PYCARD
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3508235283942401,1.0396392563674954,0.432967032967033,0.9082808342923018,1.0,15/85,16.30%,PRDX6;CEL;PGAP1;H6PD;PLA2G7;PAFAH1B3;MRPL58;LYPLA1;PLA2G12A;PLAAT5;PLAAT3;LYPLA2;LIPC;PGLS;ABHD6
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.48239098034677474,1.0349742508421456,0.4336,0.9184130961875451,1.0,5/11,18.50%,PYCARD;CASP6;CASP12;CASP2;CASP7
prerank,neurexin family protein binding (GO:0042043),0.4989940836406644,1.032607424121851,0.43369734789391573,0.9216207784406499,1.0,2/10,5.72%,CEL;NLGN1
prerank,antiporter activity (GO:0015297),0.4286860854955757,1.03207964860458,0.44695898161244696,0.9194170805772114,1.0,8/20,17.17%,SLC35C2;SLC35E2B;SLC35E2A;SLC35A1;SLC25A10;SLC25A11;SLC35E1;SLC35E3
prerank,galactosyltransferase activity (GO:0008378),-0.41980675450864474,-1.0318875764220006,0.4028169014084507,0.7722987834896582,1.0,5/11,19.20%,B4GALT7;B4GALT1;A4GALT;B4GALT2;B4GALT4
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4287720481767304,1.031749583064738,0.4508990318118949,0.9167690655475728,1.0,2/21,5.11%,CHRNA4;GRIK2
prerank,general transcription initiation factor binding (GO:0140296),0.4085854970541253,1.03124945393561,0.43826322930800543,0.9144977227086262,1.0,13/25,27.54%,DRAP1;GTF2B;ESR1;TAF11;AHR;PSMC1;TAF1;RUVBL2;YEATS2;THRA;TBP;DR1;RELA
prerank,SH3 domain binding (GO:0017124),0.36380587014273663,1.0306790512483746,0.4481955762514552,0.912385375392808,1.0,7/62,4.43%,SGIP1;ENAH;PTPN22;CBLB;PRKN;WIPF1;NCF1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.40152462349667395,-1.0295378822040255,0.4253521126760563,0.7701558843682422,1.0,6/12,19.86%,PHF2;KDM1A;KDM4C;KDM4D;KDM3B;HR
prerank,solute:proton symporter activity (GO:0015295),0.4488828163556051,1.0288553242205916,0.44395924308588064,0.9140149434967015,1.0,2/16,5.20%,SLC17A5;SLC36A2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4316400677859292,1.0288468335094716,0.42377622377622376,0.9103933968803691,1.0,5/18,16.15%,DPEP1;MT3;PRDX3;SNCA;XIAP
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.35196124298497283,-1.0280158085807793,0.4290322580645161,0.765371790061984,1.0,6/18,13.38%,SMAD6;SMAD7;ENG;TGFBR1;TGFB2;USP15
prerank,N-acetyltransferase activity (GO:0008080),0.4300473551099645,1.0278177950011447,0.43422913719943423,0.9097450342949549,1.0,7/19,27.26%,KAT2B;SMARCE1;NAA10;NAT8L;ATAT1;SAT1;NAA50
prerank,hyaluronic acid binding (GO:0005540),0.4857505357715844,1.0270359594091463,0.46747352496217853,0.908318133015462,1.0,1/10,1.24%,CHODL
prerank,cytokine receptor binding (GO:0005126),0.3428698868386377,1.0244385587429614,0.43722466960352424,0.9123231532785451,1.0,13/83,13.84%,PYCARD;CRLF1;FADD;VEGFA;PXDN;SPRED2;SPRED1;IL18;TRIP6;TYK2;IL6ST;PRLR;TGFBRAP1
prerank,adrenergic receptor binding (GO:0031690),0.440727378570842,1.0237558354624878,0.43023255813953487,0.9105556965437677,1.0,4/16,12.05%,SAV1;UCHL1;MAGI2;PDE4D
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.38057728138125524,1.0229278828798942,0.45056320400500627,0.909341837522564,1.0,8/37,14.03%,IARS2;EPRS1;FARSA;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,copper ion binding (GO:0005507),0.370883914875125,1.0224357749159103,0.42926239419588874,0.9071906244861617,1.0,11/42,18.76%,CUTA;PRNP;MT3;AOC1;LOXL3;GPC1;SUMF1;SNCA;TP53;SNCB;PARK7
prerank,growth factor activity (GO:0008083),0.34393895657915957,1.0212320120713896,0.44854586129753915,0.9070665470306598,1.0,10/74,12.11%,FGF2;FGF10;NGF;NRG3;VEGFA;BTC;AMELX;GDNF;FGF7;GRN
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.39059658983266254,-1.020741895875769,0.4408284023668639,0.7761559901710636,1.0,3/12,5.85%,IGF1;IGF2;INSR
prerank,DNA replication origin binding (GO:0003688),0.40896894868816014,1.0200823566657866,0.4576502732240437,0.9069086318063388,1.0,8/23,24.07%,DDX11;MCM4;ORC1;ORC4;ORC2;HSPD1;KAT7;ORC3
prerank,semaphorin receptor binding (GO:0030215),0.40317347128960745,1.0190747492162069,0.4396200814111262,0.9062705137378501,1.0,3/23,3.81%,SEMA3E;SEMA6C;SEMA3A
prerank,protein kinase C binding (GO:0005080),-0.2800196440662614,-1.017940593783131,0.3882978723404255,0.77509102219248,1.0,12/43,18.82%,GRK5;PARD6G;PDLIM5;PRKCB;RACK1;ADCY4;CAVIN3;SQSTM1;TIRAP;TRPV4;HSPB1;DACT2
prerank,damaged DNA binding (GO:0003684),0.3671907858714976,1.0160194879710975,0.46265060240963857,0.9113422866427392,1.0,9/44,13.81%,APTX;ERCC5;ERCC4;MPG;DDB2;RPA3;XPA;DDB1;RPA2
prerank,Hsp70 protein binding (GO:0030544),0.3909572208173704,1.0154905957667284,0.46551724137931033,0.9091977384007859,1.0,12/31,24.27%,PRKN;TSC1;PACRG;PPID;GPR37;SNCA;FICD;DNAJA1;DNAJC10;DNAJC8;PPEF2;IQCG
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3176703156643056,1.0123877536333052,0.4657258064516129,0.9144444496879387,1.0,49/254,21.26%,OSR2;ETV1;KLF15;ETV4;MEOX2;CREB3L1;PRDM16;MYC;SOX9;HOXA7;TFCP2;SOX11;RFXANK;E2F2;HOXD3;ZBTB16;ATMIN;SOX12;KLF5;HIF1A;NFATC3;ATF2;ESR1;SP1;ZNF112;ATF5;GATA3;SALL2;MDM4;HOXB7;RUNX1;MEIS3;TP53;NFIA;FOXJ1;MDM2;IRF3;KLF7;EGR1;PRRX1;FOXJ3;JUN;STAT3;PRDM2;ONECUT2;MEIS1;ZSCAN21;NFKB1;MITF
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.43570862092189466,1.0120508436595186,0.4507462686567164,0.9119819935137305,1.0,3/14,9.76%,NCF1;NOX1;NCF2
prerank,voltage-gated chloride channel activity (GO:0005247),0.48320501549467343,1.011723662541313,0.4529505582137161,0.9093869749620513,1.0,2/10,3.48%,CLCN5;ANO6
prerank,protein kinase binding (GO:0019901),0.31174905488754273,1.011560992361141,0.47147147147147145,0.9065140748348312,1.0,107/479,18.71%,ROR2;SHC4;BCL2L14;DNM1;UTRN;CNKSR2;RHOD;BICD1;ANK2;KAT2B;SOX9;DUSP4;PRKN;CDKN2B;RND3;ACVR1;PTPN2;RHOBTB3;PHYHIP;MAPK7;IRAK3;GPRC5B;MAPKAPK3;NBEA;PRKCSH;MAPKAPK2;PPP1R15A;DUSP6;PRKAR1B;SLC12A2;PDE3B;SCN5A;FBXO7;SOCS1;CKS1B;PKN1;YWHAZ;MAPKAP1;NELL2;SPRED2;CSK;FAM83H;PRKAB2;UFL1;SPRED1;GATA6;FOXM1;TBL2;LAX1;BAG5;ANKRA2;HIF1A;SYN1;SV2A;PTPN1;GRM5;PIH1D1;SPRED3;SIKE1;HINT1;ATF2;PTPRJ;ESR1;PTPN11;SLC12A4;CDC25B;CDK5R1;ERCC6L2;UNC5C;RHOH;RHOC;DVL1;PRKACA;PRDX3;TPCN2;CALM1;SPAG9;PKD1;IQGAP1;TICAM1;PKP2;ITGB1;ACSL3;DACT1;ABL1;CALM2;STX1B;TP53;CCND2;FAM83F;MYH6;RAC3;TRAP1;CSPG4;SUFU;FBXO5;TPRKB;JTB;RPTOR;NBR1;DCX;USP37;DUSP16;GYS1;INKA1;MAPRE3;MAP3K11
prerank,endopeptidase regulator activity (GO:0061135),0.3716076260229306,1.0112927182933389,0.45498783454987834,0.903846462646442,1.0,7/40,14.92%,A2M;RECK;CSTB;UCHL5;APH1A;PROS1;USP14
prerank,Tat protein binding (GO:0030957),0.49109657265626727,1.01124893159632,0.4567699836867863,0.900571046974425,1.0,1/10,0.83%,MDFIC
prerank,phospholipase activity (GO:0004620),0.34680772399539184,1.007878957405818,0.4642451759364359,0.9064586853723505,1.0,16/67,21.32%,PRDX6;PLBD1;LYPLA1;PLA2G12A;PLAAT5;PLAAT3;LYPLA2;PNPLA8;SEC23IP;LIPC;GPLD1;ABHD6;GDPD3;PLA2G4E;DDHD1;ABHD16A
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.43954184539179925,1.0056508172885872,0.45021645021645024,0.9091985310996737,1.0,5/15,19.01%,AGPAT2;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3201378797498362,-1.005191063771192,0.44,0.800594447769883,1.0,7/24,11.48%,DAPK1;CAMK2G;CAMK1D;MKNK2;CAMK1;CAMK4;CAMK2A
prerank,androgen receptor binding (GO:0050681),-0.30836262681853355,-1.0050390568411829,0.42578125,0.7923529354976987,1.0,7/25,11.46%,FOXP1;KDM1A;PRKCB;SNW1;DDX5;KDM4C;PRMT2
prerank,Wnt-activated receptor activity (GO:0042813),0.44400098629868945,1.0044269500352354,0.46824224519940916,0.9093279523560193,1.0,4/15,15.53%,ROR1;FZD7;PKD1;FZD9
prerank,mRNA binding (GO:0003729),0.31437594176488803,1.0023957842298434,0.4909274193548387,0.9114333491047049,1.0,86/249,26.29%,PABPC5;RBFOX1;CSTF3;RBMS3;CELF5;QKI;ELAVL4;TRA2B;DXO;PABPC1;CPSF6;ETF1;HNRNPAB;METTL3;LUC7L2;SRBD1;UNK;CPEB3;ZC3H12B;KHDRBS3;PPP1R8;DCP1B;NCBP1;EIF4G1;PCBP4;DAZAP1;ADARB1;CPEB1;RBM4B;CELF6;DHX33;NOVA1;SRSF6;YTHDC1;KHSRP;LUC7L;EIF4ENIF1;TP53;HNRNPU;RBM46;N4BP1;SRRM3;FUBP1;RC3H1;RNPS1;SSB;SF1;AUH;CLUH;RBFOX3;PARK7;MARF1;CNBP;SYNCRIP;HNRNPC;FUBP3;ZFP36;CELF4;HNRNPL;RBFOX2;EIF4G3;DDX6;RBMS1;FYTTD1;RIDA;SNIP1;PTBP2;ZC3H12C;YBX3;DENR;RBM25;XPO5;TUT1;PCBP2;G3BP2;THOC5;GNL3;FMR1;CIRBP;NSRP1;RBM4;RNF20;YTHDF3;RBM15;HNRNPA2B1;CPEB4
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.45177157894968356,1.0023373327050253,0.47147147147147145,0.9082708266935301,1.0,3/13,6.59%,SOX9;PRKAR1B;CSK
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.401637284157883,-1.002030255104484,0.4823848238482385,0.7917591011169048,1.0,3/10,4.93%,PRKAG2;PKIA;PRKAR1A
prerank,nuclear receptor coactivator activity (GO:0030374),0.3481779531124162,1.0012089637546497,0.470873786407767,0.9079709790105361,1.0,21/52,25.10%,FGF2;NCOA1;TACC1;PKN1;CARM1;ZMIZ1;NCOA2;BRD8;MED13;TMF1;MED12;NCOA3;MED30;RNF4;DCAF6;MED24;WDR77;CCDC62;ZMIZ2;NCOA7;ENY2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.46684123408782846,1.0007512703235981,0.47900466562986005,0.9059764813881181,1.0,1/11,4.08%,CHRNA4
prerank,triglyceride lipase activity (GO:0004806),0.4101055279036708,1.0001187210921845,0.47506925207756234,0.9043374756491563,1.0,1/20,1.19%,CEL
prerank,glycerophospholipid flippase activity (GO:0140333),-0.39895791970186345,-1.0000394624521105,0.4350453172205438,0.7887191151600148,1.0,8/11,18.40%,ATP10A;ABCA3;ABCA4;ATP11A;ATP8B2;ABCB4;ATP10B;ATP8A1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.36251792217400514,-0.9986577447642295,0.43653250773993807,0.7842736895525967,1.0,3/15,2.95%,PI4KA;PIK3R3;PIK3C2A
prerank,ribonuclease P activity (GO:0004526),0.4599908791196935,0.9986262121102594,0.4885145482388974,0.905056423796716,1.0,6/11,27.32%,RPP38;PRORP;POP1;RPP21;RPP30;RPP14
prerank,peptide hormone receptor binding (GO:0051428),0.4611896402741735,0.9981344530512478,0.48372093023255813,0.9030579138091414,1.0,1/11,3.66%,PTHLH
prerank,cyclic nucleotide binding (GO:0030551),-0.32115743996182405,-0.9971676887539708,0.46558704453441296,0.7803661065965546,1.0,4/21,12.43%,PDE5A;RAPGEF4;PDE4A;PDE2A
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.41111579399174325,-0.9969888515478628,0.46176470588235297,0.7728055139945325,1.0,4/10,16.55%,B4GALT7;B3GALT1;B4GALT1;B3GALT2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4162247001362566,0.9950238436232863,0.49027777777777776,0.9078750043238927,1.0,7/20,19.22%,USP50;SENP3;UFSP2;SENP2;USP25;USP21;SENP1
prerank,lysine-acetylated histone binding (GO:0070577),-0.32332883977484295,-0.9940538748757701,0.4233576642335766,0.7650255953864185,1.0,10/20,21.13%,MLLT3;BRD7;ZMYND8;BRD9;BRD2;ATAD2B;BAZ2A;THAP7;YEATS4;BRDT
prerank,acetylation-dependent protein binding (GO:0140033),-0.32332883977484295,-0.9940538748757701,0.4233576642335766,0.7650255953864185,1.0,10/20,21.13%,MLLT3;BRD7;ZMYND8;BRD9;BRD2;ATAD2B;BAZ2A;THAP7;YEATS4;BRDT
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3260112275466572,-0.9939673270602936,0.5055350553505535,0.7577596638556426,1.0,8/21,13.67%,PDE5A;PDE8B;PDE8A;PDE1A;PDE3A;PDE4A;PDE2A;PDE1C
prerank,mRNA 3'-UTR binding (GO:0003730),0.3361441720552396,0.9926317843155781,0.4933184855233853,0.9106013462575077,1.0,27/79,26.29%,PABPC5;RBMS3;ELAVL4;PABPC1;EXOSC8;CPEB3;ZFP36L2;PCBP4;DAZAP1;CPEB1;KHSRP;TP53;HNRNPU;RC3H1;RNPS1;AUH;HNRNPC;ZFP36;RBMS1;YBX3;TUT1;FMR1;CIRBP;RBM4;RNF20;HNRNPA2B1;CPEB4
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.3545430935437771,-0.9911753590037276,0.4676923076923077,0.7573447706384123,1.0,1/15,0.65%,PLA2G4A
prerank,GTPase activator activity (GO:0005096),0.31051869075464494,0.9902690694085171,0.5271084337349398,0.9137501598548439,1.0,73/313,17.47%,ARHGAP24;SIPA1L1;DLC1;ARHGAP32;ARHGAP19;TBC1D10A;DENND2A;AKAP13;FGD4;FRMD7;NPRL2;ARHGEF28;NUCB1;RANBP2;ELMOD2;IQGAP2;DOCK5;PLCB1;NF1;ARHGEF10;RGS11;RASA1;CHN1;ALS2;MTSS2;EPS8L1;DOCK10;ITSN1;RAP1A;EIF2B5;ARHGAP9;RGL1;LAMTOR2;ARHGEF11;ARHGEF10L;TBCK;VAV3;ADGRB3;DENND1C;DOCK1;ARHGAP11A;SPATA13;MYO9B;FARP2;RCC1;OPHN1;DNMBP;STXBP5;RCC1L;ACAP2;USP6NL;ELMOD3;TBC1D20;RAB3GAP2;ARFGAP3;ARFGAP1;ARHGAP44;RAB3IL1;IQGAP1;SGSM1;ANKRD27;ELMO1;CYTH3;RIC8B;ARFGEF1;RAP1GAP;HPS1;ELMOD1;ARHGEF4;EIF2B2;DENND10;GARNL3;RALGAPB
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3038464145290529,0.988906561861238,0.543,0.9142702944811262,1.0,115/831,16.05%,EBF2;RORA;OSR2;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;LHX5;TLX3;GLI2;SOX8;PRDM16;MYC;DMRT2;TGIF2;EBF1;HOXB8;ZNF25;ZBTB20;SOX9;HIVEP1;OTP;ZBTB37;HOXA7;SATB1;TFCP2;EGR3;NFX1;FOXP2;RFX2;SOX11;RFXANK;GLI1;E2F2;ZEB1;PHOX2A;HOXD3;PGBD1;ZFP14;RFX3;ZBTB16;RORC;MLXIPL;MLX;TRPS1;TWIST2;E2F6;LRRFIP1;GATA6;TBX18;FOXM1;ZSCAN20;GTF2B;MKX;ZBTB41;RARG;RARB;SOX12;SOX5;ZNF569;BBX;KLF5;HIF1A;ZBTB6;CHD2;ZSCAN26;ZBTB38;NFATC3;ZNF260;ATF2;ZKSCAN8;ESR1;NFE2L2;MYT1;SP1;ZNF112;HDAC6;RBAK;ZFHX4;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;NRIP1;ATF5;PER1;GATA3;ZNF83;SALL2;ZNF250;ZBTB39;NACC2;KDM6A;PAX3;ZFHX2;HIVEP3;CREM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;MEIS3;PURG;KLF9;TP53;SP3
prerank,protein phosphorylated amino acid binding (GO:0045309),0.3651707873624906,0.988666021733306,0.5121654501216545,0.9116977875467733,1.0,18/42,27.00%,FBXW7;RASA1;SAMSN1;PIK3R1;PTPN11;ABL1;GRB2;SH3BP2;BCAR3;YES1;VAV2;NCK2;CRK;HCK;LDLRAP1;SYK;SHC3;PIN1
prerank,gap junction channel activity (GO:0005243),-0.31337016499110926,-0.9871101728805847,0.4509090909090909,0.7605095372503726,1.0,4/22,10.77%,GJA1;GJB6;GJC1;GJD3
prerank,3'-5' DNA helicase activity (GO:0043138),-0.3427707256067115,-0.9847862292550503,0.4586206896551724,0.7593745150841962,1.0,4/16,9.74%,NAV2;RECQL5;ERCC3;MCM6
prerank,myosin V binding (GO:0031489),0.43270223432507066,0.9840811267684172,0.5049088359046283,0.919925523248662,1.0,7/15,25.46%,RAB14;RAB3D;RAB3A;RAB3B;RAB39B;RAB6A;RAB27B
prerank,histone methyltransferase activity (GO:0042054),0.371117707917162,0.9836813912424055,0.47570332480818417,0.9176920359471815,1.0,8/32,11.15%,SUV39H1;EED;MEN1;CARM1;PRDM9;SETD2;FBL;PRMT1
prerank,cation transmembrane transporter activity (GO:0008324),0.356071564788064,0.982643505378477,0.5011904761904762,0.9170497158707336,1.0,5/48,6.18%,SLC22A3;SLC25A2;SLC1A5;SLC36A2;SLC25A38
prerank,protein serine/threonine kinase activity (GO:0004674),0.3055000475627449,0.9819317218486027,0.549748743718593,0.9157280240956759,1.0,85/335,19.43%,WNK2;PRKCA;STK32B;PRKCQ;STK36;EGFR;ACVR1;ALPK1;MAP4K4;PAK4;MAPK7;ARAF;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;PAK5;MAPKAPK2;DYRK4;TESK2;TNIK;ACVR1C;PAK1;PKN1;CDKL5;CDK8;CDKL3;CDK13;TGFBR2;ATP23;PRKAB2;DYRK1B;PDK3;LIMK1;CDK6;GAK;CDK15;CDK19;STK39;PASK;TLK2;MAPK9;AKT3;SGK3;SGK2;SLK;MAPK14;PKMYT1;STK32A;STK19;MAPK1;TAOK3;TBK1;STK33;CSNK1G1;PRKACA;CSNK1A1;NEK7;CDK16;TRIO;TTBK1;RPS6KA2;MAP3K4;BMPR1A;ATM;PIM2;CSNK1E;CSNK1G2;HTATIP2;SGK1;RIPK1;CHUK;PKN2;TP53RK;VRK3;MAP3K11;TAF1;CSNK2A2;TESK1;BCKDK;CSNK1G3;TOP1
prerank,ribosomal small subunit binding (GO:0043024),-0.3447712632110867,-0.9798278293689275,0.49185667752442996,0.7649970386665539,1.0,5/17,15.54%,MTIF2;NPM1;ABCE1;MTIF3;NME1
prerank,cation:chloride symporter activity (GO:0015377),0.4691137289788655,0.97898492273783,0.5,0.9204514173302359,1.0,3/10,11.14%,SLC12A3;SLC12A2;SLC12A4
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3784544703777971,-0.9779030380536777,0.48066298342541436,0.7623800811764544,1.0,3/12,12.11%,NOCT;CNOT1;PAN2
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2554390441541569,-0.9770364000176891,0.5,0.7572758376780697,1.0,15/49,15.01%,MPPED2;ATP1A2;PPP1CB;PPP1CC;PXYLP1;DUSP3;LHPP;SBF1;SAMHD1;ARMT1;ACP6;PGAM5;DUSP10;PTPRO;PRUNE1
prerank,nuclear receptor binding (GO:0016922),0.31835272543438753,0.9762631482235665,0.5166130760986066,0.9242031418932308,1.0,35/111,20.23%,NCOA1;RNF6;TACC1;PKN1;WIPI1;DDX54;GTF2B;PPID;TRIP6;NCOA2;BRD8;HIF1A;MED13;ESR1;TAF11;DCAF1;TMF1;NRIP1;PRPF6;STRN;LCOR;CRY1;NCOR2;TAF7;MED12;MED25;JUP;SMARCE1;NCOA3;MED30;TACC2;PARK7;TAF1;PHB2;SMARCA4
prerank,kinase binding (GO:0019900),0.3012175216018991,0.9761041177350667,0.5841683366733467,0.9214823795264503,1.0,104/434,19.55%,SHC4;BCL2L14;DNM1;UTRN;CNKSR2;RHOD;PTPN22;BICD1;ANK2;KAT2B;GSN;PRKN;CDKN2B;EGFR;RND3;PTPN2;RHOBTB3;IRAK3;GPRC5B;NBEA;PPP1R15A;SLC12A2;DLG2;SCN5A;FBXO7;SOCS1;CKS1B;YWHAZ;MAPKAP1;LAPTM4B;SPRED2;FAM83H;PRKAB2;UFL1;SPRED1;GATA6;FOXM1;TBL2;LAX1;FLNA;BAG5;ANKRA2;TRIP6;HIF1A;SYN1;SV2A;PTPN1;PIH1D1;SPRED3;SIKE1;ATF2;PTPRJ;ESR1;PTPN11;SLC12A4;CDC25B;TOLLIP;CDK5R1;ERCC6L2;UNC5C;TAX1BP1;SGO1;RHOH;RHOC;DVL1;PRKACA;PRDX3;TPCN2;ATF5;PER1;CALM1;PKD1;IQGAP1;TICAM1;ACSL3;EIF4ENIF1;CALM2;STX1B;TP53;CCND2;FAM83F;MYH6;RAC3;TRAP1;CSPG4;PIP5K1A;SUFU;FBXO5;TPRKB;JTB;RPTOR;DCX;USP37;PIK3IP1;GYS1;INKA1;HTT;MAPRE3;PARK7;POLR2A;KCNA5;GRB2;CAB39;BCL10
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4643596824463149,0.9759107115561,0.5176110260336907,0.918773434436696,1.0,5/11,21.66%,SLC25A23;SLC35B3;SLC25A25;SLC25A24;SLC17A9
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3150348238521281,-0.9757512302591452,0.488,0.7533890157910526,1.0,9/23,14.75%,PDE5A;PDE8B;PDE8A;PDE1A;PDE3A;PDE4A;PDE2A;PDE1C;ADPRM
prerank,wide pore channel activity (GO:0022829),-0.30923336986643735,-0.9749782202532005,0.4580152671755725,0.7485770059242538,1.0,4/23,10.77%,GJA1;GJB6;GJC1;GJD3
prerank,ribonuclease activity (GO:0004540),0.34407443717756336,0.9744133621500993,0.5397196261682243,0.9195157489298098,1.0,8/56,10.78%,INTS11;RNASE6;NOB1;EXOSC8;ZC3H12B;PPP1R8;EXOSC2;RCL1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.34757413922970154,0.9743434664051895,0.5159386068476978,0.9165620188044887,1.0,17/49,21.11%,CPNE8;C2CD5;ANXA9;SYT1;RPH3A;SYT11;SYT12;MCTP1;ANXA6;DOC2B;DYSF;CPNE7;SYT2;CPNE1;PLA2G4E;SYT13;CPNE3
prerank,C-C chemokine receptor activity (GO:0016493),0.39301800235059625,0.9726565235811344,0.5209176788124157,0.9178449450630458,1.0,3/21,14.06%,CCR2;ACKR3;ACKR4
prerank,metalloexopeptidase activity (GO:0008235),0.34735322603537255,0.9723948104892296,0.5283687943262412,0.915347993009483,1.0,12/51,15.59%,DPEP1;AGBL3;LTA4H;MMP15;AGBL2;TRHDE;LNPEP;AGBL4;MMP16;AGBL1;CPD;RNPEPL1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3813910673162807,-0.970997651204143,0.49866666666666665,0.7513520308638839,1.0,5/11,13.03%,NDUFAF7;PRMT7;PRMT5;PRMT2;PRMT8
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.29801923722687007,0.9674644078699309,0.637,0.9243800377530287,1.0,127/731,19.76%,EBF2;RORA;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;TLX3;GLI2;CREB3L1;SOX8;PRDM16;MYC;DMRT2;TGIF2;EBF1;ZBTB20;SOX9;HIVEP1;ZBTB37;HOXA7;SATB1;TFCP2;EGR3;FOXP2;RFX2;SOX11;GLI1;E2F2;ZEB1;HOXD3;PGBD1;ZFP14;RFX3;ZBTB16;RORC;MLXIPL;MLX;CREB3L2;E2F6;LRRFIP1;GATA6;TBX18;ZSCAN20;MKX;ZBTB41;RARG;RARB;SOX12;SOX5;ZNF569;KLF5;HIF1A;ZBTB6;CHD2;ZSCAN26;ZBTB38;NFATC3;ZNF260;ATF2;ZKSCAN8;ESR1;NFE2L2;MYT1;SP1;ZNF112;HDAC6;ZFHX4;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;NRIP1;PER1;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;NACC2;KDM6A;PAX3;ZFHX2;HIVEP3;CREM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;MEIS3;KLF9;TP53;SP3;SREBF2;HNRNPU;NFIA;FOXJ1;PAX2;NFIX;ZKSCAN1;HEYL;NR5A1;KLF16;IRF3;ZNF697;ZNF496;KLF7;RFX7;BATF;EGR1;MED8;RUVBL2;TOP1;PRRX1;FOXJ3;PPARG;JUN;STAT3
prerank,calcium-release channel activity (GO:0015278),-0.3350434796376089,-0.9673593581541295,0.5252525252525253,0.7528860294581878,1.0,3/17,9.86%,ITPR1;RASA3;MCOLN1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.45964857422011574,0.9656689486571893,0.5282442748091603,0.9254719623856603,1.0,2/10,10.15%,APOBEC1;ADARB2
prerank,cardiolipin binding (GO:1901612),-0.39088480555000205,-0.9653259415177584,0.4958904109589041,0.7511056666985982,1.0,5/10,29.59%,STOML2;GSDMD;GSDME;UQCC3;MME
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3422622971445092,0.9645437024348654,0.5240384615384616,0.9253905588323948,1.0,13/51,17.17%,SLC28A1;ANKH;SLC16A10;SLC35C2;SLCO2B1;SLC35E2B;SLC35E2A;SLC35A1;SLC7A8;SLC25A10;SLC25A11;SLC35E1;SLC35E3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.45218124076915944,0.964485609760179,0.5142405063291139,0.9224496607551464,1.0,5/12,31.21%,TRAF4;TRAP1;TRIM37;TRAF6;TRAF3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3868092152992063,0.964007147469899,0.5280748663101604,0.9205664333383848,1.0,4/24,9.31%,PLEKHA5;SESTD1;OSBPL5;LANCL2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.34642415475409577,0.9603240810578588,0.5449101796407185,0.9265135566510613,1.0,9/53,13.82%,SLC1A3;SLC25A2;SLC1A5;SLC36A2;SLC25A38;SLC43A1;SLC7A7;SLC7A8;SLC25A15
prerank,CoA hydrolase activity (GO:0016289),0.41814785204399824,0.9602184280376489,0.5049645390070922,0.9237241517581587,1.0,6/16,25.88%,ACOT11;HIBCH;ACAA2;ACOT8;NUDT7;ACOT9
prerank,nucleotidyltransferase activity (GO:0016779),0.40227063081089753,0.9598193378568979,0.5306957708049114,0.9215513240898362,1.0,9/19,23.76%,PAPSS2;TUT4;CGAS;PNPT1;REV1;NUDT5;TENT2;TUT1;MOCS3
prerank,5'-nucleotidase activity (GO:0008253),0.42950657397870645,0.9596155290624354,0.5196374622356495,0.9190172856305876,1.0,6/13,26.67%,NT5DC2;NT5C2;NT5C3B;NT5C;NT5C3A;NT5E
prerank,calcium channel activity (GO:0005262),0.3213860941082795,0.9577791744616295,0.5562987736900781,0.9204560114043417,1.0,17/84,18.10%,CACNA1E;CACNA2D1;CACNG7;ANXA9;NCS1;CACNA1A;PSEN1;CACNB4;SLC24A5;ANXA6;TPCN2;TRPC5;PKD1;CACNA2D4;CACNA2D2;SLC24A4;SLC24A2
prerank,Toll-like receptor binding (GO:0035325),0.45630204402272906,0.9577402347849316,0.5238095238095238,0.9175363395079401,1.0,3/11,14.85%,TLR1;TOLLIP;UNC93B1
prerank,nuclear import signal receptor activity (GO:0061608),0.421808446887329,0.9535856961157011,0.529839883551674,0.9246556973133268,1.0,7/15,19.83%,IPO9;KPNB1;KPNA6;KPNA1;TNPO3;IPO5;KPNA3
prerank,metalloaminopeptidase activity (GO:0070006),0.4080056521641871,0.9530291634883753,0.5124816446402349,0.9230808152363428,1.0,6/16,15.59%,LTA4H;MMP15;TRHDE;LNPEP;MMP16;RNPEPL1
prerank,hydro-lyase activity (GO:0016836),0.35041059464987095,0.9512852938046018,0.5466998754669987,0.9240016746132699,1.0,10/41,20.12%,CYP2S1;CBS;HADHA;UROS;CDYL;PCBD2;AUH;EHHADH;PARK7;HACD2
prerank,deubiquitinase activity (GO:0101005),0.32118645406407986,0.9493718734558485,0.5633187772925764,0.9258533383885491,1.0,24/88,19.07%,USP50;USP35;USP11;MINDY4;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP1;USP25;USP21;USP2;OTUD4;USP37;OTUD7A;USP5
prerank,histone deacetylase activity (GO:0004407),-0.3128181561446958,-0.9488271155150986,0.5179856115107914,0.7828487974501583,1.0,10/19,25.72%,HDAC8;SIRT3;HDAC4;HDAC11;HDAC3;HDAC5;SUDS3;MIER2;SIRT7;HDAC10
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.29195453360005746,0.9475945867646329,0.713,0.9269235692594516,1.0,125/732,19.76%,EBF2;RORA;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;TLX3;GLI2;SOX8;PRDM16;MYC;DMRT2;TGIF2;EBF1;ZBTB20;SOX9;HIVEP1;ZBTB37;HOXA7;SATB1;TFCP2;EGR3;FOXP2;RFX2;SOX11;GLI1;E2F2;ZEB1;HOXD3;PGBD1;ZFP14;RFX3;ZBTB16;RORC;MLXIPL;MLX;E2F6;LRRFIP1;GATA6;TBX18;ZSCAN20;MKX;ZBTB41;RARG;RARB;SOX12;SOX5;ZNF569;KLF5;HIF1A;ZBTB6;CHD2;ZSCAN26;ZBTB38;NFATC3;ZNF260;ATF2;ZKSCAN8;ESR1;NFE2L2;MYT1;SP1;ZNF112;HDAC6;ZFHX4;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;NRIP1;PER1;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;NACC2;KDM6A;PAX3;ZFHX2;HIVEP3;CREM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;MEIS3;KLF9;TP53;SP3;SREBF2;HNRNPU;NFIA;FOXJ1;PAX2;NFIX;ZKSCAN1;HEYL;NR5A1;KLF16;IRF3;ZNF697;ZNF496;KLF7;RFX7;BATF;EGR1;MED8;RUVBL2;TOP1;PRRX1;FOXJ3;PPARG;JUN;STAT3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.33597463808258665,0.9464319402828464,0.5602836879432624,0.9267224161746862,1.0,16/49,23.05%,ZFAND2B;RAD23B;ZRANB3;OTUD7B;EPS15;HDAC6;ZBTB1;ZFAND6;OTUD7A;TAB3;TNIP2;WDR81;UBQLN4;TAB2;UBQLN1;UBQLN2
prerank,GTPase activity (GO:0003924),0.2981262812875791,0.9443348113125758,0.6116803278688525,0.9288675595763506,1.0,41/192,18.87%,RHOJ;GNA14;DNM1;RHOD;GNG3;RAB38;RND3;RAP2B;RHOBTB3;RAB14;RALB;ARL1;BMS1;RAB21;RAP1A;RABL3;RHOT2;ARL2;MRAS;GSPT2;TBCC;RAB22A;MTG1;RAB1A;RHOH;RHOC;ATL3;ARL8A;RAB3A;GNAI1;RAB4A;TRIM23;OPA1;GTPBP10;RAP1GAP;RAC3;RAB7A;RHOT1;NRAS;KRAS;RAB3B
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.4018131426334635,0.9433792662347252,0.5346534653465347,0.9282182245364511,1.0,5/16,22.14%,BST1;NEIL1;SMUG1;CD38;TDG
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.43716887701629686,0.9408461416174067,0.5503048780487805,0.9310920371962351,1.0,4/12,12.05%,PDE7B;PDE4B;PDE3B;PDE4D
prerank,acyl-CoA hydrolase activity (GO:0047617),0.4084898914195479,0.9407311669620367,0.5549215406562055,0.9283895428983935,1.0,4/17,20.97%,THEM4;ACOT11;ACAA2;ACOT8
prerank,O-methyltransferase activity (GO:0008171),0.441572006494648,0.9406326704444476,0.5411764705882353,0.9256630342703395,1.0,4/10,19.18%,COMT;LRTOMT;MEPCE;CMTR2
prerank,ribosomal large subunit binding (GO:0043023),0.4321284637331355,0.9389794263190192,0.5552147239263804,0.9268205163601194,1.0,3/11,14.36%,CPSF6;EIF6;DHX33
prerank,lysophospholipase activity (GO:0004622),-0.30329414129135895,-0.9385853384927625,0.5296167247386759,0.8006001277423549,1.0,6/20,17.80%,PLA2G4A;PNPLA6;ASPG;MGLL;ABHD12;LYPLAL1
prerank,microtubule motor activity (GO:0003777),0.33462731802638934,0.9383904307226533,0.5456702253855279,0.9252178177263108,1.0,12/51,19.16%,DNAH2;KIF20B;KIF19;STARD9;KIF21A;DYNC1I1;KIF5C;DYNC1I2;KIF22;KIF21B;KIF3A;KIF2A
prerank,protein phosphatase regulator activity (GO:0019888),0.3299353782043136,0.9382210384870454,0.5750577367205543,0.922720793041203,1.0,8/53,9.15%,LGALS3;PPP1R15A;RCAN1;ENSA;PPP2R3A;SHOC2;PPP2R2A;RCAN3
prerank,lipase activity (GO:0016298),0.3398579395876797,0.937083030387464,0.5639464068209501,0.9224198328184989,1.0,7/43,16.30%,PLBD1;CEL;LYPLA1;PNPLA8;SEC23IP;LIPC;ABHD6
prerank,N-acyltransferase activity (GO:0016410),0.35665185462349047,0.9370656862020348,0.568241469816273,0.9195862727339527,1.0,10/32,21.93%,CERS3;CERS6;PLAAT5;PLAAT3;SMARCE1;NAA10;GLYAT;PLA2G4E;CERS2;NAT8L
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4362563248551432,0.9366757501828893,0.5597014925373134,0.9175545959488245,1.0,5/12,21.66%,SLC25A23;SLC35B3;SLC25A25;SLC25A24;SLC17A9
prerank,protein heterodimerization activity (GO:0046982),0.29575286748718366,0.9362504383012095,0.6210418794688458,0.915699261223022,1.0,32/178,17.47%,TENM2;TENM3;ERBB3;BCL2;ERBB2;IRAK3;EXT1;UBA2;FBXO7;METTL3;MLXIPL;MLX;PAFAH1B3;NAE1;MTTP;HIP1;HIF1A;RCC1;VAPA;UBA3;KATNB1;ZBTB1;TRMT112;AHR;SNX1;TAF7;ITGB1;FZD9;TP53;ABCG4;CHUK;RALGAPB
prerank,SUMO binding (GO:0032183),0.4297365564152002,0.9354772998678196,0.5489913544668588,0.9145516663245712,1.0,6/13,22.14%,UBA2;CBX4;RNF111;USP25;RNF4;TDG
prerank,phospholipase inhibitor activity (GO:0004859),0.4406320961400098,0.9313016516174278,0.5579937304075235,0.9209888017512148,1.0,3/10,18.63%,ANXA9;SNCA;SNCB
prerank,microtubule binding (GO:0008017),0.29169990450889527,0.9312793950385774,0.6432212028542303,0.9182243801113359,1.0,50/222,19.60%,SGIP1;SAXO2;DNM1;FGF13;KIF20B;KIF19;MAP4K4;MAP1B;GAS2L3;ARL3;MAST2;STARD9;PRNP;EML1;NDE1;MACO1;KIF21A;CCDC170;CEP57;CAPN6;DYNC1I1;TUBGCP5;VAPA;MID2;KIF5C;CLASP1;HDAC6;CEP295NL;APC2;KATNB1;RMDN2;CKAP5;MDM1;KIF22;TPGS1;OPA1;GABARAPL2;MAP6D1;EML5;NAV3;DCX;KIF21B;KIF3A;MAPRE3;CAMSAP1;MID1;HOOK2;KIF2A;MAP6;CCDC66
prerank,GABA receptor binding (GO:0050811),-0.35750977063066414,-0.9304203803041948,0.5468277945619335,0.8126712042763554,1.0,6/11,20.12%,TRAK1;GABARAP;PLCL2;JAKMIP1;SHISA7;ARFGEF2
prerank,estrogen receptor binding (GO:0030331),0.35469995157508716,0.9295200118229255,0.5673202614379085,0.9194211510998108,1.0,10/32,14.16%,NCOA1;TACC1;WIPI1;DDX54;PPID;ESR1;DCAF1;NRIP1;STRN;LCOR
prerank,endoribonuclease activity (GO:0004521),0.35797392127868666,0.9289820704709025,0.578544061302682,0.9177192148741141,1.0,5/32,10.78%,INTS11;NOB1;ZC3H12B;ENDOV;RCL1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.3486797296914061,-0.9288607011421183,0.5544554455445545,0.8093682623302018,1.0,6/14,15.56%,USP7;USP9X;OTUD5;MINDY2;USP15;MINDY3
prerank,zinc ion binding (GO:0008270),0.28958647114561553,0.9281784897940119,0.6810431293881645,0.9167740532486541,1.0,57/293,19.04%,RAG2;GLI2;CSRP1;DHH;DPEP1;CBLB;PRKN;EPRS1;KMT2A;SEC24D;PDXK;KDM5B;ITGB1BP2;MT3;MBD1;GRIN2B;HHIP;LTA4H;ZEB1;AOC1;TRIM2;RPH3A;CHD3;GTF2B;TRHDE;SEC24C;PTPN1;LNPEP;MMP16;USP33;MYT1;RBAK;SIRT6;PHF8;ZFPM2;KPNB1;HPF1;SNCA;MDM4;ADAM33;GRIN2A;TRAF7;BAZ1B;PAPPA2;RCHY1;BLM;TP53;TET3;RBSN;RC3H1;ADH5;SEC24A;MDM2;KLF7;ZMYND11;TAB3;EGR1
prerank,histone acetyltransferase binding (GO:0035035),0.3825655741625429,0.926567949995184,0.5670816044260027,0.9174863739093428,1.0,8/21,24.07%,HIF1A;CITED2;TAF7;KANSL1;TP53;EGR1;KANSL1L;MEF2A
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3732127779464549,0.9258046422387977,0.556910569105691,0.9164088662913547,1.0,8/21,23.01%,PRRC1;AKAP6;WASF1;PRKACA;ARFGEF1;AKAP1;PJA2;WASF3
prerank,thiol-dependent deubiquitinase (GO:0004843),0.31497092609848487,0.9255054225067926,0.6217105263157895,0.9142973899456287,1.0,23/83,19.07%,USP50;USP35;USP11;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP1;USP25;USP21;USP2;OTUD4;USP37;OTUD7A;USP5
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.4181438229605754,0.924773437356834,0.5699558173784978,0.9132448764739823,1.0,4/13,22.38%,IDI1;SREBF2;EHHADH;ECH1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.43269552412067336,0.9240270946906117,0.5786435786435786,0.9120611480566885,1.0,2/12,5.19%,NUDT15;ENTPD2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2876157099634042,0.9237627734684334,0.729,0.9099635825916621,1.0,92/431,18.40%,WNK2;PYGL;RHOJ;RASEF;RHOD;PEAK1;STK36;RAB38;RND3;RAP2B;ADSS1;ACVR1;MAP4K4;RHOBTB3;PDXK;IRAK3;WNK3;RAB14;SIK2;ARL3;RPS6KA4;MAST2;GSS;UBA2;KSR1;CDKL5;RALB;ARL1;PDK3;BMS1;RAB21;RAP1A;SARS2;CDK6;RAB39A;RABL3;TBCK;ACLY;TLK2;AKT3;LANCL2;TUBB6;SYN1;RHOT2;ARL2;MRAS;ARL5C;EIF4G1;MYO9B;PXK;HSPA4;PI4K2A;ARF4;MSH6;ANXA6;RAB22A;DDX25;RHOH;RHOC;ATL3;ARL8A;GNAI1;SRR;PNPLA8;RAB4A;P2RY1;HARS1;AK6;RTEL1;TRIM23;BMPR1A;GTPBP10;ABCB9;ABL1;PAPOLA;BLM;OLA1;NDUFA13;HNRNPU;ABCD2;FICD;ABCF1;EIF2B2;RAC3;SMC4;HSPA9;RAB7A;PEX1;RHOT1;TUBA1A;NRAS;KRAS
prerank,syntaxin binding (GO:0019905),0.3181936865001276,0.9215697861554623,0.5900692840646651,0.9120116283347568,1.0,12/61,13.44%,SNAP23;STXBP4;PTPN2;SYNPR;CACNA1A;SYT1;SNAP29;TMED10;VPS11;SYT12;STXBP5;STX8
prerank,double-stranded RNA binding (GO:0003725),-0.22208376026379908,-0.9215226208499968,0.6585365853658537,0.818890220671668,1.0,13/70,14.23%,DDX60;SIDT1;RFTN1;DGCR8;STRBP;AGO1;ACTN1;IFIH1;TFRC;ELAVL1;OAS2;AGO3;MSN
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.35165627838537905,0.9202158091721139,0.5743073047858942,0.9122403879454378,1.0,5/29,7.08%,KAT2B;CDKN2B;PRKAR1B;SPRED2;SPRED1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3506567389717947,0.9193849719854447,0.5811320754716981,0.9112744503961112,1.0,6/34,8.25%,RAG2;IQGAP2;MAPKAP1;GBF1;ARHGAP9;GAB2
prerank,guanyl ribonucleotide binding (GO:0032561),0.2896321920205915,0.9181375612129161,0.6454918032786885,0.9113214336774713,1.0,54/196,22.95%,RHOJ;RASEF;RHOD;RAB38;RND3;RAP2B;ADSS1;RHOBTB3;RAB14;ARL3;RALB;ARL1;BMS1;RAB21;RAP1A;RAB39A;RABL3;LANCL2;TUBB6;RHOT2;ARL2;MRAS;ARL5C;ARF4;ANXA6;RAB22A;RHOH;RHOC;ATL3;ARL8A;GNAI1;RAB4A;TRIM23;GTPBP10;EIF2B2;RAC3;RAB7A;RHOT1;TUBA1A;NRAS;KRAS;RAB3B;PDE11A;RRAGA;RHOU;RABL6;GLUD1;AGAP2;PDE10A;RAB18;GBP2;RAP2A;RAB6A;RAP2C
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.29576880627396385,0.9170371595874508,0.6503642039542143,0.9110509987448013,1.0,36/147,17.28%,DENND2A;AKAP13;FGD4;FRMD7;ARHGEF28;NUCB1;DOCK5;ARHGEF10;ALS2;EPS8L1;DOCK10;ITSN1;RAP1A;EIF2B5;RGL1;LAMTOR2;ARHGEF11;VAV3;DENND1C;DOCK1;SPATA13;FARP2;RCC1;DNMBP;RCC1L;RAB3GAP2;RAB3IL1;ANKRD27;ELMO1;CYTH3;RIC8B;ARFGEF1;HPS1;ARHGEF4;EIF2B2;DENND10
prerank,alanine transmembrane transporter activity (GO:0022858),-0.35936485357082487,-0.9169177151714414,0.5736677115987461,0.8224778464917726,1.0,4/12,14.60%,SLC6A6;SLC38A7;SLC38A5;SLC36A4
prerank,phosphatidic acid binding (GO:0070300),0.38153603489348686,0.9158800541360083,0.5774456521739131,0.9107880011424945,1.0,5/19,14.92%,SESTD1;PACSIN2;MAPKAP1;GRAMD1B;OPA1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4136070840022116,0.9133762680670062,0.5837037037037037,0.9135422602665003,1.0,3/14,11.44%,PTEN;MTMR14;MTMR12
prerank,phosphotyrosine residue binding (GO:0001784),0.3457620324135286,0.9131100546391374,0.5900621118012422,0.9114134865135801,1.0,16/37,26.25%,RASA1;SAMSN1;PIK3R1;PTPN11;ABL1;GRB2;SH3BP2;BCAR3;YES1;VAV2;NCK2;CRK;HCK;LDLRAP1;SYK;SHC3
prerank,adenylate cyclase binding (GO:0008179),0.4405746622222885,0.9126472636259962,0.5646879756468798,0.9097063002806295,1.0,5/10,27.62%,AKAP6;CALM1;CALM2;ADCY5;AKAP12
prerank,disordered domain specific binding (GO:0097718),0.3712986296017712,0.9121188746303679,0.5796089385474861,0.9081218509444555,1.0,7/23,18.13%,KCNA1;FYN;CALM1;CALM2;TP53;NCOA3;MDM2
prerank,ephrin receptor activity (GO:0005003),0.38641481341554246,0.9117102434149106,0.5832147937411095,0.9037631139254589,1.0,3/17,3.35%,EFNA4;EPHB6;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.38641481341554246,0.9117102434149106,0.5832147937411095,0.9037631139254589,1.0,3/17,3.35%,EFNA4;EPHB6;EPHB2
prerank,pyrophosphatase activity (GO:0016462),0.32570519505474627,0.9110695872777822,0.6146682188591386,0.9024445875584522,1.0,11/50,12.50%,NUDT15;DXO;RNGTT;ENTPD2;BNIPL;NUDT1;NUDT22;PLPP4;NUDT10;NUDT9;NUDT3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3316523154746346,-0.9109189387706793,0.584375,0.8291094343254589,1.0,3/14,11.53%,SLC26A7;SLC26A2;SLC25A30
prerank,histone demethylase activity (GO:0032452),0.3602873020841094,0.9081519446036187,0.587431693989071,0.9060201765979854,1.0,6/27,13.88%,KDM8;KDM5B;KDM4B;PHF8;JARID2;KDM6A
prerank,myosin binding (GO:0017022),0.31985204299378384,0.907202661664882,0.6004645760743321,0.9054073855137356,1.0,18/55,22.81%,PYCARD;GSN;RAB14;SPATA6;RAB3D;STXBP5;MYOC;RAB3A;KIRREL1;MOBP;ARFGEF1;TRAK2;RAB3B;NKD2;RAB39B;TRIOBP;LLGL1;RAB6A
prerank,vitamin D receptor binding (GO:0042809),0.40152108916886625,0.9054209450251611,0.5739130434782609,0.9062887200752947,1.0,6/14,22.78%,MED13;TAF11;TAF7;MED12;MED30;MED24
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.3403740577066897,0.9053174099396729,0.5984555984555985,0.9039851413102927,1.0,11/35,23.74%,DTWD1;ELAC1;GATB;TRMT12;MRPL58;DTWD2;MTFMT;TRIT1;LCMT2;ALKBH1;NT5C3A
prerank,ATPase activator activity (GO:0001671),0.3744298931916577,0.9035921671311846,0.6134094151212554,0.9049560316034423,1.0,7/20,18.96%,DNAJB4;DNAJB6;AHSA1;DNAJC19;DNAJA2;DNAJA1;DNAJC10
prerank,glycine binding (GO:0016594),0.409342548571571,0.9016374553550552,0.5897810218978102,0.9063896883199264,1.0,3/11,20.39%,GRIN2B;SRR;GLRB
prerank,R-SMAD binding (GO:0070412),-0.31297223752665915,-0.8986522213753649,0.6140350877192983,0.849589874152037,1.0,4/18,12.68%,SMAD6;DDX5;RGCC;RANBP3
prerank,MAP-kinase scaffold activity (GO:0005078),0.4204078875448679,0.8979884552698175,0.5869894099848714,0.9114747134701815,1.0,4/11,14.88%,AKAP13;KSR1;SPAG9;IQGAP1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.314413225204889,-0.8960816785510651,0.5987261146496815,0.8487236090284251,1.0,5/15,17.38%,COX6B1;COX6A1;COX4I1;COX5B;COX5A
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3502781040847018,0.8945630959593537,0.5974025974025974,0.9156392935442227,1.0,12/27,26.14%,POLR2B;POLRMT;POLR1B;POLR2G;MED21;POLR1D;POLR1C;TENT2;POLR2A;POLR3K;POLR2F;POLR3F
prerank,aminopeptidase activity (GO:0004177),0.3465665726326844,0.8933301176230423,0.606951871657754,0.9155710279698479,1.0,6/26,10.51%,KDM8;LTA4H;MMP15;TRHDE;LNPEP;MMP16
prerank,manganese ion binding (GO:0030145),-0.23421568394402775,-0.8930572580848248,0.6729559748427673,0.8487053589415346,1.0,11/48,16.28%,MPPED2;ABL2;MTPAP;ME1;PRIMPOL;MGAT1;IMPA1;B4GALT7;ADPRM;MPPE1;B4GALT1
prerank,protein phosphatase 1 binding (GO:0008157),-0.2861916131665198,-0.8920755725122295,0.6203007518796992,0.8441417957330768,1.0,5/21,10.93%,PHACTR4;PPP1R16B;PPP1R3B;SH3RF2;PPP1R11
prerank,3'-5' exonuclease activity (GO:0008408),0.31616357173062487,0.8899415162023606,0.6331719128329297,0.9198069890205234,1.0,10/45,17.24%,USB1;REV3L;XRN2;REXO4;PNLDC1;EXOSC2;EXD2;POLG;PNPT1;WRN
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2782265770201385,0.8894268603619508,0.756811301715439,0.9183506714982053,1.0,45/232,18.13%,PDZRN3;RNF157;CBLB;PRKN;DTX4;HACE1;NFX1;TRIM44;RNF6;ZNRF2;NEURL4;UFL1;TRIM2;TRIM11;CBX4;PELI1;RNFT1;VPS11;FBXO27;NEURL1B;PIAS2;CUL3;UHRF2;HUWE1;CBL;TRIM41;RNF121;FBXO17;MEX3C;MYLIP;RNF24;NEDD4L;AREL1;NEURL3;UBE2O;RNF19A;RCHY1;XIAP;RNF111;KCMF1;RNF10;RC3H1;RNF167;TRIM9;MDM2
prerank,cell adhesion mediator activity (GO:0098631),0.3510261274178123,0.8873627652691489,0.6115702479338843,0.9198204795149316,1.0,6/24,10.12%,LRRC4C;NTNG1;CNTN6;CNTN2;DSCAM;PALLD
prerank,omega peptidase activity (GO:0008242),0.29928912471853647,0.887265448705127,0.675704989154013,0.917434443713315,1.0,23/89,19.07%,USP50;USP35;USP11;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP1;USP25;USP21;USP2;OTUD4;USP37;OTUD7A;USP5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.30528372180393765,0.8859074650593594,0.6521739130434783,0.9175359608853549,1.0,24/69,25.42%,CERS3;KAT2B;CERS6;NAA16;KAT8;GTF2B;ZDHHC8;MOGAT3;PLAAT5;HHAT;PLAAT3;DBT;NAA10;GLYAT;NAA15;PLA2G4E;CERS2;ZDHHC21;PORCN;SCP2;ZDHHC13;DGAT2;ZDHHC15;ZDHHC17
prerank,kinase activator activity (GO:0019209),-0.26606281803862025,-0.885663236297878,0.6181818181818182,0.8512509973306305,1.0,9/30,13.20%,PRKAG2;WNK1;MADD;GPRC5C;RGCC;RPLP1;MARK2;SPDYA;NCKAP1L
prerank,protein homodimerization activity (GO:0042803),0.27296040865695353,0.8846963094060454,0.854,0.917466360900718,1.0,111/589,18.84%,SOX6;TENM2;AADAT;TENM3;PDGFRA;GLIPR2;FAP;PYCARD;KIF20B;KYNU;BCL2;CBS;HM13;PSPH;PTPRT;ACVR1;EPRS1;KMT2A;VEGFA;PDXK;IRAK3;FOXP2;ERCC5;NTRK2;GSS;EXT1;HSPB6;AOC1;NAGA;CADM3;ALS2;ZBTB16;MLXIPL;MLX;SETMAR;MKLN1;CARD9;PNPO;PAFAH1B3;S100A6;LRRFIP1;TBX18;BNIP3;FGFR1;ACOX1;CADM1;RABL3;PDLIM4;FLNA;CEP57;S100A16;RPE;XPA;HIP1;CRYAB;PRDM9;SNX6;ERBB4;ZBTB38;SLK;MYO9B;MID2;GDNF;GLCE;GALM;SP1;MSH6;SFPQ;PHETA2;ZBTB1;NR6A1;GGCT;AHR;SRR;SYNDIG1;EXD2;NACC2;HARS1;NFS1;RAB11FIP3;BMPR1A;SNX1;PDCD6IP;CHMP4C;ABCB9;JUP;FZD9;RCHY1;BLM;FECH;KCNH2;PPCS;RAP1GAP;ALDH1A3;ABCG4;ABCD2;FICD;RIPK1;ACSL6;WRN;GSTZ1;CHUK;TRIM9;CAT;IRF3;PGRMC1;NUDT5;MAP3K11;MID1;PARK7;PEX11A
prerank,C-C chemokine binding (GO:0019957),0.356912330830536,0.8825678273494587,0.6350267379679144,0.9190569118159209,1.0,4/22,20.38%,CCR2;ACKR3;ACKR4;ZFP36
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.3536386896438834,-0.8824856909548834,0.6271676300578035,0.8517110518666178,1.0,5/11,22.98%,ITPR1;TRPC6;TRPC3;TRPC7;CYTH2
prerank,RNA methyltransferase activity (GO:0008173),0.3720913181751376,0.8822942689142428,0.6310679611650486,0.917005462761749,1.0,5/19,15.73%,METTL3;TRMT12;TGS1;FBL;MEPCE
prerank,1-phosphatidylinositol binding (GO:0005545),0.39436877046636154,0.8798159009833563,0.6333333333333333,0.9194071427345707,1.0,4/15,12.36%,SESTD1;WDFY3;SNX10;ZFYVE9
prerank,protein phosphatase activator activity (GO:0072542),-0.33848228637933175,-0.8797073402052582,0.6378205128205128,0.8506034233685056,1.0,3/13,5.07%,PHACTR4;IGFBP3;PTPA
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.39227896887547575,0.8791491126449431,0.6095679012345679,0.918171323682544,1.0,3/13,10.53%,PDGFRA;VEGFA;PTPRJ
prerank,chemokine receptor activity (GO:0004950),0.3504003901317164,0.8782027210750349,0.6424731182795699,0.9174360929121581,1.0,3/24,14.06%,CCR2;ACKR3;ACKR4
prerank,NF-kappaB binding (GO:0051059),-0.2834248469987542,-0.8776423260828816,0.6317991631799164,0.8488206694195153,1.0,10/24,27.30%,NFKBIA;NPM1;GSK3B;ANXA4;COMMD7;COMMD6;HDAC3;RNF25;BRMS1;SETD6
prerank,carboxypeptidase activity (GO:0004180),0.3317788975873773,0.8770110089564355,0.6482164821648216,0.9172731693283317,1.0,6/35,13.51%,NAALAD2;AGBL3;AGBL2;AGBL4;AGBL1;CPD
prerank,RNA polymerase binding (GO:0070063),0.37302941643342374,0.8769174640985675,0.6339410939691444,0.9149869695474,1.0,8/18,27.46%,BIN1;BRCA1;TCERG1L;PKN2;ZFP36;CCNT2;TCERG1;ANP32B
prerank,RNA binding (GO:0003723),0.268966212927399,0.876749691026078,0.947,0.9128018904708336,1.0,356/1321,23.17%,DCN;LGALS3;PABPC5;RBFOX1;DNM1;CSTF3;CSRP1;DDX11;RBMS3;S100A4;NQO1;DHX34;DHX8;CELF5;HNRNPDL;C1D;LRP1;QKI;GPATCH4;EPRS1;APTX;TRMT10B;WDR36;FNDC3B;TRA2B;NFX1;PRRC2B;ZNF326;DXO;PABPC1;CCDC9;FARSA;ANKHD1;CPSF6;RBM33;RPL23A;CSTB;ETF1;GOLGB1;ZNFX1;LTA4H;NOP2;SPTBN1;ZMAT3;HNRNPAB;TUFM;RP9;MRPL14;MRPL32;YWHAZ;ATXN2;POLR2B;UBAP2;NGRN;METTL3;UCHL5;MRPL16;CDK13;PLEC;BRIX1;NUDT1;EIF1B;XRN2;NOL8;DHX35;SON;BMS1;LUC7L2;LRRFIP1;SRP9;EIF3C;SARS2;SAMSN1;TUT4;ZC3H8;IBA57;MRTO4;SRBD1;DHX30;DDX54;UNK;CHD3;TBL2;CPEB3;UTP6;ZC3H12B;GDI2;FLNB;ADK;GOT2;SRSF11;ZC3H15;KHDRBS3;MRPS35;MRPS28;TFAM;PPP1R8;FLNA;BRCA1;HEATR1;S100A16;PEG10;DDX24;ANXA11;RBM10;FASN;FARS2;NSUN5;TRIP6;DCP1B;RCAN3;CASC3;CKAP4;APOBEC1;REXO4;PTPN1;CHD2;ALKBH5;NCBP1;ZFP36L2;PNLDC1;R3HDM1;HDAC2;ADARB2;FIP1L1;HUWE1;EIF4G1;RSRC2;EXOSC2;PSIP1;ENDOV;DUSP11;PCBP4;UBFD1;CLNS1A;RIMS1;FKBP4;RPP38;FBL;PRMT1;SFPQ;GSPT2;MRPL28;UPF1;COL14A1;CCDC137;RBM27;ZC3H18;EBNA1BP2;MEX3C;SNRNP40;HNRNPA3;DDX25;RCC1L;GRN;LSM3;SPATS2;YARS1;XRCC6;PRPF6;CCDC86;DAZAP1;HSP90B1;CFAP20;DHX57;ADARB1;DALRD3;KPNB1;SPOUT1;CCDC47;POLRMT;RBM4B;POLR2G;DDX42;PUS7;CELF6;MSI1;GLRX3;DHX32;RBM7;EIF1AX;EIF1;SUMO1;DHX33;NOVA1;SRSF6;YTHDC1;RBM45;NDUFV3;RTN4;ZNF638;WDR46;ELP5;SEC23IP;DDX10;KHSRP;RNMT;SLTM;TNS1;GTPBP10;DDX27;LUC7L;EIF4ENIF1;PSMC1;UBE2O;GTF2E2;XPOT;NIP7;GCN1;PURG;CSNK1E;PUS1;KYAT3;MEPCE;NIFK;NOP56;RPS27L;SNRPA;SLC25A11;SEC63;SMG6;PNPT1;NOC4L;SF3A1;HNRNPU;RAVER2;POP1;FSCN1;DDX56;RBM46;EIF4A2;ZYX;ABCF1;N4BP1;NXF1;SRRM3;FUBP1;AKAP1;RPP21;RC3H1;RNPS1;SSB;TRAP1;UBA1;SF1;PCID2;PKN2;POLR1G;CAST;FUS;BOP1;HSPA9;OTUD4;MRPS30;SART1;CLUH;NUDT5;NAA15;AATF;RBFOX3;DDX23;RPSA;PARK7;ACAA2;POLR2A;PNISR;RDX;GIGYF2;GRB2;IPO5;UBAP2L;CNBP;TOP1;RPN1;BZW1;SYNCRIP;FAM120A;ZNF106;VIRMA;PSTK;SRRM1;UBE2L3;HNRNPUL1;JUN;STAT3;MCRS1;TENT5A;UBTF;CSDE1;MRPS14;BCCIP;NSUN2;DBR1;HNRNPC;FUBP3;ZFP36;CELF4;R3HDM2;DDX31;HNRNPH2;ZBED4;MRPS9;SREK1;PEF1;ZCCHC9;MRPS31;HSPD1;SSBP1;DHX40;HNRNPL;MRPL1;CPNE3;MYO5A;SSRP1;PYM1;RBFOX2;MKRN1;PTCD3;DAP3;FDPS;EIF4G3;HARS2;NPM3;NOL10;DDX6;SRSF3;RBMS1;FYTTD1;VIM;HNRNPUL2;ALKBH8;ALDH6A1;RIDA;SNIP1;AHNAK;RPS11;PTBP2;DDX4;EDF1;NUP42;ZC3H12C;RBMX2;YBX3;SNRNP200;DYNC1H1;SF3B2;ALKBH1;DENR;WDR75;AFF2;DDX50;EXOSC3;RBM25;DHX29;WBP4;TBL3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3339844838331563,0.8744164915397964,0.6444723618090452,0.9147466742585098,1.0,5/32,11.77%,SLC1A5;SLC36A2;SLC25A38;SLC43A1;SLC7A8
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.3274710253956705,0.8740915546120556,0.655440414507772,0.9128550498669304,1.0,18/35,27.54%,MYC;DRAP1;GTF2B;PIH1D1;TAF4;TP53;PARK7;TAF1;RUVBL2;UBTF;SMARCA4;SNAPC3;RRN3;TBP;SMARCB1;DR1;HDAC1;RELA
prerank,neuropeptide receptor binding (GO:0071855),0.3807383515752912,0.872617377979982,0.6048265460030166,0.9131497783413295,1.0,3/14,25.34%,NMU;NPY;SHANK1
prerank,fibroblast growth factor binding (GO:0017134),-0.28081291171695183,-0.8711488359706588,0.6640926640926641,0.8562598670445087,1.0,7/21,15.46%,KL;RPS19;THBS1;RPS2;FGFR2;API5;FGFR4
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4189384808047427,0.8709357626704141,0.6167471819645732,0.9139968766120543,1.0,2/10,2.56%,PRDM16;SUV39H1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3507485357354942,0.8675538276265039,0.6272352132049519,0.9178382144771746,1.0,6/21,17.26%,POLN;POLE2;REV3L;POLE3;POLG;REV1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3784672280774616,0.8653009911574748,0.6455331412103746,0.9195903039278313,1.0,3/16,11.44%,PTEN;MTMR14;MTMR12
prerank,MAP kinase activity (GO:0004707),0.3862051872306218,0.864538782661604,0.6213450292397661,0.9186857827307869,1.0,4/14,11.40%,MAPK7;MAPK9;MAPK14;MAPK1
prerank,pre-mRNA binding (GO:0036002),0.33524584663500734,0.8640907692143879,0.6472114137483788,0.9171404158635501,1.0,8/28,21.09%,CELF5;TRA2B;RNPC3;RBM7;SRSF6;HNRNPU;CELF4;HNRNPL
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.35699103075218447,-0.8635733704915852,0.6304909560723514,0.8655916512966771,1.0,2/10,1.46%,CACNA1C;CACNB2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3032057220872867,-0.8633571844666341,0.673202614379085,0.8593793836407414,1.0,9/16,39.46%,CDO1;ETHE1;ALOX12;BCO2;HGD;ALOXE3;HAAO;ALOX5;PIR
prerank,telomeric DNA binding (GO:0042162),0.32758552108256306,0.861114668695064,0.6550836550836551,0.9198056712543405,1.0,14/32,28.35%,UPF3A;STN1;UPF1;XRCC6;BLM;SMG6;TERF2IP;WRN;CTC1;RAD50;ACD;HNRNPA2B1;SMG1;TELO2
prerank,nuclear localization sequence binding (GO:0008139),-0.2996341869472931,-0.8610391995111263,0.6405693950177936,0.8576671561135596,1.0,5/18,10.96%,NFKBIA;KPNA4;BRAP;RANBP6;NUP214
prerank,myosin II binding (GO:0045159),0.4093621693777383,0.8601321567509596,0.6168831168831169,0.9191357456618449,1.0,4/10,22.41%,GSN;STXBP5;TRIOBP;LLGL1
prerank,ribonuclease P RNA binding (GO:0033204),0.40468256913560763,0.8581134955781106,0.6341085271317829,0.9204667865200311,1.0,5/10,27.32%,RPP38;POP1;RPP21;RPP30;RPP14
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.3087871899300543,-0.8577776796381414,0.6277602523659306,0.8580547554575554,1.0,6/14,27.51%,SDHB;CIAO3;ACO1;ACO2;RSAD2;EXO5
prerank,phosphatase activity (GO:0016791),0.2932134214686818,0.8562168477845576,0.7228506787330317,0.9214884041630779,1.0,20/73,21.08%,ACP5;PTPN22;DUSP4;PSPH;APTX;ACP2;BPNT2;DUSP11;PTPRJ;PLPP4;PPP1CA;PLPPR4;HDHD2;MDP1;MINPP1;DUSP16;NT5C;DUSP12;PLPPR2;PTPMT1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.30076567154231454,0.8546984601462291,0.707345971563981,0.9217790621090467,1.0,11/55,18.10%,ANXA9;ATP2B3;PSEN1;SLC8A2;SLC24A5;ANXA6;ATP2B1;TRPC5;PKD1;SLC24A4;SLC24A2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.3403474569118248,-0.8540297079785196,0.6704225352112676,0.8597594251801282,1.0,2/11,13.96%,DDAH2;PADI2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.391241151107324,0.8515925626726262,0.6544117647058824,0.924825813844685,1.0,2/12,5.98%,PYCARD;APAF1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3744792962568365,0.8514246064350591,0.6303448275862069,0.9227543411288418,1.0,4/14,19.17%,KCND3;KCNJ3;KCNH2;KCNA5
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2654202974005768,0.8509194594712293,0.8145896656534954,0.9212871290163674,1.0,51/248,19.24%,RHOJ;GNA14;DNM1;KIF20B;RHOD;GNG3;RAB38;RND3;RAP2B;RHOBTB3;RAB14;RALB;ARL1;BMS1;RAB21;RAP1A;CHD3;RABL3;RHOT2;ARL2;DYNC1I1;MRAS;MYO19;GSPT2;GPR88;TBCC;RAB22A;MTG1;RAB1A;RHOH;RHOC;ATL3;ARL8A;RAB3A;GNAI1;ATP2B1;RAB4A;TRIM23;OPA1;GTPBP10;RAP1GAP;ABCG4;ABCD2;RAC3;RAB7A;RHOT1;NRAS;KRAS;RAB3B;KIF2A;RUVBL2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3513994270990998,-0.8492136219640314,0.6614583333333334,0.8630764728181981,1.0,2/10,2.53%,CD200;CXADR
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.30506406183503365,0.8481804983891362,0.6901913875598086,0.923876615382693,1.0,4/48,5.24%,PIEZO2;CALHM6;ATP6V1B2;SLC12A2
prerank,metallocarboxypeptidase activity (GO:0004181),0.33877865064543083,0.8470291631746387,0.6743295019157088,0.923525803465646,1.0,5/26,13.51%,AGBL3;AGBL2;AGBL4;AGBL1;CPD
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.399587349646112,0.8463120640838541,0.6546875,0.9223905608991879,1.0,5/10,21.56%,RPE;GLCE;GALM;GNE;DSEL
prerank,histone deacetylase binding (GO:0042826),0.28546521088355603,0.845261277776325,0.7257889009793254,0.9219559236727952,1.0,16/88,16.15%,KAT2B;PRKN;PKN1;MTA2;ANKRA2;HDAC2;SP1;SFPQ;HDAC6;RBBP4;NACC2;LCOR;NCOR2;DACT1;TP53;MTA3
prerank,ubiquitin protein ligase activity (GO:0061630),0.264223802888291,0.8451934730868988,0.8385469223007064,0.9197501176857658,1.0,44/228,18.13%,PDZRN3;RNF157;CBLB;PRKN;DTX4;HACE1;NFX1;TRIM44;RNF6;ZNRF2;NEURL4;TRIM2;TRIM11;PELI1;UBE2K;RNFT1;VPS11;FBXO27;NEURL1B;CUL3;UHRF2;HUWE1;CBL;TRIM41;RNF121;FBXO17;MEX3C;MYLIP;RNF24;NEDD4L;AREL1;NEURL3;UBE2O;RNF19A;RCHY1;UBOX5;XIAP;RNF111;KCMF1;RNF10;RC3H1;RNF167;TRIM9;MDM2
prerank,AMP binding (GO:0016208),0.3905473930453323,0.8435889763318687,0.649390243902439,0.9202444091299066,1.0,2/11,2.63%,PYGL;ACSS2
prerank,GDP binding (GO:0019003),0.29126175121851755,0.8408373712596988,0.7012687427912342,0.9228124116811566,1.0,16/63,18.87%,RASEF;RAP2B;RAB14;ARL3;RALB;RAB21;RAP1A;MRAS;RAB22A;GNAI1;RAB4A;TRIM23;RAB7A;NRAS;KRAS;RAB3B
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2622485300689621,-0.8396717406179107,0.7402597402597403,0.8763106375116944,1.0,6/24,15.14%,ZDHHC14;ZDHHC3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,phospholipase activator activity (GO:0016004),0.404874958964285,0.8391628355848308,0.6727272727272727,0.9234608364068154,1.0,1/10,8.06%,FYN
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3645545378185695,0.837992035365173,0.6873239436619718,0.9230895122183355,1.0,5/17,23.17%,DTYMK;AK5;AK3;AK8;CMPK1
prerank,adenylyltransferase activity (GO:0070566),-0.27389639007590527,-0.8375302191150896,0.7447552447552448,0.8740939032558857,1.0,8/21,19.33%,NMNAT2;MTPAP;NMNAT1;OAS2;KARS1;FLAD1;TENT4A;TENT4B
prerank,ATP binding (GO:0005524),0.2638061780112355,0.834364163712413,0.851963746223565,0.927019814503452,1.0,54/266,18.30%,WNK2;PYGL;PEAK1;STK36;ACVR1;MAP4K4;RHOBTB3;PDXK;IRAK3;WNK3;SIK2;RPS6KA4;MAST2;GSS;UBA2;KSR1;CDKL5;PDK3;SARS2;CDK6;TBCK;ACLY;TLK2;AKT3;LANCL2;SYN1;EIF4G1;MYO9B;PXK;HSPA4;PI4K2A;MSH6;DDX25;SRR;PNPLA8;P2RY1;HARS1;AK6;RTEL1;BMPR1A;ABCB9;ABL1;PAPOLA;BLM;OLA1;NDUFA13;HNRNPU;ABCD2;FICD;ABCF1;EIF2B2;SMC4;HSPA9;PEX1
prerank,DNA polymerase activity (GO:0034061),0.3328917971113544,0.831086177340123,0.680161943319838,0.9299315771112886,1.0,6/22,17.26%,POLN;POLE2;REV3L;POLE3;POLG;REV1
prerank,miRNA binding (GO:0035198),-0.24746394680536926,-0.8308542940504778,0.7522522522522522,0.8800709970112321,1.0,7/30,12.43%,YBX1;AGO1;ZC3H7B;DDX21;ELAVL1;TUT7;AGO3
prerank,calcium-activated potassium channel activity (GO:0015269),0.38922422170918647,0.830474368985505,0.6614173228346457,0.9286156068421648,1.0,3/11,17.39%,KCNMB2;KCNMB3;KCNMA1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.28379338293329043,0.8292382858929074,0.7416851441241685,0.9283749710468225,1.0,15/75,19.49%,HSD17B7;HSD17B11;H6PD;AKR1B10;HADHA;PHGDH;RDH10;DHRS3;HIBADH;CBR3;KCNAB2;UGDH;ADH5;EHHADH;LDHB
prerank,exoribonuclease activity (GO:0004532),0.3727411717676007,0.8285417012708319,0.6651515151515152,0.9271939658885835,1.0,2/12,10.32%,EXOSC8;EXOSC2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3313634987386858,0.8285034623528984,0.6939313984168866,0.9249528701058004,1.0,4/25,14.24%,POR;SQLE;MTRR;CYP27A1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3792927982905327,0.8283625127057708,0.669710806697108,0.9228963698446204,1.0,6/12,27.54%,GTF2B;TAF1;RUVBL2;TBP;HDAC1;RELA
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.37559091789783283,0.8281073196312767,0.684931506849315,0.9210700745768087,1.0,4/12,14.61%,ACVR1;TGFBR2;LTBP1;BMPR1A
prerank,phosphatidylinositol binding (GO:0035091),0.2769886339488427,0.8272501094264348,0.7841409691629956,0.9201086082268978,1.0,14/91,12.36%,RAG2;SESTD1;DPEP1;PITPNB;NCF1;WDFY3;SH3YL1;RPH3A;HIP1;DENND1C;PASK;SNX10;MREG;ZFYVE9
prerank,exonuclease activity (GO:0004527),0.2951574325566663,0.8242983362829629,0.7041062801932367,0.9227660705417147,1.0,10/46,17.24%,DXO;REV3L;XRN2;EXOSC8;REXO4;EXOSC2;EXD2;AEN;POLG;WRN
prerank,translation initiation factor activity (GO:0003743),0.30927576546567137,0.8225079535064351,0.7243107769423559,0.9233145461055339,1.0,8/36,17.18%,EIF1B;EIF3C;EIF2B5;EIF3M;EIF4G1;EIF1;EIF4A2;EIF2B2
prerank,store-operated calcium channel activity (GO:0015279),-0.34085372015354704,-0.8212917418704433,0.7031700288184438,0.891571847676158,1.0,5/10,25.37%,TRPC6;ORAI2;TRPC3;TRPC7;ORAI3
prerank,lipase activator activity (GO:0060229),0.39126723135061675,0.8211310437863605,0.6808510638297872,0.923262958100562,1.0,1/10,8.06%,FYN
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.3512050880727394,0.8209360024582788,0.6742532005689901,0.9213115017949836,1.0,2/15,14.06%,CCR2;ACKR4
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3254046852450735,-0.8184939192766981,0.7388888888888889,0.8907945056952441,1.0,5/11,18.07%,MAP3K5;MAP3K20;MAP3K7;MAP3K1;TAOK2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.3718918241055281,0.8181234704508409,0.685459940652819,0.9236453730671683,1.0,2/13,4.40%,TRMT10B;THUMPD3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.25328373972799345,0.816141008333383,0.898,0.9245363753003595,1.0,90/346,23.51%,UBE2T;PDZRN3;RNF157;CBLB;PRKN;DTX4;UBE2E2;HACE1;NFX1;TRIM44;RNF6;KLHL13;FBXO7;ZNRF2;DDB2;NEURL4;TRIM2;HECTD3;TRIM11;PELI1;BRCA1;UBE2K;RNFT1;VPS11;FBXO27;NEURL1B;CUL3;UHRF2;UBE2Z;HUWE1;CBL;RSPRY1;UBE2J2;TSPAN17;TRIM41;RNF121;FBXO17;MEX3C;MYLIP;AKTIP;MALT1;RNF24;TRIM23;NEDD4L;TRAF7;AREL1;NEURL3;UBE2O;RNF19A;RCHY1;CDC23;XIAP;RNF111;UBE2Q1;RNF182;MIB1;KCMF1;CUL4B;RNF10;RC3H1;RNF167;TRIM9;FBXO22;MDM2;ANKRD39;RNF4;TAF1;FBXO11;BCOR;UBE2L3;TRAIP;TRIM35;UBE2G1;RNF13;UBE2E1;ANAPC4;MKRN1;RNF114;UBE2D3;RNFT2;TTC3;UBR3;FBXO44;RNF123;SIAH1;PJA2;RNF187;COP1;UBE3C;RNF2
prerank,tRNA methyltransferase activity (GO:0008175),-0.290912386992238,-0.8153522659525495,0.7028753993610224,0.8899716872903068,1.0,4/16,8.47%,TRMT9B;FTSJ1;METTL2B;METTL2A
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.32004104618951845,0.810733815513757,0.72,0.9309583624167883,1.0,3/26,8.60%,B3GNT9;CSGALNACT1;CHSY1
prerank,5'-3' exonuclease activity (GO:0008409),0.36066719509561984,0.8106718415987136,0.7057057057057057,0.928816094238526,1.0,2/14,6.69%,DXO;XRN2
prerank,E-box binding (GO:0070888),0.3093166272987398,0.8103438187184666,0.7276166456494325,0.9271160572132746,1.0,9/34,22.54%,MYC;ZEB1;PER1;GATA3;AHR;SREBF2;PPARG;MITF;SNAI1
prerank,SH2 domain binding (GO:0042169),0.31119604959992103,0.8098043019817871,0.7251908396946565,0.925643238440334,1.0,1/31,0.33%,DLC1
prerank,transition metal ion binding (GO:0046914),0.251198682858911,0.8088744849917735,0.9169169169169169,0.9248402466217251,1.0,77/397,20.04%,RAG2;GLI2;CSRP1;DHH;DPEP1;CBLB;PRKN;CUTA;EPRS1;KMT2A;SEC24D;PDXK;KDM5B;ITGB1BP2;PRNP;MT3;MBD1;GRIN2B;HHIP;LTA4H;ZEB1;AOC1;AGMO;LOXL3;TRIM2;GALNT1;RPH3A;CHD3;GTF2B;SCD5;TRHDE;SEC24C;PTPN1;LNPEP;MMP16;USP33;MYT1;RBAK;GPC1;SIRT6;PHF8;SOD2;ZFPM2;KPNB1;HPF1;EXD2;SNCA;MDM4;ADAM33;GRIN2A;TRAF7;BAZ1B;GALNT3;PAPPA2;ABL1;RCHY1;PAPOLA;BLM;TP53;TET3;RBSN;RC3H1;WRN;ADH5;SEC24A;PCK2;MDM2;KLF7;ZMYND11;SNCB;PARK7;TAB3;EGR1;PPARG;FAM20C;PRDM2;DUSP12
prerank,proton transmembrane transporter activity (GO:0015078),0.297690338401813,0.8067624250858348,0.7515527950310559,0.9258713128965695,1.0,8/39,18.80%,CLCN5;ATP6V1B2;UQCRQ;NDUFA4;COX10;DMAC2L;SLC9A1;CYB5A
prerank,carboxy-lyase activity (GO:0016831),-0.25432788256585126,-0.80571614635993,0.7660377358490567,0.9006478841701322,1.0,7/23,20.15%,ECHDC1;AZIN1;AMD1;DDC;ODC1;PPCDC;BCKDHA
prerank,motor activity (GO:0003774),0.2799221124422377,0.8027440954147315,0.759493670886076,0.9300042669870376,1.0,13/60,19.16%,DNAH2;KIF20B;KIF19;STARD9;KIF21A;DYNC1I1;KIF5C;GPR88;DYNC1I2;KIF22;KIF21B;KIF3A;KIF2A
prerank,hormone receptor binding (GO:0051427),0.3592990260789346,0.8016673570528576,0.7,0.9293945129716292,1.0,3/14,17.11%,PTHLH;TYK2;NPPC
prerank,adenyl ribonucleotide binding (GO:0032559),0.25195214392276294,0.8008873431660536,0.9048096192384769,0.9283476331237529,1.0,54/291,17.18%,WNK2;PYGL;PEAK1;STK36;ACSS2;ACVR1;MAP4K4;RHOBTB3;PDXK;IRAK3;WNK3;SIK2;RPS6KA4;MAST2;PDE4B;GSS;UBA2;KSR1;CDKL5;PDK3;SARS2;CDK6;TBCK;ACLY;TLK2;AKT3;LANCL2;SYN1;EIF4G1;MYO9B;PXK;HSPA4;PI4K2A;MSH6;DDX25;PDE4D;SRR;PNPLA8;P2RY1;HARS1;AK6;RTEL1;BMPR1A;ABCB9;ABL1;PAPOLA;BLM;OLA1;NDUFA13;HNRNPU;ABCD2;FICD;ABCF1;EIF2B2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.31364276306476513,0.799670402300695,0.7171314741035857,0.9278989307629865,1.0,11/27,26.14%,POLR2B;POLRMT;POLR1B;POLR2G;MED21;POLR1D;POLR1C;POLR2A;POLR3K;POLR2F;POLR3F
prerank,amino acid:sodium symporter activity (GO:0005283),0.36789548028629904,0.7995034384517163,0.7142857142857143,0.9259775505113903,1.0,1/11,1.03%,SLC1A3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.35797612011133295,0.7989309399497324,0.7261904761904762,0.9246343961167105,1.0,4/14,23.17%,DTYMK;AK5;AK8;CMPK1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.29358883643151945,-0.7973203859363237,0.7524752475247525,0.9080618385168099,1.0,3/13,9.59%,PLPP1;LPIN2;PLPP5
prerank,vinculin binding (GO:0017166),0.36642957179028945,0.7966858292591079,0.7194570135746606,0.9258044680186265,1.0,1/11,1.32%,UTRN
prerank,acylglycerol lipase activity (GO:0047372),-0.32096020753563764,-0.7954282662324998,0.7536656891495601,0.9048886551471951,1.0,5/11,25.44%,MGLL;ABHD2;ABHD12;FAAH;LIPE
prerank,diacylglycerol kinase activity (GO:0004143),0.3731544146558189,0.7941131416186634,0.7118110236220473,0.9275637442438737,1.0,7/11,28.52%,DGKI;AGK;DGKA;DGKK;DGKD;DGKZ;DGKQ
prerank,nuclear export signal receptor activity (GO:0005049),0.3759010712247136,0.7924867370320381,0.7361769352290679,0.9278655217286155,1.0,5/11,23.25%,XPO1;EIF4ENIF1;CSE1L;NUP42;XPO5
prerank,cholesterol transfer activity (GO:0120020),0.3418881245587728,0.7922590692198531,0.7387005649717514,0.926004099157495,1.0,4/16,13.09%,GRAMD1A;MTTP;GRAMD1C;GRAMD1B
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.24963381799532516,0.7914277850064909,0.8752556237218814,0.925061671419314,1.0,38/181,20.32%,MDFIC;NCOA1;PTPRT;TACC1;MTA2;BBS5;NCOA2;LDB2;HIF1A;PIAS2;HDAC2;ATF2;NFE2L2;MAPK14;SP1;NRIP1;ZFPM2;CRY1;NCOR2;DACT1;JUP;TAF4;TP53;TAF4B;MTA3;SMARCE1;NCOA3;DNAJA1;TACC2;TAF1;CPNE1;BCL10;PRRX1;PPARG;JUN;STAT3;SMARCA4;BBS7
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.37157017136129056,0.7897371705233704,0.7040498442367601,0.9253089443142509,1.0,5/11,20.91%,NUDT1;NUDT10;NUDT3;NUDT5;NUDT11
prerank,regulatory RNA binding (GO:0061980),-0.22310398235027767,-0.7892037114155298,0.8602150537634409,0.9088744697379011,1.0,15/38,30.18%,YBX1;AGO1;ZC3H7B;DDX21;ELAVL1;TUT7;AGO3;MATR3;TARBP2;HNRNPA1;ZC3H10;AGO2;DICER1;PIWIL2;AGO4
prerank,calcium:sodium antiporter activity (GO:0005432),-0.31631669682499763,-0.787393950477524,0.7127659574468085,0.9055754860687717,1.0,3/10,10.27%,SLC8A3;SLC8B1;SLC24A3
prerank,magnesium ion binding (GO:0000287),0.25325463569229834,0.7860993002959228,0.8572916666666667,0.9286125516835669,1.0,22/135,15.65%,IDH2;PSPH;PDXK;IRAK3;SIK2;MAST2;DXO;GSS;PGM1;UBA2;ENDOV;PI4K2A;MSH6;NUDT3;GNAI1;SRR;EXD2;SNCA;IDH3A;OPA1;ABL1;PAPOLA
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2553726330728837,0.7826025208696389,0.8580375782881002,0.9314743642619594,1.0,19/134,14.66%,SLC22A3;SLC1A3;SLC27A1;SLC25A2;SLC1A5;MPC1;SLC25A21;SLC36A2;SLCO2B1;SLC25A38;MPC2;SLC2A2;SLC35A1;SLC7A8;SLC25A23;SLC16A1;SLC35B3;SLC25A15;SLC25A25
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.35365852010454696,0.7820840525259822,0.7395209580838323,0.9301695587388643,1.0,1/12,2.07%,NQO1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.30230611097960225,0.781435449989215,0.7635402906208718,0.9289353692773153,1.0,10/28,27.32%,ELAC1;ENDOV;RPP38;PRORP;POP1;RPP21;DBR1;RPP30;DROSHA;RPP14
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.34675739079301726,0.7803538962151455,0.7445255474452555,0.9283928355620692,1.0,2/14,5.98%,PYCARD;APAF1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.34014455416323497,0.7795237985070075,0.7433234421364985,0.9273704896219244,1.0,3/15,10.37%,SOCS5;SOCS1;PIK3R1
prerank,ribosome binding (GO:0043022),0.2780409021704227,0.7772281065574531,0.7765700483091788,0.928502170319428,1.0,11/46,18.60%,ETF1;NAA16;EIF3C;CPEB3;EIF6;GTPBP6;CCDC47;CPEB1;NAA10;NAA15;RPSA
prerank,ferrous iron binding (GO:0008198),-0.25740488034164244,-0.7738556071732507,0.8014184397163121,0.9203958608599152,1.0,9/21,21.72%,PHYH;FTH1;EGLN2;FTL;CDO1;ALKBH3;FXN;EGLN3;DNAJC24
prerank,hexosyltransferase activity (GO:0016758),0.2547423958246847,0.7731655755804362,0.837108953613808,0.9320817588774427,1.0,21/101,20.63%,HAS2;TMTC2;GBA2;EXT1;ALG9;B3GNT9;CSGALNACT1;CHSY1;POMGNT2;ALG5;TMTC3;RFNG;ALG1;DPY19L2;HYAL1;MTAP;POGLUT2;CHSY3;DPY19L3;ALG6;B4GALT6
prerank,calcium channel regulator activity (GO:0005246),0.29207461150886377,0.7728961390704343,0.7896039603960396,0.9303212410234026,1.0,9/37,20.89%,CACNG7;NRXN1;SGK3;CALM1;CALM2;SGK1;STIMATE;NPY;STIM2
prerank,protein kinase regulator activity (GO:0019887),0.2545737083799185,0.7693355422760226,0.8331515812431843,0.933067966664266,1.0,8/95,5.68%,CXCL10;FGF13;CCNJ;CCNC;GPRC5B;MT3;PRKAR1B;SOCS1
prerank,U6 snRNA binding (GO:0017070),-0.28878775157880743,-0.7682080927886769,0.7784615384615384,0.9226283008582084,1.0,5/14,23.15%,PRPF4;LARP7;EIF5A;SART3;RBM22
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.3150615226499951,-0.763547439018061,0.7842565597667639,0.9233804324626044,1.0,2/10,9.84%,OTUD5;STAMBPL1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.3442366928125148,0.7628702274076509,0.7496159754224271,0.9399325144783107,1.0,2/12,10.37%,GAB2;PIK3R1
prerank,glutathione transferase activity (GO:0004364),-0.2539104389522286,-0.7626599274157069,0.8395061728395061,0.9185324557216628,1.0,5/23,13.58%,LANCL1;GSTA4;GSTM1;HPGDS;MGST1
prerank,GABA receptor activity (GO:0016917),-0.2513637826179025,-0.7585925099320434,0.7972508591065293,0.918299297569072,1.0,7/21,28.64%,GPR156;GABRG1;GABRA5;GABRB1;GABRE;GABRB2;GABBR2
prerank,water transmembrane transporter activity (GO:0005372),0.35269239394995017,0.7575196579811521,0.7441860465116279,0.944917357495645,1.0,1/11,5.26%,AQP4
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.3087765662552399,-0.7557893792570862,0.8065476190476191,0.916201974533217,1.0,4/10,12.95%,ECHDC1;ECHDC2;ECHDC3;ECI1
prerank,dynactin binding (GO:0034452),0.3493186718558404,0.7554462496105553,0.7747336377473364,0.9455329838857258,1.0,3/12,10.80%,BICD1;SNX6;BICD2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.35350806057103257,0.7531969215998132,0.7963246554364471,0.9464999176430473,1.0,2/11,8.52%,PPP1R14C;PPP1R8
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2827137003178322,0.7527905488765451,0.8036890645586298,0.9449467580138762,1.0,9/34,20.29%,SUV39H1;SETD3;MEN1;PRDM9;SETD2;SETD4;KMT2E;N6AMT1;SETDB1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.2788120390738096,0.7451856880853468,0.8043758043758044,0.9528931679556659,1.0,10/34,19.41%,CKS1B;CAB39L;ALS2;CDK5R1;CALM1;CDK5R2;IQGAP1;CALM2;DBF4;CAB39
prerank,death domain binding (GO:0070513),0.34963920971192575,0.740978383509973,0.7957317073170732,0.9562251499882463,1.0,3/11,17.21%,BCL2;CRADD;RIPK1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.24793891722216616,-0.7393528446526266,0.8669201520912547,0.9320900462819338,1.0,3/19,9.86%,ITPR1;RASA3;MCOLN1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3329770684311491,0.7385073585655055,0.7792998477929984,0.9572489900876358,1.0,1/14,1.03%,SLC1A3
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.25623416488075607,0.737588842381964,0.850967007963595,0.9562588820082485,1.0,7/60,8.41%,PTEN;DUSP4;LRRC40;PPP3CB;PPP3CA;PPM1B;PPM1J
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.33996610382273573,0.7368388178339059,0.794162826420891,0.9550551029451542,1.0,11/11,66.03%,HCN1;HCN2;KCNA10;CNGA1;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4;CNGB1
prerank,protein kinase activator activity (GO:0030295),0.2545199084164015,0.735726888322728,0.8441410693970421,0.9543362437201289,1.0,14/60,19.41%,ERBB3;FGF13;GPRC5B;MT3;CAB39L;ALS2;GRM5;CDK5R1;CALM1;IQGAP1;CALM2;RPTOR;DBF4;CAB39
prerank,amino acid binding (GO:0016597),-0.2182375608609822,-0.7348919968272254,0.9027777777777778,0.9315987954815789,1.0,11/31,24.12%,NOS3;AARS1;DDAH2;NOS1;ASS1;GCLC;GLRA2;GRIN3A;GRM7;AGXT;CASTOR1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.28411588720353276,0.7304127598734415,0.8142857142857143,0.95888207597113,1.0,6/32,12.16%,KDM8;KDM4B;P4HTM;ALKBH5;HSPBAP1;PHF8
prerank,Notch binding (GO:0005112),-0.24041400640377836,-0.7294315268148623,0.8838028169014085,0.9322960625898034,1.0,8/22,21.27%,SNW1;JAG1;JAG2;NOTCH4;KCTD10;DTX1;DNER;TCIM
prerank,retinoic acid receptor binding (GO:0042974),0.30571269763036335,0.7279206795857392,0.8083832335329342,0.9598754873335733,1.0,6/17,21.43%,TACC1;RARG;NRIP1;MED25;PPARG;NSD1
prerank,MAP kinase kinase activity (GO:0004708),0.31541550076222336,0.724931062663528,0.798581560283688,0.9615306177317691,1.0,3/15,11.13%,MAPKAPK3;MAPK14;MAP2K4
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.27060184205733695,-0.7243851501363625,0.8142857142857143,0.9321991950643181,1.0,8/13,35.03%,DNASE1L1;DNA2;DICER1;GEN1;ZGRF1;DNASE1L2;EXO1;FAN1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.32688146863598194,0.7236610900607985,0.7956318252730109,0.9609799075328321,1.0,6/12,23.43%,PAPOLA;TENT2;TENT5D;TENT5A;TENT5C;TUT1
prerank,DNA polymerase binding (GO:0070182),0.3057105629299501,0.7231194997731465,0.8055944055944056,0.9595005342443943,1.0,8/18,27.59%,RTEL1;POLG2;SMG6;FANCI;SMARCA4;ACD;NABP2;LONP1
prerank,phosphatase activator activity (GO:0019211),0.3251870393578423,0.7211263722931816,0.8071748878923767,0.9598397036370264,1.0,7/14,26.57%,PPP1R15A;CALM1;CALM2;BMP2;PPP2R5A;PPP2R5E;PPP2R5C
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.34193699186130044,0.7192620347765472,0.7987012987012987,0.9599587568839572,1.0,4/10,18.50%,CASP6;CASP12;CASP2;CASP7
prerank,mRNA methyltransferase activity (GO:0008174),0.33282400896218467,0.7184753201734199,0.7947598253275109,0.9587377967931946,1.0,4/12,20.17%,METTL3;RNMT;CMTR2;NSUN2
prerank,mannosyltransferase activity (GO:0000030),0.286303645070642,0.7160383661565641,0.8324324324324325,0.9595074275859267,1.0,8/21,19.09%,TMTC2;ALG9;TMTC3;ALG1;DPY19L2;ALG8;DPM1;DPY19L3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.25915843475481504,0.7147898624862223,0.8436317780580076,0.9589769621713223,1.0,2/38,8.22%,A2M;SERPINE2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.29229988157743514,0.7141758427710635,0.8064066852367688,0.9576945305925139,1.0,2/22,5.18%,DUSP4;DUSP6
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2174346689084055,-0.713753122433495,0.9033613445378151,0.9391189650889147,1.0,9/27,25.32%,DCUN1D3;RNF144B;DCUN1D1;AUP1;SIAH2;SIAH3;RNF125;ANKIB1;ZMYM2
prerank,P-type ion transporter activity (GO:0015662),0.3243964015190952,0.7137484859862019,0.8172362555720654,0.9561191805729977,1.0,2/12,12.92%,ATP2B3;ATP2B1
prerank,alpha-actinin binding (GO:0051393),-0.22660576135217986,-0.7132405875474744,0.889344262295082,0.9336604971142063,1.0,2/24,0.90%,CACNA1C;PDLIM5
prerank,thioesterase binding (GO:0031996),0.3311883533274924,0.7064633850877698,0.8151001540832049,0.9626973682948493,1.0,1/11,4.68%,TRAF4
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.28293747546847303,0.6961182999639464,0.8464730290456431,0.972236234350216,1.0,7/22,22.71%,ZRANB3;OTUD7B;ZBTB1;OTUD7A;TAB3;WDR81;TAB2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.28823272527805865,0.6938570325820634,0.8328611898016998,0.9726790476981395,1.0,3/18,10.37%,SOCS5;SOCS1;PIK3R1
prerank,peptidoglycan binding (GO:0042834),-0.2802418586092337,-0.6926167439848732,0.8622589531680441,0.949152379682788,1.0,6/10,41.58%,PGLYRP1;NOD1;NOD2;JCHAIN;NLRP3;TLR2
prerank,rRNA binding (GO:0019843),0.2547941813015899,0.6901013299943005,0.8797546012269939,0.9745973289920393,1.0,4/42,6.29%,TST;MRPS18A;NGRN;MRPL16
prerank,palmitoyltransferase activity (GO:0016409),-0.2091791456387545,-0.6898378328958877,0.9230769230769231,0.9458903201475519,1.0,6/28,15.14%,ZDHHC14;ZDHHC3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,carboxylic acid binding (GO:0031406),-0.1906107726456479,-0.6845151731400719,0.9651741293532339,0.9451800758380104,1.0,10/38,24.12%,NOS3;EPDR1;PHYH;SESN2;NOS1;GCLC;GLRA2;GRIN3A;GRM7;CASTOR1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.25333397650148537,0.6842317893405228,0.8740554156171285,0.9785828571664669,1.0,6/34,16.28%,USB1;XRN2;PNLDC1;EXOSC2;EXD2;PNPT1
prerank,ATP hydrolysis activity (GO:0140603),0.2495296844256581,0.6818842409407768,0.8888888888888888,0.9789174976979368,1.0,13/41,25.23%,KIF20B;RHOBTB3;CHD3;MYO19;ATP2B1;ABCG4;ABCD2;RUVBL2;DDX4;CHD1L;HSPA1A;MYO18A;SMCHD1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.25855665965083213,-0.6774335835514376,0.873015873015873,0.9457510845199926,1.0,5/12,24.32%,GABRG1;GABRA5;GABRB1;GABRE;GABRB2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.30346678216132267,0.6761964471393146,0.8554033485540334,0.9828257416372967,1.0,7/13,27.61%,GABRG2;GABRA3;GLRB;GABRA2;GABRG3;GABRA4;GLRA3
prerank,tRNA binding (GO:0000049),0.2427510840602158,0.6723398137096948,0.9054842473745625,0.9846126446812372,1.0,15/43,25.20%,TRMT10B;SARS2;FARS2;DALRD3;ELP5;XPOT;PUS1;SSB;PSTK;NSUN2;ALKBH8;ALKBH1;DARS2;PTCD1;CARS1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.23010104152804423,0.6713859683264247,0.9255918827508456,0.9834876409794437,1.0,10/70,18.14%,HAS2;EXT1;B3GNT9;CSGALNACT1;CHSY1;POMGNT2;RFNG;HYAL1;POGLUT2;CHSY3
prerank,pseudouridine synthase activity (GO:0009982),0.30034398089156145,0.6708995255314858,0.8448795180722891,0.981946107983932,1.0,3/13,15.71%,PUSL1;PUS7;PUS1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3212969996549401,0.6707906698311614,0.8517350157728707,0.9799758941081305,1.0,3/10,18.52%,NAA16;NAA10;NAA15
prerank,channel activity (GO:0015267),0.2466766384509841,0.667279134589173,0.8996235884567126,0.9812983991447243,1.0,2/41,5.26%,BCL2;AQP4
prerank,DNA-binding transcription factor binding (GO:0140297),0.21030592797113576,0.6668764562132501,0.9710743801652892,0.9796702046155304,1.0,32/189,20.32%,PRDM16;MYC;BCL2;CRTC1;TLE1;YWHAZ;MTA2;BBS5;LDB2;PIAS2;HDAC2;ATF2;NFE2L2;SP1;TAF9;ZFPM2;CREM;DACT1;TP53;MTA3;TLE3;CTBP1;TLE4;PSMD9;PARK7;TAF1;CGGBP1;PRRX1;PPARG;JUN;STAT3;BBS7
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.2560810619412213,0.6633579763742039,0.8950064020486556,0.981120058999431,1.0,2/29,3.13%,SLC1A5;SLC25A21
prerank,MHC class II protein complex binding (GO:0023026),0.3093750511170712,0.6601552464557153,0.8903903903903904,0.9820966907106811,1.0,3/11,18.22%,ANXA11;CD74;MS4A1
prerank,inward rectifier potassium channel activity (GO:0005242),0.26792290317421363,0.6600942958227385,0.884514435695538,0.9800965564199009,1.0,7/24,25.25%,KCNK1;KCNJ3;KCNJ10;KCNH2;KCNK6;KCNJ13;KCNN2
prerank,methyltransferase activity (GO:0008168),0.2398623532793633,0.6597082486690912,0.908433734939759,0.9784343665894875,1.0,11/46,20.17%,SUV39H1;COMT;METTL3;AS3MT;PRMT1;COQ5;LRTOMT;MEPCE;AMT;N6AMT1;NSUN2
prerank,kinesin binding (GO:0019894),0.2592631494789166,0.659621922548461,0.8855263157894737,0.9764793081251837,1.0,6/27,17.58%,ARHGEF10;AP1G1;SNCA;CLSTN1;SPAG9;AP1AR
prerank,actinin binding (GO:0042805),0.2749637776538692,0.6591842948314394,0.8930041152263375,0.9748045126862278,1.0,7/21,21.48%,CSRP1;PDLIM4;MAGI1;KCNA5;PPARG;NFKB1;PKD2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3141229507383707,0.6584403601773804,0.8721461187214612,0.9734497032169535,1.0,1/11,6.69%,AKR1B10
prerank,RNA cap binding (GO:0000339),-0.2290847229755747,-0.6572746900661203,0.9054878048780488,0.9571351089049873,1.0,4/16,21.09%,LSM1;NCBP3;EIF3D;EIF4E3
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3079308919385996,0.656533302931534,0.8721109399075501,0.9729818443783977,1.0,5/11,27.26%,NAA16;NAA10;NAA15;NAA40;NAA50
prerank,ligand-gated anion channel activity (GO:0099095),-0.21982435219016758,-0.6548736080622134,0.9240121580547113,0.9532238388357968,1.0,6/17,24.32%,GABRG1;GABRA5;GLRA2;GABRB1;GABRE;GABRB2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2521367179040952,0.6511676156699022,0.8998699609882965,0.9757594583328035,1.0,7/29,17.88%,GBA2;GALC;CTBS;GANC;MOGS;PGGHG;ABHD10
prerank,hormone activity (GO:0005179),0.2280452609275629,0.6478896290791046,0.9374262101534829,0.9766609906530144,1.0,2/54,3.66%,CRH;PTHLH
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2392708798224878,0.6462343445925456,0.9146039603960396,0.976123622851783,1.0,7/38,14.56%,SAV1;GAB2;PIK3R1;PTPN11;MAGI2;NCK1;SPAG9
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.23895385699876037,0.6451704277963238,0.9283018867924528,0.9750344325598727,1.0,6/33,16.28%,USB1;XRN2;PNLDC1;EXOSC2;EXD2;PNPT1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.23206703157679728,0.6389136776978878,0.9279711884753902,0.9782950173676649,1.0,7/46,14.03%,EXT1;B3GNT9;MGAT3;PIGP;POMGNT2;PIGA;RFNG
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.2718732655047231,0.6357466886574764,0.8858773181169758,0.979004181603084,1.0,3/16,16.03%,SLC1A5;SLC25A10;SLC25A11
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.2938676854121507,0.6347987700186638,0.9040880503144654,0.9778240062336762,1.0,1/12,6.45%,B3GNT9
prerank,nuclease activity (GO:0004518),0.22683372493931503,0.6335295096817102,0.9413875598086124,0.9769071065101834,1.0,8/52,17.24%,RNASE6;ERCC5;SETMAR;XRN2;REXO4;AEN;N4BP1;WRN
prerank,kinase inhibitor activity (GO:0019210),0.23667493163517592,0.6290789994090631,0.95,0.9784008190430904,1.0,5/33,13.99%,SOCS1;TAOK3;RHOH;SNCA;NCK1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.3005724192503288,0.6286341907899377,0.8737704918032787,0.9767790333669386,1.0,5/10,26.55%,GABRG2;GABRA3;GABRA2;GABRG3;GABRA4
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.19426501243106334,-0.6217633511553394,0.9636363636363636,0.9695909734636217,1.0,5/22,15.44%,ATP6V0C;ATP6V0D1;ATP6V0A4;ATP6V0A2;ATP2A3
prerank,cAMP binding (GO:0030552),0.28433025711524956,0.6150008598968282,0.9062027231467473,0.9848495718807652,1.0,4/11,21.63%,PDE4B;PDE4D;HCN1;PDE10A
prerank,death receptor activity (GO:0005035),0.2854137218976853,0.6117819374850463,0.9076923076923077,0.9853007374843651,1.0,2/11,10.58%,TNFRSF10B;NGFR
prerank,N-methyltransferase activity (GO:0008170),0.25217702877000764,0.6110833117271547,0.9295580110497238,0.9838461149191613,1.0,5/20,19.52%,SETD3;FDXACB1;PRMT1;RNMT;N6AMT1
prerank,protein kinase inhibitor activity (GO:0004860),0.22188467168706508,0.6086298444267557,0.9573400250941029,0.9836560575012496,1.0,8/42,18.44%,SOCS1;SPRED2;SPRED1;TAOK3;SNCA;NCK1;RPTOR;INKA1
prerank,signal sequence binding (GO:0005048),0.23147879191078752,0.6077691769765674,0.9503105590062112,0.9822366482754978,1.0,14/35,25.99%,TOMM20;KDELR2;KPNB1;KPNA6;KDELR3;KPNA1;POM121;CAT;IPO5;KPNA3;PEX5L;CEMIP;TNPO2;SEC61A2
prerank,mannose binding (GO:0005537),-0.238545054795661,-0.603947880308552,0.9265536723163842,0.9734926695817051,1.0,9/12,55.05%,CLN5;ACR;COLEC11;LMAN1L;CLEC4D;LMAN2L;LMAN2;CLEC6A;CD207
prerank,single-stranded RNA binding (GO:0003727),0.21678242856065558,0.6001377739427497,0.9431396786155748,0.9853389986898065,1.0,7/43,16.43%,DDX11;ADARB2;ENDOV;POLR2G;RBM7;PUS1;HNRNPU
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2366240995051564,0.5975334825141922,0.9458762886597938,0.9850891372404751,1.0,6/28,16.79%,MAPKAPK3;MAPK14;MAP2K4;PRKACA;RPS6KA2;SGK1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2377853780774037,0.5936475006844983,0.9344042838018741,0.9854227289828976,1.0,3/24,14.11%,DTYMK;AK5;AK3
prerank,GABA-A receptor activity (GO:0004890),-0.19975714014095575,-0.5907169203218241,0.956386292834891,0.9742646549002606,1.0,5/18,24.32%,GABRG1;GABRA5;GABRB1;GABRE;GABRB2
prerank,snoRNA binding (GO:0030515),0.22611905445582337,0.5844410292457247,0.9574193548387097,0.9888983926774079,1.0,4/30,8.61%,NUDT1;BMS1;UTP6;HEATR1
prerank,kinase activity (GO:0016301),0.19145213690416005,0.5806900436136172,0.9882854100106496,0.9890800528023646,1.0,21/109,19.80%,MAP4K4;PDXK;NEK1;PAPSS2;PI4KB;CDKL5;STK39;PKMYT1;DGKI;CDK5R1;RFK;ETNK1;SHPK;TRRAP;ABL1;PKN2;AGK;TAF1;BCKDK;PSTK;CERKL
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.24735974614918207,0.5655426543476244,0.9457142857142857,0.9927618966135856,1.0,7/16,27.65%,ATP6V1B2;ATP6V1C1;ATP6V0E2;ATP6V0E1;TCIRG1;ATP6V1D;ATP5F1B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.24735974614918207,0.5655426543476244,0.9457142857142857,0.9927618966135856,1.0,7/16,27.65%,ATP6V1B2;ATP6V1C1;ATP6V0E2;ATP6V0E1;TCIRG1;ATP6V1D;ATP5F1B
prerank,CARD domain binding (GO:0050700),0.2525358804547603,0.5643717517454576,0.9461426491994177,0.9913646995608689,1.0,6/14,25.61%,CARD9;BCL10;CARD11;CARD16;MAVS;CARD10
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.2589757069124283,0.5627020967548555,0.9440242057488654,0.9902055999965803,1.0,2/12,14.94%,NCBP1;CYFIP1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.19035950085139156,0.5595350455172697,0.9923076923076923,0.9897100956514414,1.0,25/74,27.86%,PDXK;PAPSS2;PI4KB;ADK;DGKI;RFK;ETNK1;SHPK;FGGY;GNE;GALK2;AGK;HK2;FAM20C;HYKK;HK1;NT5C3A;DGKA;FCSK;DGKK;PIK3CA;DGKD;GK;PIK3C3;DGKZ
prerank,muscle alpha-actinin binding (GO:0051371),0.24243084385001912,0.5521706795345191,0.9542203147353362,0.9908520704410458,1.0,3/15,14.46%,PDLIM4;PALLD;LDB3
prerank,NADPH binding (GO:0070402),0.24943561924046462,0.5488385622496255,0.9470499243570348,0.99027101854528,1.0,4/13,24.09%,MTRR;CBR3;DECR1;HMGCR
prerank,MHC class I protein binding (GO:0042288),-0.20202521396359296,-0.5459106166639559,0.972972972972973,0.985258699863038,1.0,2/13,17.92%,TAPBP;TUBB4B
prerank,histone methyltransferase binding (GO:1990226),0.24948554598532496,0.5318033008924326,0.9561815336463224,0.994951272079544,1.0,3/11,15.97%,LCOR;NOP56;LCORL
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.20156430733578407,0.5255704034745402,0.986318407960199,0.995102330627498,1.0,13/33,30.10%,PRKN;UBA2;TOLLIP;RNF19A;PARK7;SIAH1;PPARA;UBE3D;DCUN1D5;TCERG1;TRAF6;ARIH1;RNF217
prerank,nucleotide diphosphatase activity (GO:0004551),0.22734507225812883,0.5110825115231983,0.9566563467492261,0.9973801800506129,1.0,5/14,24.93%,NUDT10;NUDT3;NUDT6;NUDT11;FHIT
prerank,transferrin receptor binding (GO:1990459),0.24549265063221162,0.5076349200687247,0.9676898222940227,0.996425424404935,1.0,3/10,22.72%,SNX1;CHUK;SNX4
prerank,lipid phosphatase activity (GO:0042577),-0.18504379161710788,-0.5029993105792887,0.9897959183673469,0.990253560632399,1.0,1/14,2.38%,PLPP1
prerank,lysine N-methyltransferase activity (GO:0016278),0.19971298086939612,0.47978432563840584,0.9886363636363636,1.0,1.0,2/20,9.87%,SETD3;SETD2
prerank,snRNA binding (GO:0017069),0.16944246369587715,0.4659577820795722,0.9976047904191617,1.0,1.0,11/42,25.40%,RNPC3;SNRPB2;RBM7;MEPCE;SNRPA;HNRNPU;SF3B3;CDK9;TUT1;CCNT2;SNRPA1
prerank,single-stranded DNA helicase activity (GO:0017116),0.19313304894235306,0.46051502708659936,0.9942279942279942,1.0,1.0,3/19,19.85%,CHTF18;HELQ;WRNIP1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.2065215377689365,0.4445213788401215,0.9893778452200304,1.0,1.0,3/11,22.93%,NEIL1;HMCES;ALKBH1
prerank,titin binding (GO:0031432),0.19330662406322663,0.4272573808198581,0.9969879518072289,1.0,1.0,3/13,22.65%,CALM1;CALM2;CAMK2D
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.1861662063771028,0.3901325862346614,0.9952380952380953,1.0,1.0,10/10,81.40%,EXD2;MGME1;DCLRE1A;TATDN1;FEN1;APEX1;EXO1;POLD1;DCLRE1C;DCLRE1B
prerank,MHC protein binding (GO:0042287),0.15914217954699728,0.38888434878451855,0.9986072423398329,0.9985977283583063,1.0,3/20,20.95%,ABCB9;CD74;TAP1
